[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 9068
1. Roure S, Valerio L, Pérez-Quílez O, Fernández-Rivas G, Martínez-Cuevas O, Alcántara-Román A, Viasus D, Pedro-Botet ML, Sabrià M, Clotet B: Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a non-endemic country (North Metropolitan area of Barcelona, 2002-2016). PLoS One; 2017;12(9):e0185245
Genetic Alliance. consumer health - Schistosomiasis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Epidemiological, clinical, diagnostic and economic features of an immigrant population of chronic schistosomiasis sufferers with long-term residence in a non-endemic country (North Metropolitan area of Barcelona, 2002-2016).
  • Direct microbiological diagnosis was more useful in patients with less than 5 years of residence in the EU (p = 0.05).
  • CONCLUSION: Morbidity associated with chronic long-term schistosomiasis is frequent among African immigrants in non-endemic countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Negl Trop Dis. 2015 Jul 31;9(7):e0003963 [26230990.001]
  • [Cites] J Urol. 1997 Apr;157(4):1232-5; discussion 1235-6 [9120909.001]
  • [Cites] J Trop Med. 2016;2016:5405207 [27635146.001]
  • [Cites] Eur J Public Health. 2014 Aug;24 Suppl 1:47-56 [25107998.001]
  • [Cites] PLoS Negl Trop Dis. 2013 Jul 25;7(7):e2268 [23936559.001]
  • [Cites] Sante. 2010 Oct-Dec;20(4):201-8 [21320812.001]
  • [Cites] Bull Soc Pathol Exot. 2006 May;99(2):110-2 [16821442.001]
  • [Cites] BMJ. 2011 May 17;342:d2651 [21586478.001]
  • [Cites] PLoS Negl Trop Dis. 2015 May 14;9(5):e0003752 [25973845.001]
  • [Cites] Int J Mol Sci. 2015 Jul 16;16(7):16085-103 [26193254.001]
  • [Cites] BJU Int. 2001 Dec;88(9):915-20 [11851613.001]
  • [Cites] Euro Surveill. 2015 Jun 11;20(23):null [26084315.001]
  • [Cites] Lancet. 2006 Sep 23;368(9541):1106-18 [16997665.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2015 Mar;109(3):214-20 [25575554.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2014 Mar;108(3):159-64 [24535152.001]
  • [Cites] Lancet Infect Dis. 2016 Aug;16(8):971-9 [27197551.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2002 Mar;21(3):219-23 [11957026.001]
  • [Cites] Clin Med (Lond). 2015 Feb;15(1):67-9 [25650202.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2000 Sep-Oct;94(5):531-4 [11132383.001]
  • [Cites] Lancet. 2014 Jun 28;383(9936):2253-64 [24698483.001]
  • [Cites] Infect Agent Cancer. 2013 May 24;8(1):19 [23705833.001]
  • [Cites] Res Rep Trop Med. 2014 Oct 17;2014(5):65-75 [25400499.001]
  • [Cites] Clin Vaccine Immunol. 2012 Jun;19(6):948-53 [22441394.001]
  • [Cites] Ghana Med J. 2011 Mar;45(1):16-21 [21572820.001]
  • [Cites] J Pediatr Urol. 2014 Feb;10(1):88-93 [23891456.001]
  • [Cites] Rev Med Interne. 2006 Aug;27(8):595-9 [16822596.001]
  • [Cites] Enferm Infecc Microbiol Clin. 2013 Apr;31(4):205-9 [22683176.001]
  • [Cites] Clin Microbiol Infect. 2015 Jun;21(6):529-42 [25843503.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jul 28;9(7):e0003959 [26217948.001]
  • [Cites] Trop Med Int Health. 2008 Dec;13(12):1509-17 [19055625.001]
  • [Cites] Transplantation. 1987 Dec;44(6):795-8 [2962342.001]
  • (PMID = 28953954.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


2. Alirol E, Kuesel AC, Guraiib MM, de la Fuente-Núñez V, Saxena A, Gomes MF: Ethics review of studies during public health emergencies - the experience of the WHO ethics review committee during the Ebola virus disease epidemic. BMC Med Ethics; 2017 Jun 26;18(1):43

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • (1) internally consistent and complete submissions with information documents in language participants are likely to understand, (2) close collaboration between local and international researchers from research inception, (3) generation of template agreements for data and sample sharing and use during the ongoing global consultations on bio-banks, (4) formation of Joint Scientific Advisory and Data Safety Review Committees for all studies linked to a particular intervention or group of interventions, (5) formation of a Joint Ethics Review Committee with representatives of the Ethics Committees of all institutions and countries involved to strengthen reviews through the different perspectives provided without the 'opportunity costs' for time to final approval of multiple, independent reviews, (6) direct information exchange between the chairs of advisory, safety review and ethics committees, (7) more Ethics Committee support for investigators than is standard and (8) a global consultation on criteria for inclusion of pregnant women and children in interventional studies for conditions which put them at particularly high risk of mortality or other irreversible adverse outcomes under standard-of-care.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] BMC Med Ethics. 2017 Jul 12;18(1):45 [28701168.001]
  • [Cites] Obstet Gynecol. 2013 Nov;122(5):1077-81 [24104789.001]
  • [Cites] J Infect Dis. 1999 Feb;179 Suppl 1:S11-2 [9988157.001]
  • [Cites] PLoS Pathog. 2008 Nov;4(11):e1000225 [19043556.001]
  • [Cites] PLoS One. 2015 Nov 11;10(11):e0140810 [26559945.001]
  • [Cites] J Med Ethics. 2016 Jan;42(1):50-3 [26463620.001]
  • [Cites] Trop Doct. 2002 Jan;32(1):10-5 [11991014.001]
  • [Cites] N Engl J Med. 2015 Oct 14;:null [26465681.001]
  • [Cites] Vaccine. 2007 Apr 12;25(15):2852-7 [17141380.001]
  • [Cites] J Virol. 2011 May;85(9):4222-33 [21325402.001]
  • [Cites] J Infect Dis. 1999 Feb;179 Suppl 1:S1-7 [9988155.001]
  • [Cites] J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):433-5 [21937922.001]
  • [Cites] Antiviral Res. 2008 Apr;78(1):150-61 [18336927.001]
  • [Cites] N Engl J Med. 2015 Feb 5;372(6):587-8 [25539447.001]
  • [Cites] Science. 2014 Aug 15;345(6198):718-9 [25124404.001]
  • [Cites] Med J Aust. 2003 Aug 18;179(4):195-8 [12914509.001]
  • [Cites] Public Health Ethics. 2017 Apr;10 (1):49-61 [28567113.001]
  • [Cites] Lancet. 2014 Nov 8;384(9955):1667 [25441188.001]
  • [Cites] Clin Trials. 2016 Feb;13(1):73-8 [26768557.001]
  • [Cites] Arch Neurol. 2004 May;61(5):673-8 [15148143.001]
  • [Cites] Lancet. 2017 Feb 4;389(10068):505-518 [28017403.001]
  • [Cites] N Engl J Med. 2014 Oct 16;371(16):1481-95 [25244186.001]
  • [Cites] JAMA. 2015 Jan 27;313(4):421 [25626045.001]
  • [Cites] Lancet. 2014 Nov 22;384(9957):1896-9 [25155413.001]
  • [Cites] Am J Public Health. 2016 Mar;106(3):432-5 [26794172.001]
  • [Cites] Nat Med. 2005 Jul;11(7):786-90 [15937495.001]
  • [Cites] J Infect Dis. 1999 Feb;179 Suppl 1:S76-86 [9988168.001]
  • [Cites] PLoS One. 2009;4(5):e5547 [19440245.001]
  • [Cites] Lancet. 2014 Oct 18;384(9952):1423-4 [25390318.001]
  • [Cites] N Engl J Med. 2015 Jan 1;372(1):40-7 [25372658.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2001 Feb 9;50(5):73-7 [11686289.001]
  • [Cites] BMJ. 2014 Aug 06;349:g4997 [25098954.001]
  • [Cites] Lancet Infect Dis. 2015 Oct;15(10):1156-66 [26248510.001]
  • [Cites] J Infect Dis. 1999 Feb;179 Suppl 1:S259-62 [9988192.001]
  • [Cites] Clin Vaccine Immunol. 2006 Nov;13(11):1267-77 [16988008.001]
  • [Cites] Virology. 2006 Mar 15;346(2):394-401 [16356525.001]
  • [Cites] Lancet Infect Dis. 2015 Jun;15(6):738-45 [25881871.001]
  • [Cites] J Virol. 2009 Jul;83(14):7296-304 [19386702.001]
  • [Cites] N Engl J Med. 2015 Mar 26;372(13):1274-7 [25806936.001]
  • [Cites] J Infect Dis. 1999 Feb;179 Suppl 1:S18-23 [9988160.001]
  • [Cites] BMJ. 2014 Dec 10;349:g7518 [25498325.001]
  • [Cites] JAMA. 2015 Jan 27;313(4):421-2 [25626046.001]
  • [Cites] N Engl J Med. 2014 Sep 25;371(13):1180-3 [25140855.001]
  • [Cites] BMJ. 2000 Jan 8;320(7227):79-82 [10625257.001]
  • [Cites] Bull World Health Organ. 1978;56(2):271-93 [307456.001]
  • [Cites] Obstet Med. 2015 Sep;8(3):108-113 [26457118.001]
  • [Cites] BMC Infect Dis. 2011 Dec 28;11:357 [22204600.001]
  • [Cites] Obstet Gynecol. 2015 Jun;125(6):1293-8 [26000499.001]
  • [Cites] JAMA. 2014 Oct 1;312(13):1299-300 [25211645.001]
  • [Cites] Indian J Med Ethics. 2016 Apr-Jun;1(2):76-82 [26826351.001]
  • [Cites] N Engl J Med. 2016 Apr 28;374(17):1647-60 [25830326.001]
  • (PMID = 28651650.001).
  • [ISSN] 1472-6939
  • [Journal-full-title] BMC medical ethics
  • [ISO-abbreviation] BMC Med Ethics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Children / Clinical research / Drugs / Ebola / Observational studies / Pregnancy / Research ethics / Vaccines / WHO ethics review committee
  •  go-up   go-down


3. Jayasekara H, De Silva A, Amarasinghe A: Costing of immunization service provision in Kalutara district, Sri Lanka: a cross-sectional study. WHO South East Asia J Public Health; 2016 Sep;5(2):149-154

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With the rising cost of the National Immunization Programme (NIP) in Sri Lanka, immunization costing studies could help programme managers to ensure sustainable immunization financing in the country.
  • Cost estimates were made for direct capital and recurrent costs.
  • The majority of these costs were direct recurrent costs (93.4%).
  • Vaccines (84.3%) and staff salaries (6.4%) were the main components of direct recurrent costs, while cold-chain equipment (5.3%) was the main contributor to direct capital cost.
  • Studies exploring the costing of the NIP in the country would be beneficial, to ensure sustainable immunization financing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28607243.001).
  • [ISSN] 2304-5272
  • [Journal-full-title] WHO South-East Asia journal of public health
  • [ISO-abbreviation] WHO South East Asia J Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  •  go-up   go-down


Advertisement
4. Cabibbe AM, Cirillo DM: Best approaches to drug-resistance surveillance at the country level. Int J Mycobacteriol; 2016 Dec;5 Suppl 1:S40-S41

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Best approaches to drug-resistance surveillance at the country level.
  • : In 2014, the World Health Organization (WHO) recommendation to include the endorsed rapid molecular technologies (Xpert MTB/RIF, line probe assays) into surveillance systems and surveys allowed the testing of more tuberculosis (TB) patients for drug resistance at country level than ever before.
  • These features make WGS, moreso than the conventional molecular tools, an ideal tool to monitor transmission and drug resistance trends in countries, providing deep and wide information in a standardized way.
  • Classical sequencing and NGS approaches have been successfully used in a recent study conducted in five countries with high burden of TB and multidrug resistant tuberculosis (MDR-TB) and aimed at investigating levels of resistance to pyrazinamide among patients with TB by pncA sequencing [doi: 10.1016/S1473-3099(16)30190-6].
  • This work innovatively demonstrated that the establishment of strong links between national (peripheral and reference laboratories) and supranational laboratories, with the former possibly processing indirect or direct samples and generating sequencing data, and the latter supporting them for bioinformatics analysis and data interpretation, will soon make WGS and targeted NGS the preferred tools to conduct public health surveillances in TB field, thus helping the strategies adopted by TB control programs at local and national levels.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016.
  • (PMID = 28043601.001).
  • [ISSN] 2212-554X
  • [Journal-full-title] International journal of mycobacteriology
  • [ISO-abbreviation] Int J Mycobacteriol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Drug-resistance tuberculosis / Molecular tests / Mycobacterium tuberculosis / Surveillance / Whole genome sequencing
  •  go-up   go-down


5. Balog A, Hartel T, Loxdale HD, Wilson K: Differences in the progress of the biopesticide revolution between the EU and other major crop-growing regions. Pest Manag Sci; 2017 Nov;73(11):2203-2208

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The relatively low level of biopesticide research in the EU (6880 ISI papers) versus the United States (18 839), India (9501) and China (7875) relates to the greater complexity of EU-based biopesticide regulations compared with these other countries.
  • Compared with the other aforementioned countries, far fewer biopesticide products are available in the EU market, mainly as a direct result of the severe regulatory factors present there.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Society of Chemical Industry.
  • (PMID = 28470963.001).
  • [ISSN] 1526-4998
  • [Journal-full-title] Pest management science
  • [ISO-abbreviation] Pest Manag. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; biopesticide research / environmental laws / environmentally friendly agriculture / pesticide laws / political decisions
  •  go-up   go-down


6. Ilboudo PG, Huang XX, Ngwira B, Mwanyungwe A, Mogasale V, Mengel MA, Cavailler P, Gessner BD, Le Gargasson JB: Cost-of-illness of cholera to households and health facilities in rural Malawi. PLoS One; 2017;12(9):e0185041
MedlinePlus Health Information. consumer health - Rural Health Concerns.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cholera remains an important public health problem in many low- and middle-income countries.
  • Data collected for the assessment in households included direct and indirect costs borne by cholera patients and their families while only direct costs were considered for the assessment conducted in health facilities.
  • Moreover, 52% of households used coping strategies to compensate for direct and indirect costs imposed by the disease.
  • These findings have direct policy implications regarding priority investments for the prevention and control of cholera.

  • Genetic Alliance. consumer health - Cholera.
  • MedlinePlus Health Information. consumer health - Cholera.
  • MedlinePlus Health Information. consumer health - Health Facilities.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Vaccine. 2006 May 29;24(22):4890-5 [16298025.001]
  • [Cites] Value Health. 2009 Sep;12(6):899-908 [19824189.001]
  • [Cites] BMC Infect Dis. 2013 Nov 04;13:518 [24188717.001]
  • [Cites] J Health Popul Nutr. 2003 Dec;21(4):304-8 [15043004.001]
  • [Cites] Health Econ. 2008 Dec;17(12):1393-412 [18246595.001]
  • [Cites] BMC Int Health Hum Rights. 2009 Apr 30;9:8 [19405948.001]
  • [Cites] J Health Popul Nutr. 2006 Mar;24(1):1-5 [16796143.001]
  • [Cites] J Infect Dis. 2013 Nov 1;208 Suppl 1:S8-14 [24101650.001]
  • [Cites] Bull World Health Organ. 2012 Mar 1;90(3):209-218A [22461716.001]
  • [Cites] PLoS Med. 2007 Nov 27;4(11):e336 [18044983.001]
  • [Cites] Curr Top Microbiol Immunol. 2014;379:231-58 [24402712.001]
  • [Cites] PLoS Negl Trop Dis. 2016 Dec 8;10 (12 ):e0005124 [27930668.001]
  • [Cites] Emerg Infect Dis. 2016 Mar;22(3):410-6 [26886511.001]
  • [Cites] Malawi Med J. 2012 Jun;24(2):29-33 [23638267.001]
  • [Cites] PLoS Negl Trop Dis. 2008 Feb 20;2(2):e173 [18299707.001]
  • [Cites] J Infect Dis. 2013 Nov 1;208 Suppl 1:S107-14 [24101638.001]
  • [Cites] PLoS One. 2013 Dec 03;8(12):e81231 [24312540.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Sep 09;9(9):e0004072 [26352143.001]
  • [Cites] PLoS Med. 2013;10(9):e1001512 [24058301.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 04;9(6):e0003832 [26043000.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(10):e1844 [23056660.001]
  • [Cites] Clin Mol Hepatol. 2014 Dec;20(4):327-37 [25548737.001]
  • [Cites] Epidemiol Infect. 2012 Mar;140(3):500-9 [21554781.001]
  • [Cites] Bull World Health Organ. 2016 Sep 1;94(9):667-674 [27708472.001]
  • [Cites] Health Policy Plan. 2004 Mar;19(2):127-35 [14982891.001]
  • [Cites] N Engl J Med. 2013 Feb 14;368(7):599-609 [23301694.001]
  • (PMID = 28934285.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


7. Dore GJ, Hatzakis A, Negro F, Waked I: Estimating HCV disease burden-volume 4 (editorial). J Viral Hepat; 2017 Oct;24 Suppl 2:4-7

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The advent of interferon-free, direct acting antiviral-based (DAA) therapies, with short duration (8-12 weeks), high efficacy, excellent tolerability and ease of delivery (once daily oral dosing), is one of the major advances in clinical medicine in recent decades, and provides the opportunity to address this growing global HCV burden.
  • In May 2014, January 2015 and December 2015, three supplements were published in the Journal of Viral Hepatitis presenting data from 47 countries on the historical epidemiology of HCV, the current HCV-related morbidity and mortality and potential strategies to manage the HCV disease burden in the future.
  • The countries included in those manuscripts were from multiple regions including North and South America, Europe, Asia, the Middle East, Africa and Oceania.
  • In this supplement, data from an additional 17 countries are presented, following a similar pattern as in the previous manuscripts.
  • These countries represent a mixture of high-, middle- and low-income countries that hail from five geographical regions: Africa, Asia, Europe, Middle East and South America.
  • Expert advisory panels were convened in each country to identify the best data sources to use and to review the assumptions and outputs from the model.
  • In the countries considered in the current analyses, there is a wide variance in the availability of robust data.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 John Wiley & Sons Ltd.
  • (PMID = 29105284.001).
  • [ISSN] 1365-2893
  • [Journal-full-title] Journal of viral hepatitis
  • [ISO-abbreviation] J. Viral Hepat.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; diagnosis / disease burden / epidemiology / hepatitis C / hepatitis C virus / prevalence / strategy / sustained viral response / therapies / total infections / treatment
  •  go-up   go-down


8. Morgan JR, Servidone M, Easterbrook P, Linas BP: Economic evaluation of HCV testing approaches in low and middle income countries. BMC Infect Dis; 2017 Nov 01;17(Suppl 1):697

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Economic evaluation of HCV testing approaches in low and middle income countries.
  • The advent of highly effective direct acting antiviral (DAA) therapy, which is becoming available at increasingly lower costs in low and middle income countries (LMICs), represents a major opportunity to expand access to testing and treatment.
  • Overall, the guidelines recommended focused testing in high risk-groups, particularly PWID, prisoners, and men who have sex with men; with consideration of two other approaches:- birth cohort testing in those countries with epidemiological evidence of a significant birth cohort effect; and routine access to testing across the general population in those countries with a high HCV seroprevalence above 2% - 5% in the general population.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29143681.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Cost effectiveness / Economic evaluation / Hepatitis C / Screening / Testing / WHO
  •  go-up   go-down


9. Tarp J, Bugge A, Andersen LB, Sardinha LB, Ekelund U, Brage S, Møller NC: Does adiposity mediate the relationship between physical activity and biological risk factors in youth?: a cross-sectional study from the International Children's Accelerometry Database (ICAD). Int J Obes (Lond); 2017 Oct 03;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND/OBJECTIVES: To model the association between accumulating 60 daily minutes of moderate-to-vigorous physical activity and a composite score of biological risk factors into a direct and an indirect effect, using abdominal obesity as the mediator.
  • SUBJECTS/METHODS: Cross-sectional data from the International Children's Accelerometry Database (ICAD) including 6-18-year-old children and adolescents (N=3412) from 4 countries providing at least 3 days of accelerometry-assessed physical activity.
  • Modelling the associations suggested that 0.24 standard deviations (95% CI: -0.32, -0.16) was attributed to the direct effect and -0.07 (95% CI: -0.11, -0.02) to the indirect effect indicating that 22% of the total effect was mediated by central adiposity.
  • Modelling 30 and 90 min of moderate-to-vigorous physical activity per day resulted in changes in the direct but not the indirect effect.
  • The majority of the difference was explained by the direct effect of physical activity.International Journal of Obesity advance online publication, 31 October 2017; doi:10.1038/ijo.2017.241.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29087387.001).
  • [ISSN] 1476-5497
  • [Journal-full-title] International journal of obesity (2005)
  • [ISO-abbreviation] Int J Obes (Lond)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


10. Glatz T, Höppner J: Is There a Rationale for Structural Quality Assurance in Esophageal Surgery? Visc Med; 2017 May;33(2):135-139
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, recent database analyses reveal that the perioperative mortality of esophagectomy remains high in these countries, indicating a discrepancy between surgical quality in baseline hospitals and specialized centers.
  • Usually, direct outcome measures do not provide enough statistical power to actually identify differences in surgical quality between hospitals, making structural quality measures the only feasible parameter to compare the quality of e- sophageal surgery among different centers.
  • Several analyses from different countries have shown a strong correlation between hospital volume and postoperative mortality.
  • Data from countries in which esophageal surgery has been centralized indicate beneficial effects of a centralized health care system on postoperative mortality after esophagectomy.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dis Esophagus. 2015 Jul;28(5):468-75 [24697876.001]
  • [Cites] Gesundheitswesen. 2016 Apr 6;:null [27050140.001]
  • [Cites] J Surg Oncol. 2014 Oct;110(5):599-610 [25146593.001]
  • [Cites] Dtsch Arztebl Int. 2014 Aug 18;111(33-34):556-63 [25220065.001]
  • [Cites] Langenbecks Arch Surg. 2017 Mar;402(2):323-331 [28083680.001]
  • [Cites] J Surg Oncol. 2014 Mar;109(3):287-93 [24277235.001]
  • [Cites] Ann Surg. 2015 Jul;262(1):79-85 [24979602.001]
  • [Cites] Ann Surg Oncol. 2009 Jul;16(7):1789-98 [19370377.001]
  • [Cites] Eur J Surg Oncol. 2010 Nov;36(11):1035-43 [20846818.001]
  • [Cites] Lancet Oncol. 2015 Sep;16(9):1090-8 [26254683.001]
  • [Cites] Dis Esophagus. 2017 Jan 1;30(1):1-6 [26727414.001]
  • [Cites] J Clin Oncol. 2009 Oct 1;27(28):4671-8 [19720926.001]
  • [Cites] Ann Surg. 2016 Oct 17;:null [27759620.001]
  • [Cites] Surg Endosc. 2017 Jun;31(6):2491-2497 [27660245.001]
  • [Cites] Dis Esophagus. 2004;17(4):310-4 [15569369.001]
  • [Cites] CA Cancer J Clin. 2009 May-Jun;59(3):192-211 [19414631.001]
  • [Cites] Ann Surg. 2014 Aug;260(2):244-51 [24368634.001]
  • [Cites] Ann Surg Oncol. 2015 Aug;22(8):2615-23 [25605511.001]
  • [Cites] Ann Surg. 2012 Jul;256(1):95-103 [22668811.001]
  • [Cites] Eur J Surg Oncol. 2015 Oct;41(10):1300-7 [26253194.001]
  • [Cites] Dig Surg. 2012;29(5):374-83 [23128369.001]
  • [Cites] J Am Coll Surg. 2004 Apr;198(4):626-32 [15051016.001]
  • [Cites] Z Evid Fortbild Qual Gesundhwes. 2014;108(8-9):487-94 [25523847.001]
  • [Cites] Br J Surg. 2013 Jan;100(1):83-94 [23180474.001]
  • [Cites] J Gastrointest Surg. 2012 May;16(5):1055-63 [22089950.001]
  • [Cites] Updates Surg. 2016 Jun;68(2):129-33 [27240756.001]
  • [Cites] Updates Surg. 2013 Dec;65(4):271-5 [23943409.001]
  • [Cites] Ann Surg. 2016 Nov;264(5):823-830 [27429033.001]
  • [Cites] Ann Surg Oncol. 2014 Dec;21(13):4068-74 [25005073.001]
  • [Cites] J Surg Oncol. 2009 Jun 15;99(8):481-7 [19466737.001]
  • [Cites] J Clin Oncol. 2011 May 1;29(13):1715-21 [21444866.001]
  • [Cites] N Engl J Med. 2012 May 31;366(22):2074-84 [22646630.001]
  • [Cites] Semin Thorac Cardiovasc Surg. 2014 Winter;26(4):287-94 [25837540.001]
  • [Cites] Ann Surg Oncol. 2010 Nov;17(11):2824-31 [20559740.001]
  • [Cites] Chirurg. 2007 Nov;78(11):1028-36 [17928975.001]
  • [Cites] Ann Surg. 2016 Dec;264(6):1082-1090 [26978570.001]
  • [Cites] Dig Dis Sci. 2015 Dec;60(12):3536-44 [26177703.001]
  • [Cites] N Engl J Med. 2006 Jul 6;355(1):11-20 [16822992.001]
  • [Cites] J Gastrointest Surg. 2013 Jul;17(7):1193-201 [23636882.001]
  • (PMID = 28560229.001).
  • [ISSN] 2297-4725
  • [Journal-full-title] Visceral medicine
  • [ISO-abbreviation] Visc Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Esophageal cancer / Esophagectomy / Hospital volume / Structural quality
  •  go-up   go-down


11. Pichon-Riviere A, Bardach A, Augustovski F, Alcaraz A, Reynales-Shigematsu LM, Pinto MT, Castillo-Riquelme M, Torres EP, Osorio DI, Huayanay L, Munarriz CL, de Miera-Juárez BS, Gallegos-Rivero V, Puente C, Navia-Bueno MD, Caporale J: [Financial impact of smoking on health systems in Latin America: A study of seven countries and extrapolation to the regional level]. Rev Panam Salud Publica; 2016 Oct;40(4):213-221

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Financial impact of smoking on health systems in Latin America: A study of seven countries and extrapolation to the regional level].
  • Objective: Estimate smoking-attributable direct medical costs in Latin American health systems.
  • The model was calibrated and validated for Argentina, Bolivia, Brazil, Chile, Colombia, Mexico, and Peru, countries that account for 78% of Latin America's population; the results were then extrapolated to the regional level.
  • Results: Every year, smoking is responsible for 33 576 billion dollars in direct costs to health systems.
  • The region's countries should seriously consider stronger measures, such as an increase in tobacco taxes.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28001196.001).
  • [ISSN] 1680-5348
  • [Journal-full-title] Revista panamericana de salud publica = Pan American journal of public health
  • [ISO-abbreviation] Rev. Panam. Salud Publica
  • [Language] spa
  • [Publication-type] Journal Article; English Abstract
  • [Publication-country] United States
  •  go-up   go-down


12. Stickel F, Datz C, Hampe J, Bataller R: Pathophysiology and Management of Alcoholic Liver Disease: Update 2016. Gut Liver; 2017 Mar 15;11(2):173-188
Genetic Alliance. consumer health - Liver Disease.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While alcohol consumption is slightly decreasing in several European countries, it is rising in others and remains high in many countries around the world.
  • The pathophysiology of ALD is still incompletely understood but relates largely to the direct toxic effects of alcohol and its main intermediate, acetaldehyde.
  • Still, many countries are restrictive in allocating donor livers for ALD patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Hepatol. 2002 Jan;36(1):47-52 [11804663.001]
  • [Cites] Hepatology. 2012 Jun;55(6):1931-41 [22278680.001]
  • [Cites] Hepatology. 2010 Jan;51(1):307-28 [20034030.001]
  • [Cites] Scand J Gastroenterol. 2013 May;48(5):585-91 [23506154.001]
  • [Cites] Transplantation. 2013 Mar 15;95(5):755-60 [23370710.001]
  • [Cites] World J Gastroenterol. 2010 Feb 28;16(8):966-72 [20180235.001]
  • [Cites] Nat Rev Genet. 2015 May;16(5):299-311 [25854182.001]
  • [Cites] Semin Liver Dis. 2015 Nov;35(4):361-74 [26676812.001]
  • [Cites] Clin Nutr. 2006 Apr;25(2):285-94 [16707194.001]
  • [Cites] Hepatology. 1983 Sep-Oct;3(5):701-6 [6618437.001]
  • [Cites] Adv Clin Chem. 2013;59:155-201 [23461136.001]
  • [Cites] J Affect Disord. 2015 Oct 1;185:47-59 [26143404.001]
  • [Cites] Gut. 2015 Dec;64(12):1949-60 [25731872.001]
  • [Cites] Hepatology. 2005 Aug;42(2):343-52 [16025520.001]
  • [Cites] Alcohol Clin Exp Res. 2003 Nov;27(11):1765-72 [14634492.001]
  • [Cites] J Hepatol. 2011 Apr;54(4):760-4 [21126790.001]
  • [Cites] Gastroenterology. 2014 May;146(5):1231-9.e1-6 [24440674.001]
  • [Cites] Hepatology. 2009 Feb;49(2):646-57 [19177575.001]
  • [Cites] Am J Gastroenterol. 2008 Nov;103(11):2747-56 [18721242.001]
  • [Cites] Addict Behav. 2012 Apr;37(4):561-4 [22244707.001]
  • [Cites] J Clin Gastroenterol. 2013 Sep;47(8):727-33 [23751845.001]
  • [Cites] Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13 [16206505.001]
  • [Cites] N Engl J Med. 2015 Apr 23;372(17):1619-28 [25901427.001]
  • [Cites] J Hepatol. 2017 Jan;66(1):195-211 [27575312.001]
  • [Cites] Hepatology. 2002 Mar;35(3):635-8 [11870378.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002235 [16625556.001]
  • [Cites] Cochrane Database Syst Rev. 2005 Apr 18;(2):CD002148 [15846629.001]
  • [Cites] J Hepatol. 2004 Jan;40(1):60-8 [14672615.001]
  • [Cites] BMC Med. 2014 Sep 18;12 :145 [25242656.001]
  • [Cites] Eur Neuropsychopharmacol. 2013 Feb;23(2):89-97 [22920734.001]
  • [Cites] Lancet. 1984 Aug 4;2(8397):241-4 [6146805.001]
  • [Cites] Mol Med. 2011;17 (11-12):1285-94 [21863215.001]
  • [Cites] Alcohol Clin Exp Res. 2011 Mar;35(3):566-70 [21143253.001]
  • [Cites] Exp Mol Pathol. 2015 Dec;99(3):596-610 [26342547.001]
  • [Cites] Am J Transplant. 2016 Mar;16(3):841-9 [26710309.001]
  • [Cites] Virchows Arch. 2011 May;458(5):511-23 [21442288.001]
  • [Cites] Gastroenterology. 2013 Jun;144(6):1252-61 [23622135.001]
  • [Cites] Gut. 1997 Dec;41(6):845-50 [9462221.001]
  • [Cites] J Hepatol. 2005 May;42(5):700-6 [15826720.001]
  • [Cites] Hepatology. 2007 Jun;45(6):1348-54 [17518367.001]
  • [Cites] Gastroenterology. 1984 Apr;86(4):632-6 [6698365.001]
  • [Cites] Am J Transplant. 2010 Jan;10(1):138-48 [19951276.001]
  • [Cites] Cochrane Database Syst Rev. 2002;(2):CD002800 [12076451.001]
  • [Cites] Hepatology. 2005 Jun;41(6):1407-32 [15880505.001]
  • [Cites] Joint Bone Spine. 2017 Mar;84(2):189-196 [27238189.001]
  • [Cites] N Engl J Med. 2011 Nov 10;365(19):1790-800 [22070476.001]
  • [Cites] BMJ. 2010 Mar 11;340:c1240 [20223873.001]
  • [Cites] Nat Rev Cardiol. 2015 Oct;12(10):576-87 [26099843.001]
  • [Cites] Liver Transpl. 2006 May;12(5):813-20 [16528710.001]
  • [Cites] Gastroenterology. 2016 Apr;150(4):903-10.e8 [26764182.001]
  • [Cites] Aliment Pharmacol Ther. 2016 Mar;43(5):562-74 [26806124.001]
  • [Cites] Cancer Epidemiol. 2015 Dec;39 Suppl 1:S67-74 [26115567.001]
  • [Cites] Addiction. 2016 Jul;111(7):1203-13 [26948693.001]
  • [Cites] J Hepatol. 2014 May;60(5):1026-31 [24378529.001]
  • [Cites] Arch Toxicol. 2012 Sep;86(9):1337-48 [22367091.001]
  • [Cites] Gastroenterology. 2004 Nov;127(5 Suppl 1):S35-50 [15508101.001]
  • [Cites] Hepatology. 2005 Feb;41(2):336-44 [15660387.001]
  • [Cites] J Hepatol. 2015 Sep;63(3):609-21 [25872168.001]
  • [Cites] Lancet. 2006 Jan 7;367 (9504):52-6 [16399153.001]
  • [Cites] Liver Transpl. 2007 Nov;13(11 Suppl 2):S65-8 [17969090.001]
  • [Cites] J Hepatol. 2012 Aug;57(2):399-420 [22633836.001]
  • [Cites] Adv Exp Med Biol. 2015;815:113-30 [25427904.001]
  • [Cites] World J Gastroenterol. 2010 Mar 21;16(11):1377-84 [20238405.001]
  • [Cites] Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S51-9 [26189980.001]
  • [Cites] Gut. 2011 Feb;60(2):255-60 [20940288.001]
  • [Cites] Aliment Pharmacol Ther. 2003 Aug 15;18(4):357-73 [12940921.001]
  • [Cites] Nat Rev Cancer. 2007 Aug;7(8):599-612 [17646865.001]
  • [Cites] J Hepatol. 1990 Jul;11(1):92-101 [2204661.001]
  • [Cites] Radiol Technol. 2013 Jul-Aug;84(6):577-92; quiz 593-5 [23861518.001]
  • [Cites] J Hepatol. 2004 Jul;41(1):25-30 [15246203.001]
  • [Cites] Metabolism. 2013 Dec;62(12):1850-7 [24035445.001]
  • [Cites] Aliment Pharmacol Ther. 2013 May;37(9):845-54 [23489011.001]
  • [Cites] Gastroenterology. 2009 Sep;137(3):856-64, 864.e1 [19524577.001]
  • [Cites] Dig Liver Dis. 2009 Jan;41(1):67-70 [18602355.001]
  • [Cites] J Hepatol. 2016 Sep;65(3):618-30 [27155530.001]
  • [Cites] World J Gastroenterol. 2014 Sep 14;20(34):11929-34 [25232227.001]
  • [Cites] J Hepatol. 2016 Apr;64(4):957-67 [26592352.001]
  • [Cites] Med Toxicol. 1987 Jan-Feb;2(1):1-9 [3547003.001]
  • [Cites] J Gastroenterol Hepatol. 2007 Jun;22 Suppl 1:S7-10 [17567472.001]
  • [Cites] J Gastrointestin Liver Dis. 2013 Jun;22(2):189-97 [23799218.001]
  • [Cites] Hepatology. 2004 Mar;39(3):826-34 [14999703.001]
  • [Cites] J Biol Chem. 2010 Feb 26;285(9):6706-15 [20034933.001]
  • [Cites] Alcohol Clin Exp Res. 2001 May;25(5 Suppl ISBRA):254S-261S [11391080.001]
  • [Cites] Alcohol Clin Exp Res. 1995 Jun;19(3):635-41 [7573786.001]
  • [Cites] Lancet. 1995 Oct 14;346(8981):987-90 [7475591.001]
  • [Cites] Addiction. 2005 Oct;100(10):1477-86 [16185209.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2015 Jul 1;309(1):G30-41 [25930080.001]
  • [Cites] Alcohol Alcohol. 2009 Mar-Apr;44(2):199-203 [19054785.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2014 May;11(5):300-7 [24393837.001]
  • [Cites] Scand J Gastroenterol. 2011 Sep;46(9):1127-32 [21591871.001]
  • [Cites] Hepatology. 2016 Oct;64(4):1343-55 [26940353.001]
  • [Cites] Hepatology. 2015 Jun;61(6):1945-56 [25645722.001]
  • [Cites] Nat Genet. 2015 Dec;47(12):1443-8 [26482880.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2014 May 15;306(10):G819-23 [24699333.001]
  • [Cites] Lancet. 2016 Mar 5;387(10022):978-87 [26777270.001]
  • [Cites] J Hepatol. 2013 Jul;59(1):160-8 [23511777.001]
  • [Cites] Cochrane Database Syst Rev. 2012 May 16;(5):CD008344 [22592729.001]
  • [Cites] Nat Protoc. 2013 Mar;8(3):627-37 [23449255.001]
  • [Cites] N Engl J Med. 2011 Nov 10;365(19):1781-9 [22070475.001]
  • [Cites] Hepatology. 1997 Jan;25(1):108-11 [8985274.001]
  • [Cites] Lancet. 2011 Apr 16;377(9774):1297-9 [21334738.001]
  • [Cites] Gastroenterology. 2011 Nov;141(5):1572-85 [21920463.001]
  • [Cites] J Hepatol. 2012 Jun;56(6):1299-304 [22314431.001]
  • [Cites] Proc Natl Acad Sci U S A. 2015 Dec 8;112(49):15078-83 [26575631.001]
  • [Cites] J Hepatol. 1989 Jul;9(1):105-13 [2671116.001]
  • [Cites] Hepatology. 2005 Feb;41(2):353-8 [15660383.001]
  • [Cites] Liver Int. 2015 Sep;35(9):2072-8 [25645300.001]
  • [Cites] Hepatology. 2002 Apr;35(4):868-75 [11915033.001]
  • [Cites] Alcohol Clin Exp Res. 2001 Apr;25(4):502-7 [11329488.001]
  • [Cites] Am J Gastroenterol. 2005 Nov;100(11):2583-91 [16279916.001]
  • [Cites] N Engl J Med. 1991 Jun 27;324(26):1852-7 [1904133.001]
  • [Cites] Alcohol Clin Exp Res. 2001 Aug;25(8):1181-7 [11505049.001]
  • [Cites] Hepatology. 2009 Jan;49(1):278-86 [19065677.001]
  • [Cites] World J Gastroenterol. 2015 Oct 21;21(39):11044-52 [26494961.001]
  • [Cites] Alcohol Alcohol. 2008 Sep-Oct;43(5):559-63 [18621800.001]
  • [Cites] Gut. 2007 Dec;56(12):1743-6 [17627961.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2015 Jul;12 (7):387-400 [26055245.001]
  • [Cites] Alcohol Clin Exp Res. 1996 Dec;20(9):1528-33 [8986199.001]
  • [Cites] Proteins. 2013 Mar;81(3):406-14 [23042597.001]
  • [Cites] Lancet. 2009 Jun 27;373(9682):2223-33 [19560604.001]
  • [Cites] Gastroenterology. 1978 Aug;75(2):193-9 [352788.001]
  • [Cites] Gastroenterology. 2011 Feb;140(2):488-496.e4 [20682324.001]
  • [Cites] J Hepatol. 1998 Apr;28(4):615-21 [9566830.001]
  • [Cites] Proc Soc Exp Biol Med. 2000 Sep;224(4):302-8 [10964266.001]
  • [Cites] JAMA. 2013 Sep 11;310(10):1033-41 [24026598.001]
  • [Cites] PLoS Med. 2015 Dec 22;12(12):e1001924 [26694529.001]
  • [Cites] Alcohol Clin Exp Res. 2015 Mar;39(3):566-74 [25702770.001]
  • [Cites] Aliment Pharmacol Ther. 2014 Apr;39(7):721-32 [24612165.001]
  • [Cites] J Clin Invest. 2003 Nov;112(9):1383-94 [14597764.001]
  • [Cites] Alcohol Clin Exp Res. 2015 May;39(5):905-10 [25866234.001]
  • [Cites] BMJ. 2006 Mar 4;332(7540):519-22 [16428251.001]
  • [ErratumIn] Gut Liver. 2017 May 15;11(3):447 [28452211.001]
  • (PMID = 28274107.001).
  • [ISSN] 2005-1212
  • [Journal-full-title] Gut and liver
  • [ISO-abbreviation] Gut Liver
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones
  • [Keywords] NOTNLM ; Carcinoma, hepatocellular / Corticosteroid therapy / Hepatitis, alcoholic / Liver transplantation / Malnutrition / PNPLA3
  •  go-up   go-down


13. Linnemayr S, Ryan GW, Liu J, Palar K: Value for Money in Donor HIV Funding. Rand Health Q; 2012;1(4):2
HIV InSite. treatment guidelines - Malaria and HIV .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Countries with the highest burden of human immunodeficiency virus (HIV) disease are heavily reliant on donor funding from such sources as the U.S.
  • To meet the continued need for more HIV services in developing countries, existing resources need to be better leveraged, i.e., to provide improved value for the money.
  • The authors' assessment of available input and output data suggests that current spending allocations across direct and indirect services are not based on increasing value for money.
  • Finally, given projections that funding for HIV will likely not increase, particularly for low-income countries facing the highest HIV burden, an explicit emphasis on improving value for money by finding ways to better leverage existing monies is imperative.

  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28083209.001).
  • [Journal-full-title] Rand health quarterly
  • [ISO-abbreviation] Rand Health Q
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. Veenema TG, Thornton CP, Lavin RP, Bender AK, Seal S, Corley A: Climate Change-Related Water Disasters' Impact on Population Health. J Nurs Scholarsh; 2017 Nov;49(6):625-634

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Direct health impact was characterized by four major categories: weather-related morbidity and mortality, waterborne diseases/water-related illness, vector-borne and zoonotic diseases, and psychiatric/mental health effects.
  • Flooding as an event was overrepresented in this analysis (60%), and the majority of the research reviewed was conducted in high-income or upper middle-/high-income countries (62%), despite the fact that low-income countries bear a disproportionate share of the burden on morbidity and mortality from CCRWDs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Sigma Theta Tau International.
  • (PMID = 28834176.001).
  • [ISSN] 1547-5069
  • [Journal-full-title] Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing
  • [ISO-abbreviation] J Nurs Scholarsh
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Climate change / disasters / public health
  •  go-up   go-down


15. Collineau L, Rojo-Gimeno C, Léger A, Backhans A, Loesken S, Nielsen EO, Postma M, Emanuelson U, Beilage EG, Sjölund M, Wauters E, Stärk KDC, Dewulf J, Belloc C, Krebs S: Herd-specific interventions to reduce antimicrobial usage in pig production without jeopardising technical and economic performance. Prev Vet Med; 2017 Sep 01;144:167-178

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of this study was to assess, across four countries, the technical and economic impact of herd-specific interventions aiming at reducing antimicrobial usage in pig production while implementing alternative measures.
  • A median reduction of 47.0% of antimicrobial usage was achieved across four countries when expressed in terms of treatment incidence from birth to slaughter, corresponding to a 30.5% median reduction of antimicrobial expenditures.
  • It was more influenced by a change in feed conversion ratio and daily weight gain than by a change in antimicrobial expenditures or intervention direct net cost.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier B.V. All rights reserved.
  • (PMID = 28716198.001).
  • [ISSN] 1873-1716
  • [Journal-full-title] Preventive veterinary medicine
  • [ISO-abbreviation] Prev. Vet. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Antibiotics / Compliance / Margin over feed cost / Net farm profit / Preventive measures / Technical performance
  •  go-up   go-down


16. Alves-Silva JM, Romane A, Efferth T, Salgueiro L: North African Medicinal Plants Traditionally Used in Cancer Therapy. Front Pharmacol; 2017;8:383

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Truthfully, herbalists and botanists in North African countries prescribe several plants for cancer treatment.
  • <b>Method:</b> The research was conducted on several popular search engines including PubMed, Science Direct, Scopus and Web of Science.
  • <b>Results:</b> This review on plants traditionally used by herbalists in North Africa highlights that Morocco and Algeria are the countries with most surveys on the use of medicinal plants in folk medicine.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Sci. 2016 Oct;107(10 ):1363-1372 [27486911.001]
  • [Cites] Mol Biol Rep. 2014 Sep;41(9):6247-52 [24973886.001]
  • [Cites] Anticancer Res. 2007 Jul-Aug;27(4A):2053-8 [17649821.001]
  • [Cites] J Ethnopharmacol. 2007 Mar 1;110(1):105-17 [17052873.001]
  • [Cites] Life Sci. 2013 Nov 13;93(21):783-90 [24044882.001]
  • [Cites] Ultrason Sonochem. 2016 Jul;31:449-55 [26964971.001]
  • [Cites] Biosci Biotechnol Biochem. 2005 Mar;69(3):653-8 [15785001.001]
  • [Cites] Biomed Pharmacother. 2017 Jun;90:479-491 [28391170.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(3):1829-32 [23679282.001]
  • [Cites] PLoS One. 2013 Sep 09;8(9):e72882 [24039814.001]
  • [Cites] Forsch Komplementmed. 2009 Apr;16(2):79-90 [19420953.001]
  • [Cites] Int J Prev Med. 2016 Apr 14;7:66 [27141285.001]
  • [Cites] Lung Cancer. 2011 May;72(2):154-9 [21354647.001]
  • [Cites] J Ethnopharmacol. 2013 Feb 13;145(3):746-57 [23228916.001]
  • [Cites] Biochem Pharmacol. 2011 Sep 1;82(5):464-75 [21679698.001]
  • [Cites] Oncotarget. 2015 Dec 1;6(38):41324-38 [26510914.001]
  • [Cites] Food Chem Toxicol. 2011 Jun;49(6):1270-5 [21385597.001]
  • [Cites] Food Chem Toxicol. 2012 Jun;50(6):1817-25 [22433985.001]
  • [Cites] PLoS One. 2011;6(5):e20164 [21629786.001]
  • [Cites] Int J Med Sci. 2015 Oct 03;12(10):825-31 [26516311.001]
  • [Cites] J Assoc Physicians India. 2001 Nov;49:1057-61 [11868855.001]
  • [Cites] Front Cell Dev Biol. 2014 Feb 20;2:3 [25364712.001]
  • [Cites] Food Nutr Res. 2015 Dec 22;59:29884 [26699938.001]
  • [Cites] Fitoterapia. 2012 Sep;83(6):1115-9 [22579841.001]
  • [Cites] Bioresour Technol. 2008 Dec;99(18):9004-8 [18538563.001]
  • [Cites] J Ethnopharmacol. 2010 Sep 15;131(2):321-5 [20600755.001]
  • [Cites] Drug Des Devel Ther. 2015 Jun 18;9:3119-24 [26124636.001]
  • [Cites] Avicenna J Phytomed. 2013 Spring;3(2):152-8 [25050269.001]
  • [Cites] Biochim Biophys Acta. 2014 Jan;1845(1):42-52 [24295567.001]
  • [Cites] Phytomedicine. 2002 Jan;9(1):69-74 [11924767.001]
  • [Cites] J Ethnopharmacol. 2015 Dec 4;175:147-52 [26386381.001]
  • [Cites] Oncogene. 2006 Mar 9;25(10):1463-73 [16331273.001]
  • [Cites] Pharm Biol. 2014 Feb;52(2):243-54 [24102093.001]
  • [Cites] Planta Med. 2016 Mar;82(4):312-21 [26848703.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(2):983-7 [24568529.001]
  • [Cites] Iran J Pharm Res. 2015 Spring;14(2):539-46 [25901162.001]
  • [Cites] Ann N Y Acad Sci. 2009 Aug;1171:59-76 [19723038.001]
  • [Cites] Cell Death Dis. 2013 Jun 06;4:e660 [23744360.001]
  • [Cites] Pharmacognosy Res. 2015 Apr-Jun;7(2):193-7 [25829794.001]
  • [Cites] Food Chem Toxicol. 2009 Nov;47(11):2768-75 [19699773.001]
  • [Cites] Life Sci. 2005 Aug 5;77(12 ):1319-30 [15916774.001]
  • [Cites] J Med Food. 2013 Dec;16(12):1121-30 [24328702.001]
  • [Cites] Fitoterapia. 2000 Jun;71(3):278-307 [10844168.001]
  • [Cites] J Ethnopharmacol. 2015 Dec 4;175:626-37 [26440857.001]
  • [Cites] Cell Cycle. 2016;15(2):196-212 [26825227.001]
  • [Cites] Oncol Rep. 2014 Aug;32(2):821-8 [24890449.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):25-7 [19385451.001]
  • [Cites] PLoS One. 2014 Jul 11;9(7):e102110 [25013907.001]
  • [Cites] J Ethnopharmacol. 2013 Jul 9;148(2):395-402 [23643544.001]
  • [Cites] Food Chem Toxicol. 2013 May;55:470-5 [23380204.001]
  • [Cites] Res Commun Mol Pathol Pharmacol. 2001;110(3-4):239-51 [12760491.001]
  • [Cites] Toxicol Int. 2012 Sep;19(3):287-94 [23293468.001]
  • [Cites] J Ethnopharmacol. 2014 May 28;154(1):76-87 [24685583.001]
  • [Cites] Aging Male. 2016 Jun;19(2):134-42 [26791805.001]
  • [Cites] Food Chem Toxicol. 2014 Jul;69:76-85 [24705020.001]
  • [Cites] Cancer Metastasis Rev. 2005 Jun;24(2):315-27 [15986140.001]
  • [Cites] Toxicol Lett. 2013 Oct 23;223(1):60-72 [24012840.001]
  • [Cites] J Ethnopharmacol. 2016 Dec 24;194:196-218 [27592312.001]
  • [Cites] Br J Pharmacol. 2010 Oct;161(3):541-54 [20880395.001]
  • [Cites] Eur J Clin Pharmacol. 2009 Dec;65(12):1175-8 [19809809.001]
  • [Cites] J Ethnopharmacol. 2006 May 24;105(3):358-67 [16414225.001]
  • [Cites] J Ethnopharmacol. 2003 Jun;86(2-3):149-58 [12738079.001]
  • [Cites] Pharmazie. 2005 Jul;60(7):544-7 [16076084.001]
  • [Cites] Anticancer Res. 2005 Nov-Dec;25(6B):4255-9 [16309225.001]
  • [Cites] Expert Opin Investig Drugs. 2013 Mar;22(3):369-77 [23256895.001]
  • [Cites] Braz J Med Biol Res. 2007 Jun;40(6):839-47 [17581684.001]
  • [Cites] Planta Med. 2010 Jan;76(1):86-7 [19644796.001]
  • [Cites] Mutat Res. 2011 Jan 10;706(1-2):28-35 [21040738.001]
  • [Cites] Phytother Res. 2001 May;15(3):257-9 [11351364.001]
  • [Cites] Biochem Pharmacol. 2010 May 1;79(9):1251-60 [20026309.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1392-8 [15298963.001]
  • [Cites] Cell Biol Int. 2005 Aug;29(8):687-94 [15936223.001]
  • [Cites] Biomed Res Int. 2013;2013:417928 [24288678.001]
  • [Cites] J Ethnopharmacol. 2015 May 26;166:250-60 [25797117.001]
  • [Cites] J Ethnopharmacol. 2016 Jul 21;188:96-110 [27174082.001]
  • [Cites] Z Naturforsch C. 2007 Sep-Oct;62(9-10):656-60 [18069236.001]
  • [Cites] J Tradit Complement Med. 2016 May 21;7(2):195-204 [28417090.001]
  • [Cites] Planta Med. 2002 Apr;68(4):297-301 [11988850.001]
  • [Cites] Chem Biol Interact. 2007 Nov 20;170(2):135-43 [17850779.001]
  • [Cites] PLoS One. 2016 Apr 13;11(4):e0153496 [27073921.001]
  • [Cites] J Ethnopharmacol. 1997 Nov;58(3):149-55 [9421250.001]
  • [Cites] Biomed Res Int. 2014;2014:135048 [24900952.001]
  • [Cites] J Ethnopharmacol. 1997 Oct;58(2):125-9 [9406901.001]
  • [Cites] FEBS Lett. 2001 Oct 12;506(3):225-30 [11602250.001]
  • [Cites] Saudi J Biol Sci. 2011 Oct;18(4):353-9 [23961147.001]
  • [Cites] Food Chem Toxicol. 2016 Oct;96:145-54 [27498339.001]
  • [Cites] Food Chem Toxicol. 1999 Aug;37(8):831-8 [10506006.001]
  • [Cites] Int J Mol Med. 2003 Jan;11(1):23-6 [12469212.001]
  • [Cites] Nat Prod Res. 2015;29(5):474-9 [25141946.001]
  • [Cites] Phytother Res. 2004 May;18(5):395-8 [15174000.001]
  • [Cites] Biochim Biophys Acta. 2014 Jan;1843(1):150-62 [23466868.001]
  • [Cites] Chem Biodivers. 2010 Jan;7(1):129-39 [20087986.001]
  • [Cites] Nutr Cancer. 2016;68(1):131-43 [26771897.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(10):5783-8 [24289578.001]
  • [Cites] Am J Chin Med. 2011;39(6):1075-91 [22083982.001]
  • [Cites] Food Chem Toxicol. 2009 Jan;47(1):129-33 [19010375.001]
  • [Cites] Toxicol Lett. 2012 Sep 3;213(2):151-9 [22732633.001]
  • [Cites] Lipids Health Dis. 2011 Sep 21;10:161 [21936887.001]
  • [Cites] Integr Cancer Ther. 2014 Jul;13(4):351-67 [24363284.001]
  • [Cites] Phytomedicine. 2013 Oct 15;20(13):1211-8 [23860409.001]
  • [Cites] Food Chem Toxicol. 2011 Feb;49(2):342-7 [21075159.001]
  • [Cites] Asian Pac J Cancer Prev. 2011;12(12):3299-304 [22471470.001]
  • [Cites] Pharm Biol. 2013 Dec;51(12):1508-14 [23862683.001]
  • [Cites] BMC Complement Altern Med. 2012 May 28;12:69 [22640402.001]
  • [Cites] PLoS One. 2010 Aug 12;5(8):e12124 [20711342.001]
  • [Cites] Epilepsy Res. 2011 Jan;93(1):39-43 [21112742.001]
  • [Cites] Cancer Biol Ther. 2009 Feb;8(3):272-8 [19197146.001]
  • [Cites] J Exp Clin Cancer Res. 2013 May 20;32:30 [23688286.001]
  • [Cites] Cell Mol Biol (Noisy-le-grand). 2016 Sep 30;62(11):108-114 [27755961.001]
  • [Cites] Phytomedicine. 2010 Feb;17 (2):157-60 [19576744.001]
  • [Cites] Iran J Basic Med Sci. 2013 Jan;16(1):27-38 [23638290.001]
  • [Cites] Can J Physiol Pharmacol. 1997 Dec;75(12):1356-61 [9534946.001]
  • [Cites] J Altern Complement Med. 2009 Jun;15(6):639-44 [19500003.001]
  • [Cites] Biomed Res Int. 2015;2015:914645 [26557712.001]
  • [Cites] J Ethnopharmacol. 2007 May 30;112(1):199-202 [17324542.001]
  • [Cites] Food Chem Toxicol. 2013 May;55:202-8 [23333573.001]
  • [Cites] Gene. 2016 Jun 10;584(1):97-109 [26968890.001]
  • [Cites] Sci Pharm. 2010;78(1):33-45 [21179373.001]
  • [Cites] Int J Mol Sci. 2013 Dec 02;14(12):23533-44 [24317429.001]
  • [Cites] Pharm Biol. 2010 Mar;48(3):269-74 [20645812.001]
  • [Cites] Complement Ther Med. 2015 Apr;23(2):165-74 [25847554.001]
  • [Cites] Toxicol Mech Methods. 2014 Oct;24(7):495-503 [25045923.001]
  • [Cites] BMC Complement Altern Med. 2012 Oct 30;12:202 [23110539.001]
  • [Cites] Chem Biol Interact. 2009 Sep 14;181(1):85-94 [19446539.001]
  • [Cites] Phytother Res. 2011 Sep;25(9):1294-300 [21312304.001]
  • [Cites] J Ethnopharmacol. 2015 Nov 4;174:644-58 [26165828.001]
  • [Cites] PLoS One. 2012;7(10):e46641 [23077516.001]
  • [Cites] J Ethnopharmacol. 2000 Apr;70(1):65-8 [10720790.001]
  • [Cites] Cancer Chemother Pharmacol. 2005 Jan;55(1):79-90 [15372201.001]
  • [Cites] Trends Mol Med. 2012 Jan;18(1):13-26 [22177734.001]
  • [Cites] Autophagy. 2015;11(6):867-80 [25836756.001]
  • [Cites] Oncogene. 2014 Feb 27;33(9):1158-66 [23455323.001]
  • [Cites] Anal Biochem. 2013 May 15;436(2):187-9 [23416182.001]
  • [Cites] J Ethnopharmacol. 2000 Apr;70(1):1-7 [10720783.001]
  • [Cites] Phytother Res. 2015 Aug;29(8):1123-30 [25914334.001]
  • [Cites] BMC Complement Altern Med. 2014 Mar 29;14:114 [24679057.001]
  • [Cites] Int J Oncol. 2004 Sep;25(3):555-62 [15289856.001]
  • (PMID = 28694778.001).
  • [ISSN] 1663-9812
  • [Journal-full-title] Frontiers in pharmacology
  • [ISO-abbreviation] Front Pharmacol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; North Africa / anticancer / cancer / ethnobotanical / medicinal plants
  •  go-up   go-down


17. Prokop I, Yearwood K, Da Breo H, Rooney P, Walker RH, Sobering AK: Presentation and care of a family with Huntington disease in a resource-limited community. J Clin Mov Disord; 2017;4:4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: In high-income countries patients with Huntington disease (HD) typically present to healthcare providers after developing involuntary movements, or for pre-symptomatic genetic testing if at familial risk.
  • The experience of healthcare for such progressive neurodegenerative diseases in low- and middle-income nations is in stark contrast with the standard of care in high-income countries.
  • RESULTS: Through family recollection and by direct observation we identified four generations of individuals affected with HD.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Geriatr Psychiatry Neurol. 2010 Dec;23 (4):243-59 [20923757.001]
  • [Cites] J Neural Transm (Vienna). 2012 Nov;119(11):1361-5 [22398875.001]
  • [Cites] Genet Test Mol Biomarkers. 2010 Oct;14(5):629-36 [20722493.001]
  • [Cites] Brain. 1998 Mar;121 ( Pt 3):459-67 [9549522.001]
  • [Cites] Asian Pac J Cancer Prev. 2011;12 (6):1619-26 [22126509.001]
  • [Cites] Lancet Neurol. 2011 Jan;10 (1):31-42 [21130037.001]
  • [Cites] West Indian Med J. 1963 Mar;12:39-46 [13969988.001]
  • [Cites] Cytogenet Genome Res. 2003;100(1-4):25-55 [14526163.001]
  • [Cites] Am J Hum Genet. 1997 May;60(5):1202-10 [9150168.001]
  • [Cites] Curr Neurol Neurosci Rep. 2015;15(2):514 [25620691.001]
  • [Cites] Am J Nurs. 2008 Sep;108(9 Suppl):23-7; quiz 27 [18797217.001]
  • [Cites] Intern Med J. 2013 Dec;43(12):1272-9 [23654213.001]
  • [Cites] Nat Rev Neurol. 2014 Apr;10 (4):204-16 [24614516.001]
  • [Cites] Qual Life Res. 2012 Oct;21(8):1425-35 [22081218.001]
  • [Cites] J Clin Exp Neuropsychol. 2007 May;29(4):365-76 [17497560.001]
  • [Cites] Soc Sci Med. 2004 Jan;58(1):137-49 [14572927.001]
  • [Cites] Int J Palliat Nurs. 2005 Nov;11(11):562, 564-71 [16471043.001]
  • [Cites] Patient Educ Couns. 2007 Mar;65(3):279-87 [17000074.001]
  • [Cites] Psychosom Med. 2006 May-Jun;68(3):414-20 [16738073.001]
  • [Cites] Front Biosci (Schol Ed). 2013 Jan 01;5:1-18 [23277034.001]
  • [Cites] Support Care Cancer. 2016 Jan;24(1):409-18 [26093976.001]
  • [Cites] J Neurol Sci. 2013 Dec 15;335(1-2):101-4 [24054538.001]
  • [Cites] Brain. 2003 Jul;126(Pt 7):1599-603 [12805114.001]
  • [Cites] Patient Educ Couns. 2005 Feb;56(2):139-46 [15653242.001]
  • [Cites] Cell. 1993 Mar 26;72(6):971-83 [8458085.001]
  • [Cites] J Am Board Fam Med. 2011 Jan-Feb;24(1):115-6 [21209352.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8834-8 [12857955.001]
  • [Cites] Mov Disord. 2013 Jul;28(8):1142-5 [23495076.001]
  • [Cites] Dialogues Clin Neurosci. 2007;9(2):191-7 [17726917.001]
  • [Cites] Lancet. 2000 Dec 9;356(9246):1944-5 [11130517.001]
  • [Cites] Ann Oncol. 2012 Apr;23 Suppl 3:66-9 [22628419.001]
  • [Cites] Lancet. 2007 Jan 20;369(9557):218-28 [17240289.001]
  • [Cites] Brain Res Bull. 2007 Apr 30;72(2-3):165-71 [17352941.001]
  • [Cites] Clin Genet. 2011 Sep;80(3):281-6 [20880124.001]
  • [Cites] Dialogues Clin Neurosci. 2016 Mar;18(1):91-8 [27069383.001]
  • [Cites] Trends Mol Med. 2003 Nov;9(11):490-5 [14604827.001]
  • [Cites] J Int Neuropsychol Soc. 2011 Sep;17(5):788-95 [21729402.001]
  • (PMID = 28413688.001).
  • [ISSN] 2054-7072
  • [Journal-full-title] Journal of clinical movement disorders
  • [ISO-abbreviation] J Clin Mov Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Anticipation / Cultural competency / Huntington disease / Resource-limited community / Trinucleotide repeat disorder
  •  go-up   go-down


18. O'Hara J, Hughes D, Camp C, Burke T, Carroll L, Diego DG: The cost of severe haemophilia in Europe: the CHESS study. Orphanet J Rare Dis; 2017 May 31;12(1):106

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This burden has been quantified and documented for a number of European countries in recent years.
  • However, few studies have taken a standardised methodology across multiple countries simultaneously, and sought to amalgamate all three levels of burden for severe disease.
  • The overall aim of the 'Cost of Haemophilia in Europe: a Socioeconomic Survey' (CHESS) study was to capture the annualised economic and psychosocial burden of severe haemophilia in five European countries.
  • In turn, patients provided corresponding direct and indirect non-medical cost information, including work loss and out-of-pocket expenses, as well as information on quality of life and adherence.
  • The direct and indirect costs for the patient sample were calculated and extrapolated to population level.
  • The total annual cost of severe haemophilia across the five countries for 2014 was estimated at EUR 1.4 billion, or just under EUR 200,000 per patient.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Manag Care Pharm. 2007 Nov-Dec;13(9):790-8 [18062730.001]
  • [Cites] Haemophilia. 2004 May;10(3):199-217 [15086318.001]
  • [Cites] Haemophilia. 2004 Oct;10 Suppl 4:152-6 [15479389.001]
  • [Cites] Haemophilia. 2012 Mar;18(2):276-83 [22188641.001]
  • [Cites] Haemophilia. 2005 Nov;11 Suppl 1:11-7 [16219044.001]
  • [Cites] Haemophilia. 2012 Nov;18(6):868-74 [22642565.001]
  • [Cites] Clin Interv Aging. 2007;2(3):361-8 [18044186.001]
  • [Cites] Blood. 2003 Oct 1;102(7):2358-63 [12816859.001]
  • [Cites] Haemophilia. 2016 Jan;22(1):96-102 [26278414.001]
  • [Cites] Eur J Health Econ. 2016 Apr;17 Suppl 1:53-65 [27048374.001]
  • [Cites] Blood Transfus. 2014 Apr;12 Suppl 3:s567-75 [24922297.001]
  • [Cites] J Thromb Haemost. 2004 Jul;2(7):1047-54 [15219185.001]
  • [Cites] BMC Health Serv Res. 2015 Oct 26;15:484 [26502954.001]
  • [Cites] Value Health. 2012 May;15(3):429-36 [22583452.001]
  • [Cites] Haemophilia. 2009 Jul;15(4):853-63 [19228203.001]
  • [Cites] Med Care. 1997 Nov;35(11):1095-108 [9366889.001]
  • [Cites] Hematology Am Soc Hematol Educ Program. 2011;2011:413-8 [22160067.001]
  • [Cites] Semin Thromb Hemost. 2005 Nov;31(5):561-8 [16276465.001]
  • [Cites] JAMA. 2002 Jul 17;288(3):358-62 [12117401.001]
  • [Cites] Blood. 2011 Jun 9;117(23 ):6367-70 [21471523.001]
  • [Cites] J Med Econ. 2015 Jun;18(6):457-65 [25660324.001]
  • [Cites] Blood. 2007 Aug 1;110(3):815-25 [17446349.001]
  • [Cites] Indian J Med Res. 2014 Jul;140(1):19-31 [25222774.001]
  • [Cites] Haemophilia. 2006 Mar;12(2):154-62 [16476090.001]
  • [Cites] Haemophilia. 1998 Jul;4(4):558-63 [9873794.001]
  • [Cites] Haemophilia. 2009 May;15(3):665-75 [19432921.001]
  • [Cites] Diabetologia. 2002 Jul;45(7):S5-12 [12136405.001]
  • [Cites] Orphanet J Rare Dis. 2012 May 02;7:24 [22551339.001]
  • [Cites] J Thromb Haemost. 2006 Mar;4(3):507-9 [16460431.001]
  • [Cites] Value Health. 2013 Jul-Aug;16(5):814-22 [23947975.001]
  • [Cites] Orphanet J Rare Dis. 2014 Mar 21;9:39 [24655371.001]
  • [Cites] Haemophilia. 2017 Jan;23 (1):105-114 [27761962.001]
  • [Cites] J Intern Med. 2016 Jun;279(6):498-501 [27199237.001]
  • [Cites] Haemophilia. 2013 Jul;19(4):499-502 [23517072.001]
  • [Cites] Haemophilia. 2011 Jan;17(1):21-7 [20579110.001]
  • (PMID = 28569181.001).
  • [ISSN] 1750-1172
  • [Journal-full-title] Orphanet journal of rare diseases
  • [ISO-abbreviation] Orphanet J Rare Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Burden / Cost / Haemophilia / Health economics / Health-related quality of life
  •  go-up   go-down


19. Franzo G, Massi P, Tucciarone CM, Barbieri I, Tosi G, Fiorentini L, Ciccozzi M, Lavazza A, Cecchinato M, Moreno A: Think globally, act locally: Phylodynamic reconstruction of infectious bronchitis virus (IBV) QX genotype (GI-19 lineage) reveals different population dynamics and spreading patterns when evaluated on different epidemiological scales. PLoS One; 2017;12(9):e0184401
MedlinePlus Health Information. consumer health - Coronavirus Infections.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Infectious bronchitis virus (IBV) represents one of the poultry industry major threats, particularly in high density producing countries.
  • Our analysis, based on 807 partial S1 sequences of strains collected from 18 countries between 1993 and 2015, demonstrates that this genotype originated in China well before its first identification.
  • After a prolonged local circulation, it started spreading to other European, Asian and Middle East countries in successive waves, which were mirrored by concomitant fluctuations in viral population size.
  • Interestingly, the within-Europe spread was characterized by a higher estimated migration rate compared with the inter-continental one, potentially reflecting the closer geographic and economic relationships among these countries.
  • Globally, the spreading dynamics and evolution of the QX genotype were reconstructed from its very origin to nowadays, demonstrating the need of more effective direct control measures, particularly within each country.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Genet Evol. 2016 Apr;39:349-364 [26883378.001]
  • [Cites] Mol Biol Evol. 2013 Mar;30(3):713-24 [23180580.001]
  • [Cites] Mol Phylogenet Evol. 2016 Jul;100:269-80 [27114187.001]
  • [Cites] Avian Dis. 2001 Apr-Jun;45(2):416-24 [11417821.001]
  • [Cites] PLoS One. 2010 Oct 29;5(10):e13640 [21060827.001]
  • [Cites] Avian Pathol. 2017 Feb;46(1):28-35 [27329854.001]
  • [Cites] Mol Biol Evol. 2012 Sep;29(9):2157-67 [22403239.001]
  • [Cites] Avian Pathol. 2014;43(5):406-13 [25133705.001]
  • [Cites] Mol Biol Evol. 2013 Apr;30(4):772-80 [23329690.001]
  • [Cites] Avian Dis. 1971 Jan-Mar;15(1):42-8 [5547755.001]
  • [Cites] Mol Biol Evol. 2016 Aug;33(8):2167-9 [27189542.001]
  • [Cites] Infect Genet Evol. 2012 Aug;12(6):1305-11 [22609285.001]
  • [Cites] Avian Dis. 2012 Dec;56(4):634-41 [23397833.001]
  • [Cites] Vet Rec. 2005 May 28;156(22):720 [15923564.001]
  • [Cites] Virus Res. 2011 Jun;158(1-2):225-34 [21539870.001]
  • [Cites] Vet Rec. 2010 Nov 27;167(22):877-9 [21262658.001]
  • [Cites] Arch Virol. 2001;146(5):963-73 [11448033.001]
  • [Cites] Virus Evol. 2015 May 26;1(1):vev003 [27774277.001]
  • [Cites] Vet Rec. 1987 Jun 27;120(26):617-8 [2820108.001]
  • [Cites] Vaccine. 2016 Nov 4;34(46):5670-5676 [27670071.001]
  • [Cites] Virus Evol. 2016 Mar 02;2(1):vew003 [27774296.001]
  • [Cites] Avian Pathol. 2009 Dec;38(6):449-56 [19937534.001]
  • [Cites] Avian Pathol. 2008 Jun;37(3):247-57 [18568650.001]
  • [Cites] Avian Pathol. 2011 Oct;40(5):463-71 [21834621.001]
  • [Cites] Science. 2006 Apr 21;312(5772):384-8 [16627734.001]
  • [Cites] Vaccine. 2014 Nov 28;32(50):6765-7 [25446828.001]
  • [Cites] Mol Ecol Resour. 2011 May;11(3):423-34 [21481200.001]
  • [Cites] Mol Biol Evol. 2012 Aug;29(8):1969-73 [22367748.001]
  • [Cites] Acta Vet Hung. 2015 Sep;63(3):382-8 [26551428.001]
  • [Cites] Mol Biol Evol. 2006 Oct;23(10):1891-901 [16818476.001]
  • [Cites] Bioinformatics. 2005 Mar 1;21(5):676-9 [15509596.001]
  • [Cites] Avian Pathol. 2012;41(3):239-50 [22702451.001]
  • [Cites] PLoS One. 2013 Jun 20;8(6):e67366 [23840680.001]
  • [Cites] Arch Virol. 2016 May;161(5):1229-37 [26887967.001]
  • [Cites] Vet Rec. 2008 Jan 19;162(3):99-100 [18204039.001]
  • [Cites] Vaccine. 2007 Jul 26;25(30):5637-44 [17126960.001]
  • [Cites] Avian Pathol. 2011 Feb;40(1):93-102 [21331953.001]
  • [Cites] Vet Microbiol. 2012 Mar 23;155(2-4):237-46 [22005179.001]
  • [Cites] Avian Pathol. 2011 Oct;40(5):507-14 [21854179.001]
  • [Cites] Avian Pathol. 1999 Oct;28(5):477-85 [26911602.001]
  • [Cites] Arch Virol. 2017 May;162(5):1237-1250 [28116527.001]
  • [Cites] Virus Genes. 2010 Dec;41(3):414-6 [20844944.001]
  • [Cites] J Virol. 2011 Dec;85(23):12815-20 [21957308.001]
  • [Cites] PLoS Comput Biol. 2009 Sep;5(9):e1000520 [19779555.001]
  • [Cites] Nucleic Acids Res. 2012 Jan;40(Database issue):D593-8 [22006842.001]
  • [Cites] Avian Dis. 2003 Jul-Sep;47(3):594-601 [14562886.001]
  • [Cites] Avian Pathol. 2006 Oct;35(5):379-93 [16990148.001]
  • [Cites] Avian Pathol. 2008 Oct;37(5):487-93 [18798022.001]
  • [Cites] J Virol. 2005 Sep;79(18):11555-8 [16140732.001]
  • [Cites] Virus Evol. 2016 Apr 09;2(1):vew007 [27774300.001]
  • [Cites] Viruses. 2011 Sep;3(9):1777-99 [21994806.001]
  • [Cites] Virol J. 2006 Sep 20;3:78 [16987422.001]
  • [Cites] Avian Pathol. 2011 Jun;40(3):223-35 [21711181.001]
  • [Cites] Syst Biol. 2010 May;59(3):307-21 [20525638.001]
  • [Cites] Nat Methods. 2012 Jul 30;9(8):772 [22847109.001]
  • [Cites] Vet Ital. 2007 Jul-Sep;43(3):723-30 [20422551.001]
  • (PMID = 28880958.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Mastorci F, Vassalle C, Chatzianagnostou K, Marabotti C, Siddiqui K, Eba AO, Mhamed SAS, Bandopadhyay A, Nazzaro MS, Passera M, Pingitore A: Undernutrition and Overnutrition Burden for Diseases in Developing Countries: The Role of Oxidative Stress Biomarkers to Assess Disease Risk and Interventional Strategies. Antioxidants (Basel); 2017 Jun 08;6(2)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Undernutrition and Overnutrition Burden for Diseases in Developing Countries: The Role of Oxidative Stress Biomarkers to Assess Disease Risk and Interventional Strategies.
  • In particular, developing countries are facing a double burden caused by coexisting under- and over-nutrition, which causes a change in the disease profile from infectious diseases to a chronic degenerative pattern.
  • This review discusses the under- and over-nutrition context in Mauritania and India, two countries that are experiencing a nutritional transition, and where we began a collaboration with local medical staff to integrate interventional and diagnostic guidelines.
  • Moreover, the possibility of improving the outcome by the direct employment of antioxidant remains plausible.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Diabetes Metab Syndr. 2016 Apr-Jun;10 (2 Suppl 1):S123-6 [27016886.001]
  • [Cites] BMJ. 2008 Jul 25;337:a605 [18658189.001]
  • [Cites] Curr Diabetes Rev. 2017;13(1):65-80 [27515855.001]
  • [Cites] Antioxidants (Basel). 2015 Nov 12;4(4):719-36 [26783955.001]
  • [Cites] Clin Biochem. 2008 Oct;41(14-15):1162-7 [18692492.001]
  • [Cites] Int J Biomed Sci. 2014 Jun;10(2):118-23 [25018680.001]
  • [Cites] Proc Nutr Soc. 2008 Feb;67(1):82-90 [18234135.001]
  • [Cites] Proc Nutr Soc. 2014 Aug;73(3):385-8 [24824339.001]
  • [Cites] Int J Cardiol. 2015;187:519-24 [25846664.001]
  • [Cites] Ann N Y Acad Sci. 2014 Apr;1311:88-101 [24725148.001]
  • [Cites] Clin Chem Lab Med. 2011 Sep;49(9):1509-13 [21679134.001]
  • [Cites] Toxicol Appl Pharmacol. 2012 Jun 15;261(3):255-62 [22521606.001]
  • [Cites] Indian J Pediatr. 2009 Jul;76(7):705-9 [19381504.001]
  • [Cites] Mol Cell Biochem. 2016 Aug;419(1-2):193-203 [27421852.001]
  • [Cites] Epidemiol Health. 2016 Dec 14;38:e2016057 [28092932.001]
  • [Cites] Diabetes Technol Ther. 2015 Feb;17(2):134-41 [25478993.001]
  • [Cites] J Diabetes. 2011 Dec;3(4):278-92 [21649865.001]
  • [Cites] Coron Artery Dis. 2003 May;14(3):213-8 [12702924.001]
  • [Cites] J Diabetes Metab Disord. 2015 Apr 14;14:24 [25897417.001]
  • [Cites] Dis Markers. 2009;26(5-6):273-85 [19773616.001]
  • [Cites] Br J Nutr. 2012 Oct;108(7):1325-35 [22863082.001]
  • [Cites] J Clin Diagn Res. 2013 Oct;7(10):2146-8 [24298460.001]
  • [Cites] Lancet. 2015 Apr 4;385(9975):1333-42 [25499546.001]
  • [Cites] Heart. 2013 Nov;99(21):1554-61 [23680886.001]
  • [Cites] Indian Heart J. 2014 May-Jun;66(3):263-71 [24973830.001]
  • [Cites] Coron Artery Dis. 2015 Mar;26(2):176-83 [25369999.001]
  • [Cites] Clin Chem Lab Med. 2002 Aug;40(8):802-9 [12392309.001]
  • [Cites] Br J Nutr. 2016 Oct;116(8):1416-1424 [27725001.001]
  • [Cites] Matern Child Nutr. 2011 Apr;7 Suppl 1:113-32 [21410892.001]
  • [Cites] Arch Physiol Biochem. 2013 Feb;119(1):15-21 [23373727.001]
  • [Cites] Glob Health Action. 2014 May 15;7:23248 [24848651.001]
  • [Cites] J Nat Sci Biol Med. 2016 Jul-Dec;7(2):155-60 [27433066.001]
  • [Cites] Nutrition. 2015 Jul-Aug;31(7-8):916-22 [26059364.001]
  • [Cites] Circulation. 2001 Nov 27;104(22):2746-53 [11723030.001]
  • [Cites] Clin Biochem. 2009 May;42(7-8):739-41 [19101532.001]
  • [Cites] Food Sci Nutr. 2014 Nov;2(6):700-5 [25493188.001]
  • [Cites] Food Sci Nutr. 2015 May;3(3):257-71 [25988001.001]
  • [Cites] Nutr Health. 2001;15(2):97-111 [11694072.001]
  • [Cites] Fertil Steril. 2012 Feb;97(2):414-9 [22196713.001]
  • [Cites] J Atheroscler Thromb. 2012;19(8):712-7 [22785135.001]
  • [Cites] Int J Equity Health. 2016 Jul 08;15(1):104 [27391031.001]
  • (PMID = 28594364.001).
  • [ISSN] 2076-3921
  • [Journal-full-title] Antioxidants (Basel, Switzerland)
  • [ISO-abbreviation] Antioxidants (Basel)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; antioxidants / cardiovascular disease / epidemiological transition / inflammatory biomarkers / non-communicable diseases / nutrition / oxidative stress biomarkers
  •  go-up   go-down


21. Kobayashi LC, Glymour MM, Kahn K, Payne CF, Wagner RG, Montana L, Mateen FJ, Tollman SM, Berkman LF: Childhood deprivation and later-life cognitive function in a population-based study of older rural South Africans. Soc Sci Med; 2017 Oct;190:20-28

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Linear regression models adjusted for age, sex, and country of birth were used to estimate the total and direct effects of each childhood risk factor, and the indirect effects mediated by years of education.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28837862.001).
  • [ISSN] 1873-5347
  • [Journal-full-title] Social science & medicine (1982)
  • [ISO-abbreviation] Soc Sci Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Aging / Cognitive aging / Cognitive function / Education / Rural / Self-rated health / Socioeconomic conditions / South Africa
  •  go-up   go-down


22. Ravuvu A, Friel S, Thow AM, Snowdon W, Wate J: Protocol to monitor trade agreement food-related aspects: the Fiji case study. Health Promot Int; 2017 Apr 26;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Specific trade agreements appear to have played an influential role in the volume and types of foods entering different countries, yet there is currently no systematic and objective monitoring of trade agreements for their impacts on food environments.
  • Recently, INFORMAS was set up to monitor and benchmark food environments, government policies and private sector actions within countries and globally.
  • This paper describes the INFORMAS trade protocol, an approach to collecting food-related information about four domains of trade: trade in goods; trade in services and foreign direct investment; domestic supports, and policy space.
  • The application of the monitoring protocol also highlights challenges for data collection associated with each trade domain that should be considered for future data collection and analysis in other low and middle income countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.
  • (PMID = 28453626.001).
  • [ISSN] 1460-2245
  • [Journal-full-title] Health promotion international
  • [ISO-abbreviation] Health Promot Int
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; food environments / monitoring / non-communicable diseases / trade agreements
  •  go-up   go-down


23. Zaprutko T, Kopciuch D, Kus K, Merks P, Nowicka M, Augustyniak I, Nowakowska E: Affordability of medicines in the European Union. PLoS One; 2017;12(2):e0172753
MedlinePlus Health Information. consumer health - Schizophrenia.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The analysis concerned 2012 and was conducted between 2013 and 2015 in all the European Union (EU) countries divided into 3 groups depending on the date of their accession to the EU.
  • Due to unavailability in some countries, the exact number of analyzed medicines varies.
  • The cheapest drugs were found in various countries but never in the poorest ones like Bulgaria or Romania.
  • Unaffordability of medications may lead to the patients' non-compliance and therefore to increased direct and indirect costs of treatment.

  • MedlinePlus Health Information. consumer health - Drug Safety.
  • MedlinePlus Health Information. consumer health - Multiple Sclerosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Health Policy Plan. 2013 Oct;28(7):692-704 [23174879.001]
  • [Cites] PLoS One. 2014 Feb 12;9(2):e87576 [24533058.001]
  • [Cites] Indian J Palliat Care. 2016 Apr-Jun;22(2):163-7 [27162427.001]
  • [Cites] Health Policy. 2007 May;81(2-3):376-84 [16945449.001]
  • [Cites] Schizophr Bull. 2004;30(2):279-93 [15279046.001]
  • [Cites] Health Econ Rev. 2011 Nov 21;1(1):18 [22828053.001]
  • [Cites] Lancet. 2009 Jan 17;373(9659):240-9 [19042012.001]
  • [Cites] Psychiatr Q. 2015 Dec;86(4):569-79 [25736799.001]
  • [Cites] PLoS Med. 2016 May 31;13(5):e1002032 [27243629.001]
  • [Cites] BMC Health Serv Res. 2015 Aug 27;15:345 [26310243.001]
  • [Cites] Eur Neuropsychopharmacol. 2011 Oct;21(10):718-79 [21924589.001]
  • [Cites] Health Aff (Millwood). 2008 Jan-Feb;27(1):221-33 [18180499.001]
  • [Cites] Health Policy. 2012 Jan;104(1):50-60 [22014843.001]
  • [Cites] PLoS One. 2016 Jul 13;11(7):e0159129 [27411042.001]
  • [Cites] Croat Med J. 2011 Apr 15;52(2):183-97 [21495202.001]
  • [Cites] Afr J Prim Health Care Fam Med. 2014 Jun 24;6(1):E1-6 [26245401.001]
  • [Cites] Int J Technol Assess Health Care. 2012 Oct;28(4):358-66 [22980497.001]
  • [Cites] Annu Rev Public Health. 2004;25:475-95 [15015931.001]
  • [Cites] Int J Clin Pharmacol Ther. 2005 Oct;43(10):472-9 [16240704.001]
  • [Cites] BMC Health Serv Res. 2011 Jan 26;11:17 [21269426.001]
  • [Cites] Rev Saude Publica. 2011 Feb;45(1):14-23 [21085885.001]
  • [Cites] Rev Panam Salud Publica. 2011 Jan;29(1):46-51 [21390419.001]
  • [Cites] Int J Pharm Pract. 2009 Apr;17(2):79-88 [20214255.001]
  • [Cites] South Med Rev. 2012 Dec;5(2):34-41 [23532710.001]
  • [Cites] BMJ. 2005 Oct 22;331(7522):958-60 [16239695.001]
  • [Cites] Value Health. 2015 Jun;18(4):484-92 [26091603.001]
  • (PMID = 28241019.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Drugs, Essential
  •  go-up   go-down


24. Hauck FR, McEntire BL, Raven LK, Bates FL, Lyus LA, Willett AM, Blair PS: Research Priorities in Sudden Unexpected Infant Death: An International Consensus. Pediatrics; 2017 Jul 27;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Despite the success of safe sleep campaigns and the progress in understanding risk factors, the rate of reduction in the cases of sudden infant death syndrome has now slowed and it remains a leading cause of postneonatal mortality in many developed countries.
  • The Global Action and Prioritization of Sudden Infant Death Project was an international consensus process that aimed to define and direct future research by investigating the priorities of expert and lay members of the sudden unexpected infant death (SUID) community across countries.
  • Scientific researchers, clinicians, counselors, educators, and SUID parents from 25 countries took part across 2 online surveys to identify potential research priorities.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 by the American Academy of Pediatrics.
  • (PMID = 28751613.001).
  • [ISSN] 1098-4275
  • [Journal-full-title] Pediatrics
  • [ISO-abbreviation] Pediatrics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Ahmed Bhuiyan M, Rashid Khan HU, Zaman K, Hishan SS: Measuring the impact of global tropospheric ozone, carbon dioxide and sulfur dioxide concentrations on biodiversity loss. Environ Res; 2017 Oct 21;160:398-411

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study is to examine the impact of air pollutants, including mono-nitrogen oxides (NOx), nitrous oxide (N<sub>2</sub>O), sulfur dioxide (SO<sub>2</sub>), carbon dioxide emissions (CO<sub>2</sub>), and greenhouse gas (GHG) emissions on ecological footprint, habitat area, food supply, and biodiversity in a panel of thirty-four developed and developing countries, over the period of 1995-2014.
  • The results reveal that NOx and SO<sub>2</sub> emissions both have a negative relationship with ecological footprints, while N<sub>2</sub>O emission and real GDP per capita have a direct relationship with ecological footprints.
  • SO<sub>2</sub> emission has a direct relationship with per capita food production, while GDP per capita significantly affected per capita food production and food supply variability across countries.
  • Trade liberalization policies considerably affected the potential habitat area and biological diversity in a panel of countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 29065379.001).
  • [ISSN] 1096-0953
  • [Journal-full-title] Environmental research
  • [ISO-abbreviation] Environ. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Air pollutants / Biological diversity / Ecological footprint / Panel cointegrating regressions
  •  go-up   go-down


26. Morgan C, Bowling M, Bartram J, Lyn Kayser G: Water, sanitation, and hygiene in schools: Status and implications of low coverage in Ethiopia, Kenya, Mozambique, Rwanda, Uganda, and Zambia. Int J Hyg Environ Health; 2017 Aug;220(6):950-959
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Little multi-country research has been published on WaSH in rural schools in Sub-Saharan Africa.
  • In this multi-national cross-sectional WaSH study, we document WaSH access, continuity, quality, quantity, and reliability in 2270 schools that were randomly sampled in rural regions of six Sub-Saharan African countries: Ethiopia, Kenya, Mozambique, Rwanda, Uganda, and Zambia.
  • Data collection included: school WaSH surveys containing internationally established WaSH indicators, direct observation, and field- and laboratory-based microbiological water quality testing.
  • Fewer than 23% of rural schools in the six countries studied met the World Health Organization's recommended student-to-latrine ratios for boys and for girls.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier GmbH. All rights reserved.
  • (PMID = 28539190.001).
  • [ISSN] 1618-131X
  • [Journal-full-title] International journal of hygiene and environmental health
  • [ISO-abbreviation] Int J Hyg Environ Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Disparities / Education / Handwashing / Health / Menstruation / WaSH
  •  go-up   go-down


27. Westbrook C: Opening the debate on MRI practitioner education - Is there a need for change? Radiography (Lond); 2017 Sep;23 Suppl 1:S70-S74

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It was conducted as part of a study exploring the value of direct-entry into MRI via a specialized undergraduate degree without first qualifying as a radiographer.
  • Direct entry via a specialized undergraduate degree is permitted in some countries, and research suggests that this is a beneficial way of learning MRI.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Crown Copyright © 2017. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 28780957.001).
  • [ISSN] 1532-2831
  • [Journal-full-title] Radiography (London, England : 1995)
  • [ISO-abbreviation] Radiography (Lond)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Education / Magnetic Resonance Imaging (MRI) / Radiography / Specialism / Specialist education
  •  go-up   go-down


28. Kim YC, Jeong BH: No Correlation of the Disease Severity of Influenza A Virus Infection with the rs12252 Polymorphism of the Interferon-Induced Transmembrane Protein 3 Gene. Intervirology; 2017;60(1-2):69-74

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to examine whether an SNP of the IFITM3 gene is correlated with the disease severity of pandemic IAV (H1N1) infection in a Korean population, we investigated the genotype and allele frequencies of this polymorphism in 300 healthy Koreans by automatic direct sequencing and compared the disease severity based on epidemiological studies of the H1N1 virus reported in several countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 S. Karger AG, Basel.
  • (PMID = 28813716.001).
  • [ISSN] 1423-0100
  • [Journal-full-title] Intervirology
  • [ISO-abbreviation] Intervirology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; 2009 influenza A pandemic / Epidemiology / Genetic polymorphism / H1N1 / IFITM3 / Interferon-induced transmembrane protein 3
  •  go-up   go-down


29. Lalloo D, Demou E, Stevenson M, Gaffney M, Macdonald EB: Comparison of competency priorities between UK occupational physicians and occupational health nurses. Occup Environ Med; 2017 May;74(5):384-386
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: The competencies required of occupational physicians (OPs) and occupational health nurses (OHNs) separately have been studied in various countries but little research has made direct comparisons between these two key occupational health (OH) professional groups.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
  • [Cites] Int J Occup Environ Health. 2005 Apr-Jun;11(2):185-98 [15875895.001]
  • [Cites] Occup Med (Lond). 2016 Nov 1;66(8):649-655 [27492470.001]
  • [Cites] AAOHN J. 2006 Jul;54(7):327-35 [16862880.001]
  • [Cites] Eval Health Prof. 2013 Sep;36(3):352-81 [23975760.001]
  • [Cites] Occup Environ Med. 2000 Feb;57(2):98-105 [10711277.001]
  • [Cites] Occup Med (Lond). 2000 Jul;50(5):369-72 [10975137.001]
  • [Cites] Occup Environ Med. 2016 Jul;73(7):452-8 [27076063.001]
  • [Cites] Collegian. 2006 Jul;13(3):18-24 [17036451.001]
  • [Cites] J Adv Nurs. 2007 Jun;58(6):585-93 [17484746.001]
  • [Cites] Occup Med (Lond). 2004 May;54(3):147-52 [15133136.001]
  • (PMID = 28232635.001).
  • [ISSN] 1470-7926
  • [Journal-full-title] Occupational and environmental medicine
  • [ISO-abbreviation] Occup Environ Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Delphi study / competencies / occupational health nurse / occupational physician / training
  •  go-up   go-down


30. Lackenbauer W, Janssen J, Roddam H, Selfe J: Is keep/refer decision making an integral part of national guidelines for the physiotherapy profession within Europe? A review. Physiotherapy; 2016 Nov 28;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, it is currently unknown how individual European countries have implemented this in their national guidelines.
  • OBJECTIVES: To determine if keep/refer decision making abilities are an integral part of national guidelines for the physiotherapy profession of member countries of the European Network of Physiotherapy in Higher Education (ENPHE).
  • Despite the fact that in the WCPT guidelines keep/refer decision making abilities are clearly described as a core element, there exists huge inconsistency as to how various European (with direct and non direct access systems) countries have included them in their national guidelines.
  • CONCLUSION: Despite the fact that most ENPHE member countries deem a close collaboration between health care professionals important and that physiotherapists should know the limitation of their expertise, keep/refer decision making abilities as explicitly stated in the WCPT guidelines were not included in the majority of guidelines that were reviewed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Chartered Society of Physiotherapy. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 28823566.001).
  • [ISSN] 1873-1465
  • [Journal-full-title] Physiotherapy
  • [ISO-abbreviation] Physiotherapy
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Keep/refer decision making ability / National competency guidelines / Physiotherapy
  •  go-up   go-down


31. Voysey M, Fanshawe TR, Kelly DF, O'Brien KL, Kandasamy R, Shrestha S, Thorson S, Hinds J, Pollard AJ: Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries. Clin Infect Dis; 2017 Oct 21;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Serotype-specific correlates of protection for pneumococcal carriage: an analysis of immunity in 19 countries.
  • Background: Pneumococcal conjugate vaccines (PCVs) provide direct protection against disease in those vaccinated, and interrupt transmission through the prevention of nasopharyngeal carriage.
  • Protective correlates were on average 2.15 times higher in low/lower middle income countries than in high/upper middle income countries (GMR 2.15, 95%CI 1.46-3.17, p=0.0024).
  • Higher antibody concentrations are required for protection in low-income countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29069415.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


32. Diallo AF, Cong X, Henderson WA, McGrath J: Management of childhood diarrhea by healthcare professionals in low income countries: An integrative review. Int J Nurs Stud; 2017 Jan;66:82-92
MedlinePlus Health Information. consumer health - Diarrhea.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of childhood diarrhea by healthcare professionals in low income countries: An integrative review.
  • Nevertheless uptake of these interventions have been slow in developing countries and many children suffering from diarrhea are not receiving adequate care according to the World Health Organization recommended guidelines for the clinical management of childhood diarrhea.
  • OBJECTIVES: The aim of this integrative review is to appraise healthcare professionals' management of childhood diarrhea in low-income countries.
  • METHOD: A comprehensive search performed from December 2014 to April 2015 used five databases and focused on observational studies of healthcare professional's management of childhood diarrhea in low-income countries.
  • Only one study used direct observation of the healthcare professionals during practice and the remaining eight used a combination of research designs.
  • [MeSH-major] Developing Countries. Diarrhea / therapy

  • Genetic Alliance. consumer health - Diarrhea.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Elsevier Ltd. All rights reserved.
  • (PMID = 28043020.001).
  • [ISSN] 1873-491X
  • [Journal-full-title] International journal of nursing studies
  • [ISO-abbreviation] Int J Nurs Stud
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Antibiotics use / Childhood diarrhea / Clinical management of childhood diarrhea / Healthcare providers / Low income countries / Oral rehydration therapy / Prescribing behaviors / World Health Organization
  •  go-up   go-down


33. Garland NY, Kheng S, De Leon M, Eap H, Forrester JA, Hay J, Oum P, Sam Ath S, Stock S, Yem S, Lucas G, Weiser TG: Using the WHO Surgical Safety Checklist to Direct Perioperative Quality Improvement at a Surgical Hospital in Cambodia: The Importance of Objective Confirmation of Process Completion. World J Surg; 2017 Dec;41(12):3012-3024

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Using the WHO Surgical Safety Checklist to Direct Perioperative Quality Improvement at a Surgical Hospital in Cambodia: The Importance of Objective Confirmation of Process Completion.
  • In addition to cultural and organizational barriers faced by high-income countries, resource-constrained settings face scarcity of durable and consumable goods.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29038828.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Torres-Mejía G, Navarro-Lechuga E, Tuesca-Molina RJ, Ángeles-Llerenas A: The Epidemiological Challenges of Breast Cancer among Premenopausal Women in Limited Resource Settings. Rev Invest Clin; 2017 Mar-Apr;69(2):59-65

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this context, the aim of the present review is to identify factors that make breast cancer in premenopausal women an epidemiological challenge in developing countries.
  • Breast cancer in premenopausal women should be included in the political and strategic agendas in developing countries to direct the necessary resources for prevention, detection, and control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28453504.001).
  • [ISSN] 0034-8376
  • [Journal-full-title] Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
  • [ISO-abbreviation] Rev. Invest. Clin.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


35. Fitzpatrick C, Haines A, Bangert M, Farlow A, Hemingway J, Velayudhan R: An economic evaluation of vector control in the age of a dengue vaccine. PLoS Negl Trop Dis; 2017 Aug;11(8):e0005785
MedlinePlus Health Information. consumer health - Dengue.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We employ a dynamic Markov model of the effects of vector control on dengue in both vectors and humans over a 15-year period, in six countries: Brazil, Columbia, Malaysia, Mexico, the Philippines, and Thailand.
  • We evaluate the cost (direct medical costs and control programme costs) and cost-effectiveness of sustained vector control, outbreak response and/or medical case management, in the presence of a (hypothetical) highly targeted and low cost immunization strategy using a (non-hypothetical) medium-efficacy vaccine.
  • High-burden endemic countries should proceed to map populations to be covered by sustained vector control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Trop Med Hyg. 1988 Jan;38(1):172-80 [3341519.001]
  • [Cites] Cad Saude Publica. 2009;25 Suppl 1:S115-24 [19287856.001]
  • [Cites] Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14688-93 [26553981.001]
  • [Cites] N Engl J Med. 2015 Sep 24;373(13):1195-206 [26214039.001]
  • [Cites] Infect Dis Poverty. 2016 May 03;5:44 [27142081.001]
  • [Cites] Am J Trop Med Hyg. 2014 Dec;91(6):1235-42 [25294616.001]
  • [Cites] Am J Trop Med Hyg. 2011 May;84(5):764-72 [21540387.001]
  • [Cites] Vaccine. 2013 Aug 20;31(37):3957-61 [23791696.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2395-400 [8146129.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 01;9(6):e0003810 [26030922.001]
  • [Cites] Lancet. 2011 May 14;377(9778):1673-80 [21546076.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jun 26;9(6):e0003894 [26115104.001]
  • [Cites] Am J Trop Med Hyg. 2011 Feb;84(2):200-7 [21292885.001]
  • [Cites] Am J Trop Med Hyg. 2000 Mar;62(3):378-83 [11037781.001]
  • [Cites] BMC Bioinformatics. 2016 Apr 16;17 :166 [27083696.001]
  • [Cites] Trans R Soc Trop Med Hyg. 2007 Jun;101(6):578-86 [17368696.001]
  • [Cites] Am J Trop Med Hyg. 2008 Jun;78(6):862-7 [18541760.001]
  • [Cites] Am J Trop Med Hyg. 2015 Nov;93(5):1020-7 [26416116.001]
  • [Cites] Emerg Infect Dis. 2013 Apr;19(4):542-50 [23628282.001]
  • [Cites] BMC Public Health. 2013 Nov 06;13:1048 [24195519.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jul 21;9(7):e0003937 [26196686.001]
  • [Cites] Int J Infect Dis. 2007 May;11(3):263-7 [16899384.001]
  • [Cites] N Engl J Med. 2015 Jan 8;372(2):113-23 [25365753.001]
  • [Cites] Sci Total Environ. 2012 Aug 1;431:385-91 [22705874.001]
  • [Cites] PLoS Negl Trop Dis. 2016 Mar 17;10(3):e0004551 [26986468.001]
  • [Cites] Pathog Glob Health. 2015 Feb;109(1):10-8 [25546339.001]
  • [Cites] Vaccine. 2004 Mar 12;22(9-10):1275-80 [15003657.001]
  • [Cites] PLoS Med. 2016 Nov 29;13(11):e1002181 [27898668.001]
  • [Cites] Am J Trop Med Hyg. 2008 Sep;79(3):364-71 [18784227.001]
  • [Cites] Nature. 2013 Apr 25;496(7446):504-7 [23563266.001]
  • [Cites] PLoS Negl Trop Dis. 2013;7(2):e2055 [23437406.001]
  • [Cites] PLoS Negl Trop Dis. 2014 May 08;8(5):e2848 [24810901.001]
  • [Cites] Med Vet Entomol. 2008 Sep;22(3):203-21 [18816269.001]
  • [Cites] Trop Med Int Health. 2012 Jun;17(6):767-74 [22943302.001]
  • [Cites] Arch Virol. 2013 Jul;158(7):1445-59 [23471635.001]
  • [Cites] J Coll Physicians Surg Pak. 2013 Jul;23(7):463-7 [23823947.001]
  • [Cites] BMJ. 2015 Jul 08;351:h3267 [26156323.001]
  • [Cites] J R Soc Interface. 2013 Jul 03;10(86):20130414 [23825116.001]
  • [Cites] PLoS Negl Trop Dis. 2010 Oct 26;4(10):e858 [21049010.001]
  • [Cites] PLoS Negl Trop Dis. 2016 Dec 21;10 (12 ):e0005179 [28002420.001]
  • [Cites] Lancet Infect Dis. 2016 Aug;16(8):880-2 [27477966.001]
  • [Cites] Trop Med Int Health. 2012 Jan;17(1):123-32 [21906216.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Mar 01;5(3):e975 [21390158.001]
  • [Cites] PLoS Negl Trop Dis. 2015 May 07;9(5):e0003655 [25951103.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Nov 06;8(11):e3260 [25375830.001]
  • [Cites] Malays J Pathol. 2002 Jun;24(1):23-7 [16329552.001]
  • [Cites] Pharmacoeconomics. 2015 Nov;33(11):1107-35 [26048354.001]
  • [Cites] Rev Panam Salud Publica. 2006 Jul;20(1):39-43 [17018223.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(8):e1760 [22880140.001]
  • [Cites] Epidemics. 2015 Jun;11:92-102 [25979287.001]
  • [Cites] Epidemiol Infect. 2014 Mar;142(3):545-61 [23800514.001]
  • [Cites] PLoS Negl Trop Dis. 2012;6(8):e1799 [22953017.001]
  • [Cites] Am J Trop Med Hyg. 2009 May;80(5):846-55 [19407136.001]
  • [Cites] Math Biosci. 2007 Aug;208(2):571-89 [17303188.001]
  • [Cites] Lancet. 2014 Oct 11;384(9951):1358-65 [25018116.001]
  • [Cites] BMC Public Health. 2009 May 27;9:155 [19473500.001]
  • [Cites] Am J Trop Med Hyg. 1997 Feb;56(2):159-67 [9080874.001]
  • [Cites] Am J Trop Med Hyg. 1998 Aug;59(2):265-71 [9715944.001]
  • [Cites] Int J Health Geogr. 2014 Dec 09;13:50 [25487167.001]
  • [Cites] BMC Infect Dis. 2014 Aug 20;14:447 [25139524.001]
  • [Cites] PLoS One. 2012;7(11):e49085 [23139836.001]
  • [Cites] Nihon Koshu Eisei Zasshi. 2015;62(5):238-50 [26118707.001]
  • [Cites] Expert Rev Vaccines. 2016;15(4):519-28 [26642099.001]
  • [Cites] Am J Trop Med Hyg. 2012 Sep;87(3):554-8 [22826478.001]
  • [Cites] Trop Med Int Health. 2007 Sep;12(9):1026-36 [17875014.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Dec;5(12):e1426 [22206028.001]
  • [Cites] Rev Panam Salud Publica. 2003 Jul;14(1):9-16 [12952602.001]
  • [Cites] J Infect Dis. 2010 Jan 1;201(1):5-14 [19929380.001]
  • [Cites] Am J Trop Med Hyg. 2016 Nov 2;95(5):1137-1147 [27601519.001]
  • [Cites] Lancet. 2016 Aug 6;388(10044):556-7 [27529102.001]
  • [Cites] PLoS Negl Trop Dis. 2016 May 26;10 (5):e0004588 [27227829.001]
  • (PMID = 28806786.001).
  • [ISSN] 1935-2735
  • [Journal-full-title] PLoS neglected tropical diseases
  • [ISO-abbreviation] PLoS Negl Trop Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Dengue Vaccines
  •  go-up   go-down


36. Paradies P, Iarussi F, Sasanelli M, Capogna A, Lia RP, Zucca D, Greco B, Cantacessi C, Otranto D: Occurrence of strongyloidiasis in privately owned and sheltered dogs: clinical presentation and treatment outcome. Parasit Vectors; 2017 Jul 20;10(1):345

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The increasing number of reports of human infections by Strongyloides stercoralis from a range of European countries over the last 20 years has spurred the interest of the scientific community towards this parasite and, in particular, towards the role that infections of canine hosts may play in the epidemiology of human disease.
  • Strongyloides stercoralis infection was diagnosed by coproscopy on direct faecal smear and via the Baermann method.
  • Data indicate that S. stercoralis infection may pose a concern for sheltered animals and raise questions on potential risks of infection for staff of municipal shelters in southern European countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Vet Scand. 2007 Dec 12;49:37 [18076758.001]
  • [Cites] Rev Bras Parasitol Vet. 2012 Apr-Jun;21(2):101-6 [22832748.001]
  • [Cites] Cochrane Database Syst Rev. 2016 Jan 18;(1):CD007745 [26778150.001]
  • [Cites] AIDS. 2007 Mar 12;21(5):649-50 [17314529.001]
  • [Cites] Exp Parasitol. 1984 Jun;57(3):287-96 [6723900.001]
  • [Cites] WormBook. 2015 Jul 16;:1-17 [26183912.001]
  • [Cites] J Parasitol. 2002 Jun;88(3):536-9 [12099422.001]
  • [Cites] PLoS Negl Trop Dis. 2013 May 09;7(5):e2214 [23675546.001]
  • [Cites] Vet Parasitol. 2006 Mar 15;136(2):137-45 [16321470.001]
  • [Cites] Vet Rec. 2009 May 2;164(18):559-60 [19411688.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Nov 05;9(11):e0004150 [26540412.001]
  • [Cites] Ann Trop Med Parasitol. 2011 Sep;105(6):413-24 [22117850.001]
  • [Cites] Parasitol Int. 2014 Aug;63(4):597-603 [24704609.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Jan 09;8(1):e2640 [24427320.001]
  • [Cites] Vet Parasitol. 2007 Jun 20;147(1-2):132-9 [17448603.001]
  • [Cites] J Am Vet Med Assoc. 1992 Sep 1;201(5):726-30 [1399774.001]
  • [Cites] Dtsch Tierarztl Wochenschr. 1993 Nov;100(11):426-8 [8261912.001]
  • [Cites] Emerg Infect Dis. 2009 Sep;15(9):1531-3 [19788836.001]
  • [Cites] Singapore Med J. 2014 Jul;55(7):367-71 [25091885.001]
  • [Cites] Med Microbiol Immunol. 2006 Jun;195(2):49-54 [16538445.001]
  • [Cites] Clin Microbiol Infect. 2015 Jun;21(6):543-52 [25887711.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Feb 10;9(2):e0003491 [25668740.001]
  • [Cites] Vet Parasitol. 2013 Mar 31;193(1-3):78-84 [23265188.001]
  • [Cites] Vet Parasitol. 2007 Sep 1;148(2):170-3 [17573197.001]
  • [Cites] Biomed Res Int. 2014;2014:696508 [24883320.001]
  • (PMID = 28728589.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Clinical presentation / Dog / Faecal monitoring / Strongyloides stercoralis / Treatment / Zoonosis
  •  go-up   go-down


37. Wilson A, Vento M, Shah PS, Saugstad O, Finer N, Rich W, Morton RL, Rabi Y, Tarnow-Mordi W, Suzuki K, Wright IM, Oei JL: A review of international clinical practice guidelines for the use of oxygen in the delivery room resuscitation of preterm infants. Acta Paediatr; 2017 Aug 09;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A search of public databases using the terms 'clinical practice guidelines', 'preterm', 'oxygen' and 'resuscitation' was made and complemented by direct query to consensus groups, resuscitation expert committees and clinicians.
  • Data were extracted to include the three criteria for assessment: country of origin, gestation and initial FiO<sub>2</sub> and target SpO<sub>2</sub> for the first 10 minutes of life.
  • Most countries suggested altering FiO<sub>2</sub> to meet SpO<sub>2</sub> targets recommended by expert committees, However, specific five-minute SpO<sub>2</sub> targets differed by up to 20% (70-90%) between guidelines.
  • Five countries did not specify SpO<sub>2</sub> targets.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] ©2017 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.
  • (PMID = 28792628.001).
  • [ISSN] 1651-2227
  • [Journal-full-title] Acta paediatrica (Oslo, Norway : 1992)
  • [ISO-abbreviation] Acta Paediatr.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Norway
  • [Keywords] NOTNLM ; Clinical practice guidelines / Oxygen / Preterm and resuscitation
  •  go-up   go-down


38. Blackman I, Papastavrou E, Palese A, Vryonides S, Henderson J, Willis E: Predicting variations to missed nursing care: A three-nation comparison. J Nurs Manag; 2017 Jul 27;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: This study expands on previous MISSCARE research but now applies and predicts missed care within three countries.
  • RESULTS: Five latent variables have direct predictor effects on missed care frequencies.
  • CONCLUSION: Cross country comparisons of missed nursing care allow for a more refined identification of strategies for remediation for both managers and clinicians.
  • IMPLICATIONS FOR NURSING MANAGEMENT: Reliable consensus estimates about the types and frequencies of missed care can be scaled with variables identified to predict missed care across three different countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 John Wiley & Sons Ltd.
  • (PMID = 28752529.001).
  • [ISSN] 1365-2834
  • [Journal-full-title] Journal of nursing management
  • [ISO-abbreviation] J Nurs Manag
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Australia / Cyprus / Italy / missed nursing / multi-variate analysis
  •  go-up   go-down


39. Gräfe L, Böger D, Büntzel J, Eßer D, Hoffmann K, Jecker P, Müller A, Radtke G, Volk GF, Koscielny S, Guntinas-Lichius O: [Direct Microlaryngoscopy: A Population-Based Analysis on Outcome, Complications and Surgery Rates]. Laryngorhinootologie; 2017 Jul;96(7):467-472

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Direct Microlaryngoscopy: A Population-Based Analysis on Outcome, Complications and Surgery Rates].
  • Although microlaryngoscopy is an integral part of surgical routine of otorhinolaryngologists, there is no population-based data published on surgery rates and efficiency of microlaryngoscopy country-wide or nation-wide.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © Georg Thieme Verlag KG Stuttgart · New York.
  • (PMID = 28470661.001).
  • [ISSN] 1438-8685
  • [Journal-full-title] Laryngo- rhino- otologie
  • [ISO-abbreviation] Laryngorhinootologie
  • [Language] ger
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


40. Boglione L, Cardellino CS, Cusato J, De Nicolò A, Cariti G, Di Perri G, D'Avolio A: Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. Infect Genet Evol; 2017 Jul;51:167-172
University of Turin Instituional Repository AperTO. Full Text from .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The new direct-acting antivirals agents (DAAs) rapidly changed the treatment approach in chronic hepatitis C (CHC); however, the interferon (IFN)-free therapies availability is currently different in some countries, due to higher costs of these drugs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier B.V.
  • (PMID = 28315743.001).
  • [ISSN] 1567-7257
  • [Journal-full-title] Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
  • [ISO-abbreviation] Infect. Genet. Evol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Fibrosis / Genotype 1 / Genotype 4 / HCV / IL28B / PEG-IFN
  •  go-up   go-down


41. Cher BP, Chen C, Yoong J: Prevalence-based, disease-specific estimate of the social cost of smoking in Singapore. BMJ Open; 2017 Apr 07;7(4):e014377

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These include direct and indirect costs of inpatient treatment, premature mortality, loss of productivity due to medical leaves and smoking breaks.
  • Direct healthcare costs amounted to US$14.9 million where ischaemic heart disease and lung cancer had the highest cost burden.
  • CONCLUSIONS: The social cost of smoking is smaller in Singapore than in other Asian countries.
  • This is partly because of the nature of such costs (indirect or intangible costs such as productivity losses are often not salient) or data limitations (a potentially significant fraction of direct healthcare expenditure may be in private primary care where costs are not systematically captured and reported).
  • The case of Singapore thus illustrates that even in countries perceived as success stories, strong multisectoral anti-tobacco strategies and a supporting research agenda continue to be needed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
  • [Cites] BMJ Open. 2014 Jul 09;4(7):e005199 [25009135.001]
  • [Cites] BMC Pulm Med. 2011 Jun 14;11:36 [21672193.001]
  • [Cites] Int J Cancer. 2008 Jan 1;122(1):155-64 [17893872.001]
  • [Cites] Milbank Q. 1986;64(4):489-547 [3102916.001]
  • [Cites] N Engl J Med. 1978 Mar 9;298(10):569-71 [625314.001]
  • [Cites] Int J Cardiol. 2014 Jun 1;174(1):64-72 [24742812.001]
  • [Cites] Br J Psychiatry. 2012 Jun;200(6):454-61 [22539779.001]
  • [Cites] Tob Control. 2011 Jul;20(4):266-72 [21339491.001]
  • [Cites] BMC Cancer. 2012 Sep 03;12:385 [22943444.001]
  • [Cites] Int J Chron Obstruct Pulmon Dis. 2015 Jul 21;10:1409-16 [26229460.001]
  • [Cites] PLoS One. 2013 Jul 26;8(7):e69915 [23922856.001]
  • [Cites] Singapore Med J. 2002 Jul;43(7):340-4 [12437040.001]
  • [Cites] Am J Epidemiol. 2013 Aug 1;178(3):325-38 [23785114.001]
  • [Cites] Tob Control. 2003 Mar;12(1):37-44 [12612360.001]
  • [Cites] Tob Control. 2014 Sep;23(5):428-33 [23733918.001]
  • [Cites] PLoS One. 2014 Jan 23;9(1):e86397 [24466073.001]
  • [Cites] Tob Control. 2016 Jan;25(1):96-100 [25512430.001]
  • [Cites] Diabetes Care. 1999 Nov;22(11):1887-98 [10546025.001]
  • (PMID = 28389491.001).
  • [ISSN] 2044-6055
  • [Journal-full-title] BMJ open
  • [ISO-abbreviation] BMJ Open
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; PUBLIC HEALTH / Tobacco and smoking
  •  go-up   go-down


42. Kulhánová I, Bray F, Fadhil I, Al-Zahrani AS, El-Basmy A, Anwar WA, Al-Omari A, Shamseddine A, Znaor A, Soerjomataram I: Profile of cancer in the Eastern Mediterranean region: The need for action. Cancer Epidemiol; 2017 Apr;47:125-132

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Many countries in the Eastern Mediterranean region (EMR) are undergoing marked demographic and socioeconomic transitions that are increasing the cancer burden in region.
  • METHODS: GLOBOCAN 2012 data were used to estimate cancer incidence and mortality by country, cancer type, sex and age in 22 EMR countries.
  • We calculated age-standardized incidence and mortality rates (per 100,000) using direct method of standardization.
  • RESULTS: The cancer incidence and mortality rates vary considerably between countries in the EMR.
  • For females, breast cancer is the most common cancer in all 22 countries, followed by cervical cancer, which ranks high only in the lower-income countries in the region.
  • For males, lung, prostate, and colorectal cancer in combination represent almost 30% of the cancer burden in countries that have attained very high levels of human development.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier Ltd.
  • (PMID = 28268206.001).
  • [ISSN] 1877-783X
  • [Journal-full-title] Cancer epidemiology
  • [ISO-abbreviation] Cancer Epidemiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Cancer / Eastern Mediterranean region / Incidence / Mortality / Risk factors
  •  go-up   go-down


43. Gassasse Z, Smith D, Finer S, Gallo V: Association between urbanisation and type 2 diabetes: an ecological study. BMJ Glob Health; 2017;2(4):e000473

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this study is to investigate the association between urbanisation and T2D at country level, worldwide, and to explore the role of intermediate variables (physical inactivity, sugar consumption and obesity).
  • Methods: Data for 207 countries were collected from accessible datasets.
  • Direct acyclic graphs were used to describe the association between urbanisation, T2D and their intermediate variables (physical inactivity, sugar consumption and obesity).
  • In middle-income countries (MIC) UP, AI and GDP were significantly associated with T2D prevalence, while in high-income countries (HIC), physical inactivity and obesity were the main determinant of T2D prevalence.
  • Conclusions: The type of urban growth, not urbanisation per se, predicted T2D prevalence at country level.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2016 Dec 10;388(10062):2912-2924 [27671668.001]
  • [Cites] J Urban Health. 2007 May;84(3 Suppl):i16-26 [17356903.001]
  • [Cites] Popul Health Metr. 2006 Apr 24;4:5 [16635266.001]
  • [Cites] Soc Work Public Health. 2014;29(4):335-41 [24871771.001]
  • [Cites] Public Health Nutr. 2016 May;19(7):1270-8 [26365215.001]
  • [Cites] Diabet Med. 2012 Jun;29(6):755-60 [22132939.001]
  • [Cites] Int J Health Serv. 2009;39(4):749-70 [19927413.001]
  • [Cites] Environ Res. 2012 May;115:37-50 [22480534.001]
  • [Cites] Public Health. 2014 Oct;128(10):886-95 [25369353.001]
  • [Cites] Am J Public Health. 2004 Sep;94(9):1574-9 [15333317.001]
  • [Cites] Int J Occup Med Environ Health. 2014 Dec 18;:null [25519942.001]
  • [Cites] J Epidemiol Community Health. 2015 Jul;69(7):715-8 [25987723.001]
  • [Cites] Nutr Metab Cardiovasc Dis. 2014 Oct;24(10 ):1105-11 [24954422.001]
  • [Cites] J Glob Health. 2014 Jun;4(1):010404 [24976963.001]
  • [Cites] Global Health. 2005 Aug 03;1:14 [16078989.001]
  • [Cites] PLoS Med. 2010 Apr 27;7(4):e1000268 [20436961.001]
  • [Cites] Urban Stud. 2015 Jul;52(9):1594-1614 [26321770.001]
  • [Cites] Lancet. 2016 May 28;387(10034):2207-17 [27045735.001]
  • [Cites] Int J Equity Health. 2012 Jun 12;11:31 [22691443.001]
  • [Cites] Global Health. 2006 Mar 28;2:4 [16569239.001]
  • [Cites] Int J Hyg Environ Health. 2003 Aug;206(4-5):269-78 [12971682.001]
  • [Cites] Lancet Diabetes Endocrinol. 2017 Aug;5(8):585-596 [28601585.001]
  • [Cites] Int J Diabetes Dev Ctries. 2010 Apr;30(2):63-8 [20535308.001]
  • [Cites] Diabetologia. 2012 Dec;55(12):3182-92 [22923063.001]
  • [Cites] Lancet. 2012 Mar 3;379(9818):843-52 [22386037.001]
  • [Cites] World J Diabetes. 2012 Jun 15;3(6):110-7 [22737281.001]
  • [Cites] Public Health Nutr. 2016 Sep;19(13):2336-46 [27265445.001]
  • [Cites] Diabetologia. 2016 Apr;59(4):709-18 [26831300.001]
  • [Cites] Am J Clin Nutr. 2014 Jun;99(6):1479-86 [24740206.001]
  • [Cites] Ann N Y Acad Sci. 2013 Apr;1281:64-91 [23551121.001]
  • [Cites] J Urban Health. 2008 Nov;85(6):938-51 [18931915.001]
  • (PMID = 29104770.001).
  • [ISSN] 2059-7908
  • [Journal-full-title] BMJ global health
  • [ISO-abbreviation] BMJ Glob Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; descriptive study / environmental health / epidemiology / nutrition / public health
  •  go-up   go-down


44. Samms-Vaughan M, Lambert M: The impact of polyvictimisation on children in LMICs: the case of Jamaica. Psychol Health Med; 2017 Jan 29;:1-14

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : Children who experience polyvictimization in high-income countries (HICs) are at higher risk for mental health-related trauma symptoms.
  • There is limited information on the impact of polyvictimisation on children with high levels of exposure, as occurs in some low- and middle-income countries (LMICs).
  • Findings from Structural Equational Modelling indicated that for both genders, exposure to polyvictimisation had a direct negative effect on intellectual functioning, and an indirect negative effect on achievement mediated through intellectual functioning.
  • For boys, polyvictimisation had a direct negative effect on behavioural risk.
  •   In Jamaica, a LMIC country with high levels of polyvictimisation, there is a significant negative effect of polyvictimisation on children.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28133980.001).
  • [ISSN] 1465-3966
  • [Journal-full-title] Psychology, health & medicine
  • [ISO-abbreviation] Psychol Health Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Jamaica / LMIC / Polyvictimisation / Violence / childhood
  •  go-up   go-down


45. Sah AK, Joshi B, Khadka DK, Gupta BP, Adhikari A, Singh SK, Rai G, Vaidya GS, Rajbhandari R, Pant B, Rai SK: Comparative Study of GeneXpert MTB/RIF Assay and Multiplex PCR Assay for Direct Detection of Mycobacterium tuberculosis in Suspected Pulmonary Tuberculosis Patients. Curr Microbiol; 2017 Sep;74(9):1026-1032

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative Study of GeneXpert MTB/RIF Assay and Multiplex PCR Assay for Direct Detection of Mycobacterium tuberculosis in Suspected Pulmonary Tuberculosis Patients.
  • Pulmonary tuberculosis (PTB) is one of the major infectious diseases in developing countries.
  • The objective of this study was to compare rapid diagnostics technique, GeneXpert MTB/RIF (GeneXpert) and Multiplex PCR assay (MPCR) targeting IS6110 segment and mpb64 gene for direct detection of Mycobacterium tuberculosis (MTB) in suspected PTB patients.
  • Thus, we recommend MPCR alongside GeneXpert for the better diagnostic accuracy of PTB in a resource-limited country where tuberculosis is endemic.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Ophthalmic Inflamm Infect. 2013 Jan 28;3(1):25 [23514226.001]
  • [Cites] Pathology. 1978 Jul;10(3):257-61 [364389.001]
  • [Cites] J Clin Microbiol. 1990 Mar;28(3):495-503 [1691208.001]
  • [Cites] J Clin Microbiol. 1997 Jun;35(6):1492-8 [9163468.001]
  • [Cites] J Bacteriol. 2008 May;190(9):3408-10 [18326566.001]
  • [Cites] Indian J Med Microbiol. 2013 Oct-Dec;31(4):370-3 [24064644.001]
  • [Cites] Indian J Med Microbiol. 2013 Jan-Mar;31(1):24-8 [23508425.001]
  • [Cites] Lancet Infect Dis. 2013 Apr;13(4):349-61 [23531388.001]
  • [Cites] J Glob Infect Dis. 2013 Apr;5(2):49-53 [23853431.001]
  • [Cites] J Clin Microbiol. 2011 Dec;49(12):4138-41 [21956978.001]
  • [Cites] Indian J Med Res. 2013 Mar;137(3):442-4 [23640550.001]
  • [Cites] J Clin Microbiol. 2013 Nov;51(11):3631-7 [23985924.001]
  • [Cites] Pak J Med Sci. 2015 Jan-Feb;31(1):105-10 [25878624.001]
  • [Cites] J Clin Microbiol. 1996 May;34(5):1209-15 [8727904.001]
  • [Cites] BMC Genomics. 2013 Jun 25;14:422 [23800083.001]
  • [Cites] J Clin Microbiol. 2012 Feb;50(2):326-36 [22162548.001]
  • [Cites] Cochrane Database Syst Rev. 2013 Jan 31;(1):CD009593 [23440842.001]
  • [Cites] Tuberk Toraks. 2011;59(3):213-20 [22087516.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2009 Jan 16;58(1):7-10 [19145221.001]
  • [Cites] Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Dec;82(6):780-4 [4617483.001]
  • [Cites] Indian J Med Microbiol. 2012 Apr-Jun;30(2):182-6 [22664434.001]
  • [Cites] PLoS One. 2011;6(6):e20458 [21738575.001]
  • [Cites] Tuberculosis (Edinb). 2007 Sep;87(5):393-404 [17627889.001]
  • [Cites] Lancet. 2010 May 29;375(9729):1920-37 [20488517.001]
  • [Cites] J Clin Microbiol. 1991 Nov;29(11):2578-86 [1685494.001]
  • [Cites] Int Orthop. 2012 Feb;36(2):255-9 [21442201.001]
  • [Cites] PLoS One. 2013 Oct 29;8(10):e77456 [24204834.001]
  • [Cites] Int J Mycobacteriol. 2013 Sep;2(3):179-82 [26785988.001]
  • [Cites] J Clin Microbiol. 2011 Aug;49(8):3068-70 [21677069.001]
  • [Cites] BMC Infect Dis. 2014 Nov 14;14:589 [25395048.001]
  • [Cites] J Biol Chem. 2010 Dec 3;285(49):38270-82 [20889498.001]
  • [Cites] Indian J Med Microbiol. 2013 Oct-Dec;31(4):366-9 [24064643.001]
  • [Cites] J Clin Diagn Res. 2016 May;10(5):DC09-12 [27437212.001]
  • (PMID = 28612135.001).
  • [ISSN] 1432-0991
  • [Journal-full-title] Current microbiology
  • [ISO-abbreviation] Curr. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Hayashida K, Kajino K, Simukoko H, Simuunza M, Ndebe J, Chota A, Namangala B, Sugimoto C: Direct detection of falciparum and non-falciparum malaria DNA from a drop of blood with high sensitivity by the dried-LAMP system. Parasit Vectors; 2017 Jan 13;10(1):26

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Direct detection of falciparum and non-falciparum malaria DNA from a drop of blood with high sensitivity by the dried-LAMP system.
  • BACKGROUND: Because of the low sensitivity of conventional rapid diagnostic tests (RDTs) for malaria infections, the actual prevalence of the diseases, especially those caused by non-Plasmodium falciparum (non-Pf) species, in asymptomatic populations remain less defined in countries lacking in well-equipped facilities for accurate diagnoses.
  • Our direct blood dry LAMP system (CZC-LAMP) was applied to the diagnosis of malaria as simple, rapid and highly sensitive method as an alternative for conventional RDTs in malaria endemic areas where laboratory resources are limited.
  • The direct blood LAMP diagnostic methods, in which 1 μl of anticoagulated blood were used as the template, showed the sensitivities of 98.1% for Pf, 92.1% for non-Pf, and the specificities of 98.1% for Pf, 100% for non-Pf.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28086864.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


47. Russell GM, Miller WL, Gunn JM, Levesque JF, Harris MF, Hogg WE, Scott CM, Advocat JR, Halma L, Chase SM, Crabtree BF: Contextual levers for team-based primary care: lessons from reform interventions in five jurisdictions in three countries. Fam Pract; 2017 Oct 23;
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Contextual levers for team-based primary care: lessons from reform interventions in five jurisdictions in three countries.
  • Objective: To synthesize findings across five jurisdictions in three countries to identify common contextual factors influencing the successful implementation of teamwork within PC practices.
  • Team-based PC was promoted when funding extended beyond fee-for-service, where care delivery did not require direct physician involvement and where governance was inclusive of non-physician disciplines.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29069376.001).
  • [ISSN] 1460-2229
  • [Journal-full-title] Family practice
  • [ISO-abbreviation] Fam Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Evaluation studies / health care reform / policy / primary health care / qualitative research
  •  go-up   go-down


48. Tetteh S, Bibb RJ, Martin SJ: Maxillofacial prostheses challenges in resource constrained regions. Disabil Rehabil; 2017 Oct 24;:1-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, interviews were conducted with researchers, clinicians and prosthetists that had direct experience of volunteering or working in resource-limited countries.
  • RESULTS: Results from the review and interviews suggest rehabilitating patients in resource-limited countries remains challenging and efforts to improve the situation requires a multifactorial approach.
  • CONCLUSIONS: In conclusion, public health awareness programmes to reduce the causation of injuries and bespoke maxillofacial prosthetics training programmes to suit these countries, as opposed to attempting to replicate Western training programmes.
  • The possibility of developing training programs to suit these resource limited countries and not necessarily follow conventional fabrication methods must be looked into further by educational entities.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29065718.001).
  • [ISSN] 1464-5165
  • [Journal-full-title] Disability and rehabilitation
  • [ISO-abbreviation] Disabil Rehabil
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Facial prosthetic / facial disfigurement / maxillofacial / rehabilitation / resource-limited areas
  •  go-up   go-down


49. Banović B, Turanjanin V, Miloradović A: An Ethical Review of Euthanasia and Physician-assisted Suicide. Iran J Public Health; 2017 Feb;46(2):173-179

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: In the majority of countries, active direct euthanasia is a forbidden way of the deprivation of the patients' life, while its passive form is commonly accepted.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] HEC Forum. 2013 Sep;25(3):229-43 [23338120.001]
  • [Cites] S Afr Med J. 2012 May 22;102(6 Pt 2):334 [22668890.001]
  • [Cites] Ann Intern Med. 1994 Nov 15;121(10 ):793-802 [7944057.001]
  • [Cites] Iran J Public Health. 2014 Oct;43(10):1316-23 [26056652.001]
  • [Cites] Aging (Milano). 1998 Apr;10(2):93-101 [9666189.001]
  • [Cites] J Med Ethics. 2008 Jan;34(1):28-32 [18156518.001]
  • [Cites] J Evang Theol Soc. 1988 Mar;31(1):81-90 [11652028.001]
  • [Cites] Wien Med Wochenschr. 2003;153(17-18):387-91 [14571664.001]
  • [Cites] Med Health Care Philos. 2004;7(3):333-9 [15679025.001]
  • [Cites] Med Health Care Philos. 2013 May;16(2):197-209 [22020798.001]
  • [Cites] J Med Philos. 1992 Dec;17(6):665-81 [1479311.001]
  • (PMID = 28451551.001).
  • [ISSN] 2251-6085
  • [Journal-full-title] Iranian journal of public health
  • [ISO-abbreviation] Iran. J. Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Keywords] NOTNLM ; Active euthanasia / Ethics / Morality / Passive euthanasia / Physician-assisted suicide
  •  go-up   go-down


50. Briolant S, Pradines B, Basco LK: [Role of primaquine in malaria control and elimination in French-speaking Africa]. Bull Soc Pathol Exot; 2017 Aug;110(3):198-206
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primaquine, an 8-aminoquinoline, is a relatively unknown and underutilized drug in French-speaking African countries.
  • There is an ethical concern in administering primaquine as a gametocytocide as it does not confer any direct benefit to the treated patient.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28417346.001).
  • [ISSN] 0037-9085
  • [Journal-full-title] Bulletin de la Societe de pathologie exotique (1990)
  • [ISO-abbreviation] Bull Soc Pathol Exot
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] France
  • [Keywords] NOTNLM ; Drug resistance / Duffy antigen / French-speaking Africa / G6PD deficiency / Malaria / Plasmodium falciparum / Plasmodium ovale / Plasmodium vivax / Primaquine
  •  go-up   go-down


51. Hiby E, Hiby L: Direct Observation of Dog Density and Composition during Street Counts as a Resource Efficient Method of Measuring Variation in Roaming Dog Populations over Time and between Locations. Animals (Basel); 2017 Aug 03;7(8)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Direct Observation of Dog Density and Composition during Street Counts as a Resource Efficient Method of Measuring Variation in Roaming Dog Populations over Time and between Locations.
  • Dog population management is conducted in many countries to address the public health risks from roaming dogs and threats to their welfare.
  • The implementation of this method in seven locations reveals significant difference in roaming dog density between locations and reduction in density within one location subject to intervention.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMC Vet Res. 2008 Jan 31;4:6 [18237372.001]
  • [Cites] BMC Vet Res. 2012 Dec 05;8:236 [23217194.001]
  • [Cites] Prev Vet Med. 2013 Feb 1;108(2-3):209-17 [22906504.001]
  • [Cites] Vet Rec. 2013 May 4;172(18):473 [23492927.001]
  • [Cites] BMC Vet Res. 2011 Aug 11;7:46 [21834979.001]
  • [Cites] Vet Rec. 2006 Sep 16;159(12):379-83 [16980523.001]
  • [Cites] Prev Vet Med. 2010 Oct 1;97(1):51-7 [20696487.001]
  • [Cites] Prev Vet Med. 2010 May 1;94(3-4):272-81 [20096943.001]
  • [Cites] BMC Vet Res. 2017 May 30;13(1):143 [28558736.001]
  • (PMID = 28771177.001).
  • [ISSN] 2076-2615
  • [Journal-full-title] Animals : an open access journal from MDPI
  • [ISO-abbreviation] Animals (Basel)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; animal welfare / dog / dog population management / evaluation / monitoring / population density / stray dog / strip transect / survey
  •  go-up   go-down


52. Shah R, Shah S: Delayed presentation or delayed diagnosis? A retrospective study of prospectively collected data of 482 foot and ankle injuries. Injury; 2017 Aug;48 Suppl 2:S27-S32
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Delayed presentation of injury cases is common in developing countries like India.
  • Of these twenty six cases were never treated by qualified orthopaedic surgeons and were labelled as direct delayed presentations, and the remaining 72 cases who were treated by qualified orthopaedic surgeons, but could not be diagnosed and presented late, were labelled as indirect delayed presentations.
  • CONCLUSIONS: In developing countries like India, patients did neglect their foot and ankle injuries and presented late.
  • This is contrary to the common belief that in developing countries like India, only patients would be solely responsible for delayed presentations after injury.
  • Because delayed diagnosis by clinicians seemed more alarming than delayed presentation by patients, focus of prevention of foot and ankle injuries in developing countries should shift more towards educating clinicians than patients.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28802418.001).
  • [ISSN] 1879-0267
  • [Journal-full-title] Injury
  • [ISO-abbreviation] Injury
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Delayed diagnosis / Delayed presentation / Failure to diagnose / Failure to suspect / Foot and ankle injuries / Indirect delayed presentations
  •  go-up   go-down


53. Sommer R, Bullinger M, Chaplin J, Do JK, Power M, Pleil A, Quitmann J: Experiencing health-related quality of life in paediatric short stature - a cross-cultural analysis of statements from patients and parents. Clin Psychol Psychother; 2017 Jul 04;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Direct assessment of the patient perspective is necessary to thoroughly understand patients' experiences of disease.
  • We aimed to examine information from children with short stature on their perceived HrQoL within 5 European countries.
  • Domains and respective coding frequencies per category were compared across countries and respondents.
  • Because socioemotional topics were rated in all the countries to be most important, interventions aimed at improving HrQoL should target social and emotional responses to short stature.
  • Social and emotional aspects of living with short stature are the most frequently discussed topics by children as well as by parents across countries; these topics provide important objectives for tailoring appropriate psychosocial interventions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 John Wiley & Sons, Ltd.
  • (PMID = 28675583.001).
  • [ISSN] 1099-0879
  • [Journal-full-title] Clinical psychology & psychotherapy
  • [ISO-abbreviation] Clin Psychol Psychother
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; children / cross-cultural research / parents / qualitative research / quality of life / short stature
  •  go-up   go-down


54. Ibrahim A, Umar UI, Usman UM, Owolabi LF: Economic evaluation of childhood epilepsy in a resource-challenged setting: A preliminary survey. Epilepsy Behav; 2017 Nov;76:84-88

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Considerable disease variability exists between patients with epilepsy, and the societal costs for epilepsy care are overall high, because of high frequency in the general population especially in children from developing countries.
  • Prevalence-based costs were stratified by patients' sociodemographic characteristics and socioeconomic scores (SES).
  • The 'bottom-up' and 'human capital' approaches were used to generate estimates on the direct and indirect (productivity losses) costs of epilepsy, respectively.
  • Majority (61.3%) belong to the low socioeconomic class (Ogunlesi SES class IV and V) and reside (80.6%) in an urban setting.
  • The total direct and indirect costs per month were ₦2,149,965.00 ($8497.88) and ₦363,187.80 ($1435.52), respectively.
  • Investigative procedures are the principal cost drivers (₦15,861.17 or $18.15) comprising approximately 58.7% of the total direct costs per patient.
  • CONCLUSIONS: Cost of investigations contributed immensely to the total direct cost of care in our study.
  • With the present economic situation in the country, out-of-pocket payments may contribute significantly to catastrophic expenditures and worsening of secondary treatment gap in children with epilepsy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 28917500.001).
  • [ISSN] 1525-5069
  • [Journal-full-title] Epilepsy & behavior : E&B
  • [ISO-abbreviation] Epilepsy Behav
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Direct cost / Economic recession / Epilepsy / Indirect cost
  •  go-up   go-down


55. Mobaraki H, Azami-Aghdash S, Sarabi Asiabar A, Rezapour A, Kafaei Mehr MH, Emamgolizadeh S: Cost-effectiveness of Eplerenone in treatment of cardiovascular diseases: a systematic review. Med J Islam Repub Iran; 2017;31:4

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The required information were collected using key Mesh words from the following databases: Google scholar, PubMed, Science Direct, MagIran, SID, Scopus, and handsearching journals and the references of the selected articles.
  • The selected studies have been conducted in 8 countries (The United States, Britain, Australia, Switzerland, France, Spain, the Netherlands, and Canada).
  • Incremental cost-effectiveness ratio was high in the United States compared to European countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Medicine (Baltimore). 2016 May;95(18):e3531 [27149456.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(8):3715-20 [24870782.001]
  • [Cites] Arch Cardiovasc Dis. 2008 Sep;101(9):515-21 [19041835.001]
  • [Cites] Clin Ther. 2003 Sep;25(9):2388-404 [14604739.001]
  • [Cites] Med J Islam Repub Iran. 2015 Aug 10;29:246 [26793637.001]
  • [Cites] Cardiovasc Drugs Ther. 2006 Jun;20(3):193-204 [16775667.001]
  • [Cites] N Engl J Med. 2003 Apr 3;348(14):1309-21 [12668699.001]
  • [Cites] Med J Islam Repub Iran. 2016 Feb 14;30:327 [27390697.001]
  • [Cites] Circulation. 2005 Mar 8;111(9):1106-13 [15723981.001]
  • [Cites] Am J Cardiovasc Drugs. 2014 Jun;14(3):209-16 [24610254.001]
  • [Cites] Curr Hypertens Rep. 2014 Feb;16(2):414 [24407447.001]
  • [Cites] Am J Cardiol. 2004 Apr 15;93(8):990-6 [15081441.001]
  • [Cites] Heart. 2014 Nov;100(21):1681-7 [24993605.001]
  • [Cites] Pharmacoeconomics. 2005;23(10):1057-72 [16235978.001]
  • [Cites] Int J Cardiol. 2014 Nov 15;177(1):219-28 [25499383.001]
  • [Cites] Value Health. 2012 May;15(3):420-8 [22583451.001]
  • [Cites] Int J Cardiol. 2015 Dec 1;200:8-11 [25466561.001]
  • [Cites] J Am Coll Cardiol. 2011 Nov 1;58(19):1958-66 [22032706.001]
  • [Cites] Am J Cardiovasc Drugs. 2016 Oct;16(5):365-76 [27300508.001]
  • [Cites] Ann Pharmacother. 2005 Jan;39(1):68-76 [15590870.001]
  • [Cites] Circulation. 2012 Jan 17;125(2):271-9 [22128223.001]
  • [Cites] Proc (Bayl Univ Med Cent). 2004 Apr;17(2):217-20 [16200104.001]
  • [Cites] Circulation. 2009 Jan 27;119(3):398-407 [19139382.001]
  • [Cites] J Evid Based Med. 2014 Feb;7(1):26-31 [25155563.001]
  • [Cites] J Med Ethics. 2013 Feb;39(2):110-4 [23015747.001]
  • [Cites] Eur J Health Econ. 2008 Feb;9(1):69-78 [17447095.001]
  • [Cites] J Renin Angiotensin Aldosterone Syst. 2011 Sep;12(3):340-7 [21393354.001]
  • [Cites] Neth Heart J. 2005 Nov;13(11):393-400 [25696430.001]
  • [Cites] Am J Cardiovasc Drugs. 2010;10(1):55-63 [20104935.001]
  • (PMID = 28638811.001).
  • [ISSN] 1016-1430
  • [Journal-full-title] Medical journal of the Islamic Republic of Iran
  • [ISO-abbreviation] Med J Islam Repub Iran
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Iran
  • [Keywords] NOTNLM ; Cardiovascular Disease / Cost-effectiveness / Eplerenone / Systematic Review
  •  go-up   go-down


56. Sprawls P: WE-H-201-04: Models for Developing Medical Physics Educators and Education Programs in the Developing Countries and the Potential Role of US Universities and Individual Medical Physicists. Med Phys; 2016 Jun;43(6):3839

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] WE-H-201-04: Models for Developing Medical Physics Educators and Education Programs in the Developing Countries and the Potential Role of US Universities and Individual Medical Physicists.
  • : The desperate need for radiotherapy in low and mid-income countries (LMICs) has been well documented.
  • Wil Ngwa - A recent United Nations Study reports that in developing countries more people have access to cell phones than toilets.
  • Yakov Pipman - The number and scope of volunteer Medical Physics activities in support of low-to-middle income countries has been increasing gradually.
  • Perry Sprawls - With the growing capability and complexity of medical imaging methods in all countries of the world, the expanding role of medical physicists includes optimizing imaging procedures with respect to image quality, radiation dose, and other conflicting factors.
  • With access to appropriate educational resources local medical physicists in all countries can provide direct clinical support and educational for other medical professionals.
  • This is being supported through the process of Collaborative Teaching that combines the capabilities and experience of medical physicists in countries spanning the spectrum of economic, technological, and clinical development.
  • 2. Use collaborative teaching resources to enhance the role of medical physicists in all countries of the world.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2016 American Association of Physicists in Medicine.
  • (PMID = 28047760.001).
  • [ISSN] 2473-4209
  • [Journal-full-title] Medical physics
  • [ISO-abbreviation] Med Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Cancer / Learning / Medical image quality / Medical physicists / Physics education / Radiation therapy / Telephones
  •  go-up   go-down


57. Higgs ES, Dubey SA, Coller BAG, Simon JK, Bollinger L, Sorenson RA, Wilson B, Nason MC, Hensley LE: Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak. Curr Top Microbiol Immunol; 2017 Sep 17;
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Past experience with limited localized outbreaks, lack of licensed medical countermeasures, reluctance by first responders to direct scarce resources to clinical research, community resistance to outside interventions, and lack of local infrastructure were among the factors delaying clinical research during the outbreak.
  • Each of the three Ebola virus disease-affected countries, Sierra Leone, Guinea, and Liberia, conducted a phase II/III Ebola virus vaccine trial.
  • Thoughtful and intensive community engagement in each country enabled the critical community partnership and acceptance of the phase II/III in each country.
  • Due to the delayed clinical trial initiation, relative to the epidemiologic peak of the outbreak in the three countries, vaccine interventions may or may not have played a major role in bringing the epidemic under control.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28918539.001).
  • [ISSN] 0070-217X
  • [Journal-full-title] Current topics in microbiology and immunology
  • [ISO-abbreviation] Curr. Top. Microbiol. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


58. El Fezzazi H, Branchu M, Carrasquilla G, Pitisuttithum P, Perroud AP, Frago C, Coudeville L: Resource Use and Costs of Dengue: Analysis of Data from Phase III Efficacy Studies of a Tetravalent Dengue Vaccine. Am J Trop Med Hyg; 2017 Oct 16;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A tetravalent dengue vaccine (CYD-TDV) has recently been approved in 12 countries in southeast Asia and Latin America for individuals aged 9-45 years or 9-60 years (age indication approvals vary by country) living in endemic areas.
  • Data on utilization of medical and nonmedical resources as well as time lost from school and work were collected during the active phase of two phase III efficacy studies performed in 10 countries in the Asia-Pacific region and Latin America (NCT01373281; NCT01374516).
  • Country-specific unit costs were derived from available literature.
  • The estimated direct and indirect cost (2014 I$) associated with dengue episodes per participant in the CYD-TDV group was 73% lower than in the control group (I$6.72 versus I$25.08); representing a saving of I$I8.36 (95% confidence interval [CI]:17.05-19.78) per participant with vaccination.
  • This is the first study providing information on dengue costs among vaccinated individuals and direct confirmation that vaccination has the potential to reduce dengue illness costs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29141713.001).
  • [ISSN] 1476-1645
  • [Journal-full-title] The American journal of tropical medicine and hygiene
  • [ISO-abbreviation] Am. J. Trop. Med. Hyg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


59. Worsley A, Wang W, Sarmugam R, Pham Q, Februhartanty J, Ridley S: Family Food Providers' Perceptions of the Causes of Obesity and Effectiveness of Weight Control Strategies in Five Countries in the Asia Pacific Region: A Cross-Sectional Survey. Nutrients; 2017 Jan 18;9(1)
MedlinePlus Health Information. consumer health - Obesity.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Family Food Providers' Perceptions of the Causes of Obesity and Effectiveness of Weight Control Strategies in Five Countries in the Asia Pacific Region: A Cross-Sectional Survey.
  • The rise of the middle classes in developing countries and the associated epidemiological transition raises the importance of assessing this population group's awareness of the causes of obesity and effective weight control strategies in order to develop effective health promotion strategies.
  • The CFA and SEM showed that demographics, region of residence, personal values and perceptions of the causes of obesity (<i>Unhealthy food behaviours</i>, influences <i>Beyond personal control</i> and <i>Environmental influences</i>) had direct and indirect associations with three weight control methods factors, named: <i>Healthy habits, Eat less, sit less</i>, and <i>Dieting.
  • Further research is required among lower socio economic status (SES) populations.

  • Genetic Alliance. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Obes Rev. 2013 Nov;14 Suppl 2:1-8 [24102826.001]
  • [Cites] Int J Obes Relat Metab Disord. 2003 Dec;27(12):1465-71 [14634676.001]
  • [Cites] J Econ Perspect. 2008;22(2):3-28 [19212452.001]
  • [Cites] Am J Prev Med. 2013 Apr;44(4):358-64 [23498101.001]
  • [Cites] Lancet. 2013 Feb 23;381(9867):670-9 [23410611.001]
  • [Cites] Health Educ Res. 2006 Dec;21(6):848-61 [17095572.001]
  • [Cites] Med J Aust. 2007 May 7;186(9):458-60 [17484707.001]
  • [Cites] J Am Diet Assoc. 2000 Aug;100(8):947-9 [10955055.001]
  • [Cites] Am J Clin Nutr. 2004 Jan;79(1):6-16 [14684391.001]
  • [Cites] PLoS Med. 2012;9(7):e1001254 [22802734.001]
  • [Cites] Asia Pac J Clin Nutr. 2000 Mar;9(1):24-32 [24394312.001]
  • [Cites] J Epidemiol Community Health. 1995 Feb;49(1):28-32 [7707001.001]
  • (PMID = 28106781.001).
  • [ISSN] 2072-6643
  • [Journal-full-title] Nutrients
  • [ISO-abbreviation] Nutrients
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Asia Pacific / food providers / obesity / perceptions / survey / weight concerns
  •  go-up   go-down


60. Ladeira C, Frazzoli C, Orisakwe OE: Engaging One Health for Non-Communicable Diseases in Africa: Perspective for Mycotoxins. Front Public Health; 2017;5:266

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In many African countries, the public health impact of chronic (indoor) and/or repeated (dietary) mycotoxin exposure is largely ignored hitherto, with impact on human health, food security, and export of African agricultural food products.
  • Starting from Nigeria as leading African Country, this article (i) overviews available data on mycotoxins exposure in Africa;.
  • (iii) identifies milestones for mycotoxins risk management already reached in West Africa; and (iv) points out preliminary operationalization aspects for shielding communities from direct (on health) and indirect (on trade, economies, and livelihoods) effects of mycotoxins.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Ist Super Sanita. 2009;45(1):65-75 [19567981.001]
  • [Cites] Food Chem Toxicol. 2013 Jul;57:276-83 [23562706.001]
  • [Cites] Int Rev Psychiatry. 2008 Jun;20(3):281-9 [18569180.001]
  • [Cites] Environ Health Perspect. 2003 Feb;111(2):217-20 [12573908.001]
  • [Cites] Front Public Health. 2017 May 05;5:80 [28529937.001]
  • [Cites] Appl Environ Microbiol. 2013 Apr;79(7):2225-32 [23354708.001]
  • [Cites] Zoonoses Public Health. 2010 Dec;57(7-8):e136-42 [20163579.001]
  • [Cites] Afr Health Sci. 2007 Dec;7(4):223-7 [21499487.001]
  • [Cites] Int J Toxicol. 2014 May;33(3):155-161 [24728861.001]
  • [Cites] Afr J Reprod Health. 2015 Sep;19(3):9-17 [26897908.001]
  • [Cites] Environ Health Perspect. 2015 Feb;123(2):173-8 [25325363.001]
  • [Cites] Environ Health Perspect. 2005 Dec;113(12):1763-7 [16330360.001]
  • [Cites] Mutat Res. 1999 Mar 8;424(1-2):167-81 [10064859.001]
  • [Cites] Food Microbiol. 2014 Aug;41:52-9 [24750813.001]
  • [Cites] Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2012;29(6):962-71 [22376138.001]
  • [Cites] Nature. 1991 Apr 4;350(6317):427-8 [1849234.001]
  • [Cites] Nutr Neurosci. 2016;19(1):43-6 [25597866.001]
  • [Cites] Toxicology. 2001 Oct 15;167(2):101-34 [11567776.001]
  • [Cites] Int J Epidemiol. 2003 Aug;32(4):556-62 [12913029.001]
  • [Cites] Toxicol Lett. 2012 Nov 15;214(3):268-78 [22982764.001]
  • [Cites] Niger Med J. 2015 Jul-Aug;56(4):231-5 [26759504.001]
  • [Cites] Appl Environ Microbiol. 2007 Apr;73(8):2762-4 [17308181.001]
  • [Cites] Toxicol Lett. 2013 Mar 13;217(3):243-50 [23296098.001]
  • [Cites] Mycopathologia. 2011 Jun;171(6):435-9 [21104323.001]
  • [Cites] Biol Reprod. 2007 Nov;77(5):840-7 [17652666.001]
  • [Cites] Front Public Health. 2017 Jul 28;5:182 [28804707.001]
  • [Cites] Mycotoxin Res. 2010 May;26(2):133-40 [23605317.001]
  • [Cites] Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Oct;25(10):1246-56 [18608489.001]
  • [Cites] Mutagenesis. 2002 Nov;17(6):471-81 [12435844.001]
  • [Cites] Birth Defects Res A Clin Mol Teratol. 2005 Jul;73(7):487-97 [15959874.001]
  • [Cites] J Toxicol Environ Health A. 2012;75(22-23):1330-40 [23095151.001]
  • [Cites] J Food Prot. 2004 Jan;67(1):96-102 [14717358.001]
  • [Cites] Mycopathologia. 1993 Oct;124(1):41-6 [8159216.001]
  • [Cites] BMC Public Health. 2013 Apr 18;13:361 [23597167.001]
  • [Cites] Mycopathologia. 2006 Jul;162(1):57-63 [16830193.001]
  • [Cites] Am J Clin Nutr. 2010 Jul;92 (1):154-60 [20484447.001]
  • [Cites] J Agric Food Chem. 2011 May 25;59(10):5173-80 [21495720.001]
  • [Cites] Can Fam Physician. 2002 Feb;48:298-302 [11889889.001]
  • [Cites] J Expo Sci Environ Epidemiol. 2008 Jul;18(4):392-9 [17940556.001]
  • [Cites] Exp Toxicol Pathol. 2002 Feb;53(6):481-7 [11926291.001]
  • [Cites] Toxins (Basel). 2014 Jan 28;6(2):523-38 [24476712.001]
  • [Cites] Toxins (Basel). 2012 Oct;4(10 ):836-48 [23162700.001]
  • [Cites] Ethiop Med J. 1996 Oct;34(4):243-9 [9164040.001]
  • [Cites] Afr Health Sci. 2009 Dec;9(4):218-26 [21503172.001]
  • [Cites] Toxicol Lett. 2011 Oct 10;206(2):210-7 [21803136.001]
  • [Cites] Vet Rec. 2015 May 9;176(19):496-7 [25953874.001]
  • [Cites] J AOAC Int. 1993 Jul-Aug;76(4):842-6 [8374329.001]
  • [Cites] Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(6):1064-80 [24684161.001]
  • [Cites] Food Chem Toxicol. 2013 Oct;60:218-37 [23907020.001]
  • [Cites] J Toxicol Environ Health A. 2013;76(15):944-51 [24156697.001]
  • [Cites] Toxicol Sci. 2014 May;139(1):83-98 [24496642.001]
  • [Cites] Food Addit Contam. 2007 Jun;24(6):621-9 [17487603.001]
  • [Cites] Congenit Anom (Kyoto). 2010 Mar;50(1):29-39 [20201966.001]
  • [Cites] Food Addit Contam Part B Surveill. 2014;7(1):17-20 [24779973.001]
  • [Cites] BMJ. 1992 Sep 12;305(6854):609-13 [1393072.001]
  • [Cites] Crit Rev Food Sci Nutr. 2013;53(4):349-65 [23320907.001]
  • [Cites] Mol Autism. 2014 Jul 30;5:40 [25126405.001]
  • [Cites] Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Nov;25(11):1353-64 [19680843.001]
  • [Cites] Int J Food Microbiol. 2008 May 10;124(1):1-12 [18258326.001]
  • [Cites] Annu Rev Food Sci Technol. 2014;5:351-72 [24422587.001]
  • [Cites] Cell Tissue Res. 2005 Oct;322(1):33-41 [15912407.001]
  • [Cites] Int J Fertil Menopausal Stud. 1994 Jul-Aug;39(4):208-14 [7951403.001]
  • [Cites] Trop Med Int Health. 2014 Mar;19(3):348-354 [24372685.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 1996 Mar;5(3):179-89 [8833618.001]
  • [Cites] Toxicol Lett. 2013 Apr 26;218(3):200-6 [23402939.001]
  • [Cites] BMJ. 2002 Jul 6;325(7354):20-1 [12098724.001]
  • [Cites] Niger J Physiol Sci. 2009 Dec;24(2):85-90 [20234744.001]
  • [Cites] J Stored Prod Res. 2000 Oct 15;36(4):365-382 [10880814.001]
  • [Cites] J Vet Med Sci. 2014 Jun;76(6):789-97 [24572628.001]
  • [Cites] East Afr Med J. 2008 Jul;85(7):311-7 [19133419.001]
  • [Cites] Afr J Health Sci. 2004;11(1-2):43-54 [17298116.001]
  • [Cites] Trop Med Int Health. 2010 Feb;15(2):160-7 [20003033.001]
  • [Cites] Asian Pac J Trop Biomed. 2012 Jun;2(6):465-8 [23569951.001]
  • [Cites] Front Psychiatry. 2014 Aug 04;5:53 [25136320.001]
  • [Cites] Food Chem Toxicol. 2013 Feb;52:1-11 [23137957.001]
  • [Cites] Environ Health Perspect. 2011 Dec;119(12):1794-9 [21843999.001]
  • [Cites] Int J Epidemiol. 2000 Apr;29(2):285-91 [10817127.001]
  • [Cites] J Pathol. 1991 Jul;164(3):225-33 [1890547.001]
  • [Cites] Nutr Res Rev. 2012 Jun;25(1):162-79 [22651937.001]
  • [Cites] Mycopathologia. 2001;152(1):35-40 [11694094.001]
  • [Cites] Int J Vitam Nutr Res. 2010 Dec;80(6):355-68 [21792816.001]
  • [Cites] Food Chem Toxicol. 2009 May;47(5):1009-21 [19353812.001]
  • [Cites] Toxicol Lett. 2013 Jul 18;220(3):238-46 [23688591.001]
  • [Cites] Food Chem Toxicol. 2013 Dec;62:927-34 [24128729.001]
  • [Cites] Int Immunol. 2005 Jun;17(6):807-14 [15944194.001]
  • [Cites] Afr J Med Med Sci. 1991 Mar;20(1):23-7 [1905466.001]
  • [Cites] Eur J Cancer Care (Engl). 2010 Jul;19(4):516-21 [20030698.001]
  • [Cites] Mycopathologia. 2004 Jan;157(1):111-5 [15008353.001]
  • [Cites] Toxicol Rep. 2017 Jul 01;4:474-483 [28959677.001]
  • [Cites] Mol Nutr Food Res. 2010 Nov;54(11):1659-67 [20521269.001]
  • [Cites] Anal Bioanal Chem. 2007 Sep;389(1):147-57 [17508207.001]
  • [Cites] J Agric Food Chem. 2012 Sep 12;60(36):9352-63 [22835072.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2004 Sep 3;53(34):790-3 [15343146.001]
  • [Cites] Food Addit Contam Part B Surveill. 2016 Sep;9(3):217-22 [27088795.001]
  • [Cites] Food Chem Toxicol. 2005 Apr;43(4):623-35 [15721211.001]
  • [Cites] Brain Res. 2011 Mar 22;1380:85-97 [20868653.001]
  • [Cites] J Agric Food Chem. 2008 Jun 11;56(11):3900-11 [18444660.001]
  • [Cites] Clin Microbiol Rev. 2003 Jul;16(3):497-516 [12857779.001]
  • [Cites] Food Chem Toxicol. 2008 Feb;46(2):519-26 [17920747.001]
  • [Cites] Hum Reprod Update. 2011 May-Jun;17(3):418-33 [21266373.001]
  • [Cites] Sci Rep. 2016 Apr 29;6:25175 [27125631.001]
  • [Cites] Int J Food Microbiol. 2009 Oct 31;135(2):99-104 [19716615.001]
  • [Cites] Food Chem Toxicol. 2009 May;47(5):915-26 [18272277.001]
  • [Cites] Environ Int. 2014 May;66:138-45 [24583186.001]
  • [Cites] Ann Occup Hyg. 2015 Mar;59(2):173-81 [25324565.001]
  • [Cites] Toxins (Basel). 2012 Oct;4(10 ):788-809 [23162698.001]
  • [Cites] Mycotoxin Res. 2011 May;27(2):97-104 [21836766.001]
  • [Cites] Int J Food Microbiol. 2000 Nov 1;61(2-3):147-57 [11078165.001]
  • [Cites] Food Chem Toxicol. 2007 Jul;45(7):1210-5 [17306915.001]
  • [Cites] Environ Mol Mutagen. 2014 May;55(4):354-62 [24288346.001]
  • [Cites] J Food Prot. 2017 Jan;80(1):57-67 [28221872.001]
  • [Cites] Appl Environ Microbiol. 2004 Nov;70(11):6394-400 [15528497.001]
  • [Cites] Toxicol Sci. 2011 Mar;120 Suppl 1:S28-48 [20881231.001]
  • [Cites] Int J Epidemiol. 2007 Oct;36(5):1119-25 [17576701.001]
  • [Cites] Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2103-8 [20488220.001]
  • [Cites] Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Feb;25(2):146-51 [18286404.001]
  • [Cites] Front Public Health. 2017 Feb 02;4:294 [28210616.001]
  • [Cites] Vet Hum Toxicol. 1986 Feb;28(1):1-5 [3705429.001]
  • [Cites] Food Chem Toxicol. 2009 May;47(5):984-91 [18037552.001]
  • [Cites] Food Addit Contam. 2006 Jul;23(7):700-8 [16751147.001]
  • [Cites] Crit Rev Toxicol. 2011 Oct;41(9):740-55 [21711088.001]
  • [Cites] Food Addit Contam Part B Surveill. 2016 Sep;9(3):230-5 [27134068.001]
  • [Cites] J Nutr. 2004 Apr;134(4):711-6 [15051815.001]
  • [Cites] Int J Food Microbiol. 2007 Oct 20;119(1-2):109-15 [17881074.001]
  • [Cites] Food Chem. 2012 Nov 15;135(2):423-9 [22868109.001]
  • [Cites] J Appl Toxicol. 2008 Jul;28(5):681-8 [18027362.001]
  • [Cites] Int J Food Microbiol. 2010 Jul 15;141(3):213-21 [20626099.001]
  • [Cites] Am J Clin Nutr. 2004 Nov;80(5):1106-22 [15531656.001]
  • [Cites] Int J Food Microbiol. 2009 Mar 15;130(1):27-34 [19193467.001]
  • [Cites] Environ Health Perspect. 2004 Sep;112(13):1334-8 [15345349.001]
  • [Cites] Afr J Psychiatry (Johannesbg). 2011 Jul;14(3):208-10 [21863205.001]
  • [Cites] Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2539-41 [20478351.001]
  • [Cites] J Health Popul Nutr. 2011 Aug;29(4):415-9 [21957681.001]
  • [Cites] J Biol Chem. 1997 Jul 18;272(29):18020-5 [9218430.001]
  • [Cites] Pan Afr Med J. 2015 Jan 30;20:90 [26090048.001]
  • [Cites] Theriogenology. 2010 Oct 1;74(6):968-78 [20570324.001]
  • [Cites] PLoS Negl Trop Dis. 2014 May 22;8(5):e2884 [24851901.001]
  • [Cites] Analyst. 2001 Feb;126(2):179-83 [11235100.001]
  • [Cites] Food Chem Toxicol. 2009 May;47(5):1022-39 [18761390.001]
  • [Cites] Food Chem Toxicol. 2009 May;47(5):932-50 [18255210.001]
  • (PMID = 29085817.001).
  • [ISSN] 2296-2565
  • [Journal-full-title] Frontiers in public health
  • [ISO-abbreviation] Front Public Health
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; food safety / food security / immune system / risk assessment / risk management
  •  go-up   go-down


61. Knudsen MT, Hermansen JE, Cederberg C, Herzog F, Vale J, Jeanneret P, Sarthou JP, Friedel JK, Balázs K, Fjellstad W, Kainz M, Wolfrum S, Dennis P: Characterization factors for land use impacts on biodiversity in life cycle assessment based on direct measures of plant species richness in European farmland in the 'Temperate Broadleaf and Mixed Forest' biome. Sci Total Environ; 2017 Feb 15;580:358-366

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characterization factors for land use impacts on biodiversity in life cycle assessment based on direct measures of plant species richness in European farmland in the 'Temperate Broadleaf and Mixed Forest' biome.
  • Based on a unique dataset derived from field recording of plant species diversity in farmland across six European countries, the present study provides new midpoint occupation Characterization Factors (CF) expressing the Potentially Disappeared Fraction (PDF) to estimate land use impacts on biodiversity in the 'Temperate Broadleaf and Mixed Forest' biome in Europe.
  • While species richness differs between countries, the calculated CFs are able to distinguish between different land use types (pastures (monocotyledons or mixed), arable land and hedges) and management practices (organic or conventional production systems) across countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 Elsevier B.V. All rights reserved.
  • (PMID = 27979626.001).
  • [ISSN] 1879-1026
  • [Journal-full-title] The Science of the total environment
  • [ISO-abbreviation] Sci. Total Environ.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Biodiversity damage potential / Conventional farming / General habitat categories / LCA / Organic agriculture / Potentially disappeared fraction of species
  •  go-up   go-down


62. Medeiros GC, Torres AR, Boisseau CL, Leppink EW, Eisen JL, Fontenelle LF, do Rosário MC, Mancebo MC, Rasmussen SA, Ferrão YA, Grant JE: A cross-cultural clinical comparison between subjects with obsessive-compulsive disorder from the United States and Brazil. Psychiatry Res; 2017 Aug;254:104-111

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Although OCD is a global problem, the literature comparing, in a direct and standardized way, the manifestations across countries is scarce.
  • This is the largest direct cross-cultural comparison to date in the OCD field.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.
  • [Cites] Arch Gen Psychiatry. 2005 Jun;62(6):593-602 [15939837.001]
  • [Cites] J Clin Psychopharmacol. 1994 Aug;14(4):247-54 [7962680.001]
  • [Cites] J Am Acad Child Adolesc Psychiatry. 2002 Mar;41(3):262-8 [11886020.001]
  • [Cites] Nat Rev Neurosci. 2014 Jun;15(6):410-24 [24840803.001]
  • [Cites] Aust N Z J Psychiatry. 2015 Sep;49(9):851 [25916798.001]
  • [Cites] Psychiatr Clin North Am. 2000 Sep;23(3):493-507 [10986723.001]
  • [Cites] J Clin Psychiatry. 1997 Jul;58(7):330-4; quiz 335-6 [9269260.001]
  • [Cites] Arch Gen Psychiatry. 2007 Jul;64(7):830-42 [17606817.001]
  • [Cites] Mol Psychiatry. 2006 May;11(5):495-504 [16432526.001]
  • [Cites] J Anxiety Disord. 1997 May-Jun;11(3):317-28 [9220303.001]
  • [Cites] J Psychiatr Res. 2004 Jul-Aug;38(4):403-11 [15203292.001]
  • [Cites] Arch Gen Psychiatry. 1989 Nov;46(11):1006-11 [2684084.001]
  • [Cites] J Psychiatr Res. 2003 Mar-Apr;37(2):127-33 [12842166.001]
  • [Cites] Gastroenterol Hepatol Bed Bench. 2012 Spring;5(2):79-83 [24834204.001]
  • [Cites] Mol Psychiatry. 2010 Jan;15(1):53-63 [18725912.001]
  • [Cites] Am J Psychiatry. 2001 Oct;158(10):1733-5 [11579014.001]
  • [Cites] J Clin Psychiatry. 2006 Nov;67(11):1713-20 [17196050.001]
  • [Cites] Rev Bras Psiquiatr. 2012 Oct;34(3):249-60 [23429770.001]
  • [Cites] Hum Psychopharmacol. 2016 Jul;31(4):319-24 [27271200.001]
  • [Cites] Aggress Violent Behav. 2013 Sep;18(5):471-483 [24027422.001]
  • [Cites] Br J Psychiatry. 2006 Jan;188:81-2 [16388075.001]
  • [Cites] Psychiatry Res. 2015 Dec 15;230(2):430-5 [26474662.001]
  • [Cites] Br J Psychiatry. 1996 Jul;169(1):101-7 [8818377.001]
  • [Cites] Acta Psychiatr Scand. 2005 May;111(5):329-30 [15819725.001]
  • [Cites] J Abnorm Psychol. 2008 Aug;117(3):662-72 [18729617.001]
  • [Cites] Depress Anxiety. 2010 Jun;27(6):495-506 [20533366.001]
  • [Cites] Behav Res Ther. 2007 Jul;45(7):1683-91 [17067548.001]
  • [Cites] Rev Bras Psiquiatr. 2008 Sep;30(3):185-96 [18833417.001]
  • [Cites] Clin Psychol Psychother. 2010 Mar-Apr;17(2):110-21 [19701960.001]
  • [Cites] Br J Psychiatry. 2007 Jan;190:77-8 [17197661.001]
  • [Cites] J Affect Disord. 2004 Apr;79(1-3):241-6 [15023501.001]
  • [Cites] N Engl J Med. 2014 Aug 14;371(7):646-53 [25119610.001]
  • [Cites] J Clin Psychiatry. 2006 May;67(5):703-11 [16841619.001]
  • [Cites] Am J Psychiatry. 2001 Nov;158(11):1899-903 [11691698.001]
  • [Cites] Soc Psychiatry Psychiatr Epidemiol. 2004 Mar;39(3):212-7 [14999454.001]
  • [Cites] J Clin Psychiatry. 2005 Apr;66(4):428-35; quiz 546 [15816784.001]
  • [Cites] Depress Anxiety. 2008;25(12):1020-7 [18833578.001]
  • [Cites] Psychiatr Clin North Am. 2000 Sep;23(3):509-17 [10986724.001]
  • [Cites] BMC Psychiatry. 2005 Jan 13;5:2 [15649315.001]
  • [Cites] Int J Psychol. 2011 Apr 1;46(2):136-43 [22044185.001]
  • [Cites] J Anxiety Disord. 2009 Apr;23(3):401-6 [19108983.001]
  • [Cites] World J Biol Psychiatry. 2012 Apr;13(4):312-5 [21923568.001]
  • (PMID = 28457988.001).
  • [ISSN] 1872-7123
  • [Journal-full-title] Psychiatry research
  • [ISO-abbreviation] Psychiatry Res
  • [Language] eng
  • [Grant] United States / NIMH NIH HHS / MH / R01 MH060218
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Keywords] NOTNLM ; Clinical aspects / Cross-cultural psychiatry / Obsessive-compulsive disorder / Transcultural psychiatry
  •  go-up   go-down


63. Huic A, Jelic M, Kamenov Z: Essentialist Beliefs About Homosexuality Predict Positive and Negative Behavioral Intentions Toward Lesbian Women and Gay Men. J Homosex; 2017 Sep 21;:1-25

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A sample of 997 exclusively heterosexual adults participated in an online study set in Croatia, a country with high homophobia undergoing social change that threatens the higher status of the heterosexual majority.
  • Importantly, essentialist beliefs had both indirect (with attitudes as mediators) and direct effects on behavioral intentions speaking in favor of their robust role in explaining LG-related phenomena.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28934073.001).
  • [ISSN] 1540-3602
  • [Journal-full-title] Journal of homosexuality
  • [ISO-abbreviation] J Homosex
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Essentialist beliefs / attitudes toward LGs / homosexuality / negative behavior / positive behavior
  •  go-up   go-down


64. Huybrechts KF, Desai RJ, Park M, Gagne JJ, Najafzadeh M, Avorn J: The Potential Return on Public Investment in Detecting Adverse Drug Effects. Med Care; 2017 Jun;55(6):545-551
MedlinePlus Health Information. consumer health - Drug Reactions.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Many countries lack fully functional pharmacovigilance programs, and public budgets allocated to pharmacovigilance in industrialized countries remain low due to resource constraints and competing priorities.
  • RESULTS: We found that earlier drug withdrawal made possible by active safety surveillance would most likely have resulted in savings in direct medical costs of $773-$884 million for rofecoxib, $3-$10 million for cerivastatin, and $38-$63 million for troglitazone in the United States through the prevention of adverse events.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JAMA. 2004 Dec 1;292(21):2585-90 [15572716.001]
  • [Cites] Epidemiology. 2012 Mar;23(2):238-46 [22266893.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):417-26 [15269925.001]
  • [Cites] Am J Med. 2003 Mar;114(4):299-306 [12681458.001]
  • [Cites] N Engl J Med. 2011 Dec 8;365(23):2151-3 [22150034.001]
  • [Cites] Am J Health Syst Pharm. 2003 Mar 15;60(6):578-81 [12659062.001]
  • [Cites] N Engl J Med. 2005 Mar 17;352(11):1092-102 [15713943.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2016 Sep;25(9):1023-32 [27146123.001]
  • [Cites] J Manag Care Pharm. 2011 Sep;17(7):531-46 [21870894.001]
  • [Cites] Med Care. 2013 Aug;51(8 Suppl 3):S4-10 [23752258.001]
  • [Cites] JAMA. 2004 Dec 1;292(21):2622-31 [15572720.001]
  • [Cites] Lancet. 2004 Dec 4-10;364(9450):2021-9 [15582059.001]
  • [Cites] Lancet. 2001 Jun 9;357(9271):1870-5 [11410214.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2014 Jun;23(6):619-27 [24788694.001]
  • [Cites] JAMA. 1999 Apr 21;281(15):1381-6 [10217053.001]
  • [Cites] Drug Saf. 2010 Aug 1;33(8):689-703 [20635827.001]
  • [Cites] Curr Med Res Opin. 2008 Feb;24(2):461-8 [18194592.001]
  • [Cites] N Engl J Med. 2007 Nov 29;357(22):2219-21 [18046025.001]
  • [Cites] JAMA. 2017 Feb 14;317(6):581-582 [28056124.001]
  • [Cites] Am Heart J. 2012 Aug;164(2):186-93 [22877803.001]
  • [Cites] Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003685 [15674912.001]
  • [Cites] Arch Intern Med. 2005 Jan 24;165(2):158-60 [15668360.001]
  • [Cites] Am J Gastroenterol. 2003 Jan;98 (1):175-9 [12526954.001]
  • [Cites] N Engl J Med. 2012 Jul 19;367(3):193-7 [22808954.001]
  • [Cites] Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):762-72 [17457957.001]
  • [Cites] N Engl J Med. 2014 Jun 5;370(23):2165-7 [24897081.001]
  • (PMID = 28505041.001).
  • [ISSN] 1537-1948
  • [Journal-full-title] Medical care
  • [ISO-abbreviation] Med Care
  • [Language] eng
  • [Grant] United States / NIMH NIH HHS / MH / K01 MH099141
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


65. Xiao F, Pu J, Wen Q, Huang Q, Zhang Q, Huang B, Huang S, Lan A, Zhang Y, Li J, Zhao D, Shen J, Wu H, He Y, Li H, Yang X: Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. Oncotarget; 2017 Jul 18;8(29):48488-48506

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Cancer is the leading cause of death in economically developed countries and the second leading cause of death in developing countries.
  • We searched the PubMed, EMBASE, Science Direct, Web of Science, and CNKI databases for studies published from January 1, 2005 to January 1, 2016.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Neurobiol. 2016 May;53(4):2705-14 [26264164.001]
  • [Cites] Hum Genet. 2006 Jul;119(6):659-68 [16738949.001]
  • [Cites] Cancer Epidemiol. 2009 Oct;33(3-4):257-60 [19736055.001]
  • [Cites] Carcinogenesis. 2006 Sep;27(9):1835-41 [16571649.001]
  • [Cites] Anticancer Res. 2007 Jul-Aug;27(4C):2893-6 [17695467.001]
  • [Cites] Hum Mutat. 2005 Apr;25(4):353-9 [15776433.001]
  • [Cites] Gene. 2015 Oct 15;571(1):9-16 [26232607.001]
  • [Cites] Carcinogenesis. 2005 Jul;26(7):1263-71 [15746160.001]
  • [Cites] J Toxicol Environ Health A. 2008;71(13-14):887-97 [18569591.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1336-40 [16835333.001]
  • [Cites] Mol Biol Rep. 2012 Jan;39(1):709-14 [21553048.001]
  • [Cites] Tumour Biol. 2015 Sep;36(10):7569-79 [25916209.001]
  • [Cites] Urol Oncol. 2011 Nov-Dec;29(6):641-6 [19914098.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1614-9 [16985021.001]
  • [Cites] Cancer Causes Control. 2010 Feb;21(2):289-300 [19902366.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):258-65 [16492913.001]
  • [Cites] Tumour Biol. 2014 Apr;35(4):3905-15 [24347488.001]
  • [Cites] Gene. 2014 Aug 10;546(2):156-61 [24933002.001]
  • [Cites] Tumour Biol. 2014 Jun;35(6):5245-57 [24504678.001]
  • [Cites] World J Gastroenterol. 2014 Nov 28;20(44):16765-73 [25469049.001]
  • [Cites] Carcinogenesis. 2009 May;30(5):785-92 [19270000.001]
  • [Cites] Mutat Res. 2007 Jun 1;619(1-2):68-80 [17363013.001]
  • [Cites] Breast Cancer Res Treat. 2010 Aug;123(1):203-12 [20111903.001]
  • [Cites] BMC Cancer. 2007 Aug 16;7:162 [17705814.001]
  • [Cites] Biol Res. 2013;46(2):161-7 [23959014.001]
  • [Cites] Int J Mol Epidemiol Genet. 2012;3(1):1-17 [22493747.001]
  • [Cites] Breast Cancer Res Treat. 2006 Jul;98(2):209-15 [16685590.001]
  • [Cites] Cancer Epidemiol. 2011 Apr;35(2):170-4 [20863780.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Oct;16(10 ):2033-41 [17932351.001]
  • [Cites] Cancer Genet Cytogenet. 2007 May;175(1):47-51 [17498557.001]
  • [Cites] Curr Med Chem. 2013;20(10):1225-31 [23432583.001]
  • [Cites] Tumour Biol. 2014 Nov;35(11):11243-59 [25113251.001]
  • [Cites] Carcinogenesis. 2009 Mar;30(3):472-9 [19029193.001]
  • [Cites] Clin Cancer Res. 2007 Jun 15;13(12):3753-8 [17575242.001]
  • [Cites] Carcinogenesis. 2007 Jun;28(6):1254-8 [17264068.001]
  • [Cites] Carcinogenesis. 2006 May;27(5):997-1007 [16308313.001]
  • [Cites] Prostate. 2010 Feb 1;70(2):113-9 [19760636.001]
  • [Cites] Lung Cancer. 2011 Aug;73(2):138-46 [21195504.001]
  • [Cites] World J Gastroenterol. 2015 Jul 14;21(26):7988-8003 [26185370.001]
  • [Cites] Int J Hematol. 2013 Dec;98(6):681-6 [24258710.001]
  • [Cites] Oncotarget. 2016 Nov 8;7(45):73935-73944 [27738340.001]
  • [Cites] Mutat Res. 2007 Jul 28;631(2):101-10 [17531525.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(18):7713-8 [25292051.001]
  • [Cites] Anticancer Res. 2009 Oct;29(10):3903-7 [19846926.001]
  • [Cites] Genet Mol Res. 2014 May 16;13(2):3812-8 [24938468.001]
  • [Cites] Medicine (Baltimore). 2016 Mar;95(10 ):e2927 [26962789.001]
  • [Cites] Cell. 2011 Mar 4;144(5):646-74 [21376230.001]
  • [Cites] Am J Epidemiol. 2005 Jan 1;161(1):1-14 [15615908.001]
  • [Cites] PLoS Med. 2016 Apr 12;13(4):e1001992 [27071029.001]
  • [Cites] Pediatr Hematol Oncol. 2009 Sep;26(6):467-72 [19657998.001]
  • [Cites] Tumour Biol. 2014 Mar;35(3):1907-15 [24101192.001]
  • [Cites] Clin Chim Acta. 2005 Sep;359(1-2):150-5 [16002061.001]
  • [Cites] Clin Chem Lab Med. 2007;45(7):822-8 [17617021.001]
  • [Cites] Gene. 2013 Nov 10;530(2):309-14 [23973729.001]
  • [Cites] Reprod Biomed Online. 2016 Jul;33(1):39-49 [27157932.001]
  • [Cites] Int J Cancer. 2008 Nov 1;123(9):2095-104 [18709642.001]
  • [Cites] Oncol Lett. 2015 Apr;9(4):1657-1661 [25789018.001]
  • [Cites] Int J Clin Exp Med. 2015 Nov 15;8(11):20236-44 [26884936.001]
  • [Cites] DNA Cell Biol. 2010 Apr;29(4):183-90 [20070155.001]
  • [Cites] BMJ. 2003 Sep 6;327(7414):557-60 [12958120.001]
  • [Cites] Int J Cancer. 2005 Sep 20;116(5):768-73 [15849729.001]
  • [Cites] Lung Cancer. 2008 Feb;59(2):171-9 [17913280.001]
  • [Cites] Carcinogenesis. 2006 May;27(5):1030-7 [16311243.001]
  • [Cites] Chin J Cancer. 2015 Mar 05;34(3):108-14 [25962431.001]
  • [Cites] Mol Biol Rep. 2010 Jan;37(1):301-9 [19669592.001]
  • [Cites] Breast Cancer Res Treat. 2007 Jan;101(1):65-71 [16823510.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2569-78 [16284380.001]
  • [Cites] Carcinogenesis. 2006 Mar;27(3):610-8 [16258177.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2526-32 [17164380.001]
  • [Cites] JAMA. 2006 Feb 8;295(6):676-80 [16467236.001]
  • [Cites] Breast Cancer Res Treat. 2010 Jan;119(1):201-11 [19360465.001]
  • [Cites] Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):97-100 [18315909.001]
  • [Cites] Clin Exp Otorhinolaryngol. 2010 Mar;3(1):42-7 [20379402.001]
  • [Cites] Indian J Hum Genet. 2012 Jan;18(1):47-55 [22754221.001]
  • [Cites] Oncotarget. 2016 Nov 15;7(46):76021-76035 [27738347.001]
  • [Cites] Anticancer Res. 2008 May-Jun;28(3B):1853-6 [18630471.001]
  • [Cites] Oral Oncol. 2010 Oct;46(10):761-6 [20850372.001]
  • [Cites] Oncotarget. 2017 Feb 7;8(6):9806-9822 [28039461.001]
  • [Cites] Carcinogenesis. 2006 Jul;27(7):1377-85 [16399771.001]
  • [Cites] Carcinogenesis. 2006 Mar;27(3):560-7 [16195237.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1828-31 [16030124.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):878-84 [15824159.001]
  • [Cites] Urology. 2009 Mar;73(3):675-80 [19041121.001]
  • [Cites] CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29 [25559415.001]
  • [Cites] Tumour Biol. 2014 Apr;35(4):2959-65 [24234258.001]
  • [Cites] Ai Zheng. 2009 Nov;28(11):1163-7 [19895736.001]
  • [Cites] Mol Vis. 2011 Jan 12;17:127-33 [21245954.001]
  • [Cites] Exp Mol Med. 2005 Apr 30;37(2):86-90 [15886521.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2005 Jun;14(6):1539-44 [15941969.001]
  • [Cites] Asian Pac J Cancer Prev. 2013;14(1):231-6 [23534729.001]
  • [Cites] Oncol Lett. 2012 Aug;4(2):247-251 [22844363.001]
  • [Cites] Am J Hum Genet. 2006 Mar;78(3):464-79 [16465622.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):536-42 [16537713.001]
  • [Cites] Tumour Biol. 2015 Nov;36(11):8953-72 [26081619.001]
  • [Cites] Int J Cancer. 2007 May 15;120(10):2148-56 [17290401.001]
  • [Cites] Chin J Physiol. 2010 Apr 30;53(2):130-5 [21793320.001]
  • [Cites] Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2101-8 [16609022.001]
  • [Cites] Exp Mol Pathol. 2011 Aug;91(1):331-4 [21419115.001]
  • [Cites] DNA Repair (Amst). 2005 Sep 28;4(10):1068-74 [16054878.001]
  • [Cites] Breast Cancer Res Treat. 2010 Aug;123(1):227-31 [20127278.001]
  • [Cites] Carcinogenesis. 2007 Aug;28(8):1697-702 [17470448.001]
  • [Cites] Asian Pac J Cancer Prev. 2014;15(16):6619-25 [25169498.001]
  • [Cites] PLoS One. 2012;7(4):e35220 [22536360.001]
  • [Cites] Carcinogenesis. 2008 Nov;29(11):2132-8 [18701435.001]
  • [Cites] Reprod Biomed Online. 2008 Jul;17(1):36-41 [18616887.001]
  • [Cites] Mol Biol Rep. 2012 Feb;39(2):1895-901 [21643959.001]
  • [Cites] Oncotarget. 2016 Nov 29;7(48):79901-79913 [27821804.001]
  • [Cites] Mol Cancer. 2008 May 02;7:36 [18454848.001]
  • [Cites] Mol Biol Rep. 2012 Jan;39(1):57-69 [21614524.001]
  • [Cites] Sci Rep. 2014 Feb 17;4:4112 [24531312.001]
  • [Cites] J Cancer. 2016 Jan 01;7(2):144-52 [26819637.001]
  • [Cites] Biomarkers. 2014 Sep;19(6):509-16 [25089939.001]
  • [Cites] Tumour Biol. 2013 Oct;34(5):2843-8 [23700156.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):306-11 [16492920.001]
  • [Cites] J Exp Clin Cancer Res. 2009 Dec 14;28:153 [20003391.001]
  • [Cites] Carcinogenesis. 2000 Apr;21(4):551-5 [10753184.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1633-8 [17684138.001]
  • [Cites] Sci Rep. 2014 Sep 11;4:6281 [25209371.001]
  • [Cites] Cancer Causes Control. 2008 Dec;19(10):1077-83 [18478337.001]
  • [Cites] J Appl Genet. 2010;51(3):343-52 [20720310.001]
  • [Cites] Medicine (Baltimore). 2015 Sep;94(39):e1593 [26426637.001]
  • [Cites] Int J Cancer. 2009 Sep 15;125(6):1431-9 [19444904.001]
  • [Cites] Mol Biol Rep. 2011 Mar;38(3):1507-13 [20842450.001]
  • (PMID = 28489582.001).
  • [ISSN] 1949-2553
  • [Journal-full-title] Oncotarget
  • [ISO-abbreviation] Oncotarget
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Keywords] NOTNLM ; ERCC2 Asp312Asn / cancer / meta-analysis / polymorphism / trial sequence analysis
  •  go-up   go-down


66. Wang LE, Liu G, Liu X, Liu Y, Gao J, Zhou B, Gao S, Cheng S: The weight of unfinished plate: A survey based characterization of restaurant food waste in Chinese cities. Waste Manag; 2017 Aug;66:3-12
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The scales and patterns of consumer food waste, especially in developing countries, however, remain poorly understood, which may hinder the global effort of reducing food waste.
  • In this study, based on a direct weighing method and a survey of 3557 tables in 195 restaurants in four case cities, we investigated the amount and patterns of restaurant food waste in China in 2015.
  • This equals to approximately 11kg/cap/year and is not far from that of western countries, although per capita GDP of China is still much lower.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28438432.001).
  • [ISSN] 1879-2456
  • [Journal-full-title] Waste management (New York, N.Y.)
  • [ISO-abbreviation] Waste Manag
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Chinese cities / Consumer behavior / Food waste / Plate waste / Restaurant
  •  go-up   go-down


67. Kim H, Ryu DR: A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival. Kidney Res Clin Pract; 2017 Mar;36(1):22-28

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Peritoneal dialysis (PD) is an established treatment for ESRD patients worldwide; it has a variety of advantages, including autonomy and flexibility, as well as economic benefits in many countries compared to hemodialysis (HD).
  • Although direct comparison of survival rate between the dialysis modalities by randomized controlled trials is difficult due to the ethical issues, it has always been a crucial point when deciding which dialysis modality should be recommended to patients.
  • Recently, in many countries, including the United States, Brazil, Spain, Australia, and New Zealand, the survival rate in PD patients has significantly improved.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nefrologia. 2014;34(1):18-33 [24463879.001]
  • [Cites] Nephrol Dial Transplant. 2012 Sep;27(9):3568-75 [22391139.001]
  • [Cites] Kidney Int. 2003 Sep;64(3):1071-9 [12911559.001]
  • [Cites] Am J Kidney Dis. 1999 Apr;33(4):617-32 [10196002.001]
  • [Cites] Semin Dial. 2006 Jan-Feb;19(1):32-40 [16423180.001]
  • [Cites] Arch Intern Med. 2011 Jan 24;171(2):110-8 [20876398.001]
  • [Cites] Medicine (Baltimore). 2012 May;91(3):144-51 [22525667.001]
  • [Cites] Adv Perit Dial. 1989;5:91-6 [2577437.001]
  • [Cites] Kidney Res Clin Pract. 2014 Mar;33(1):9-18 [26877945.001]
  • [Cites] Kidney Int. 2014 Nov;86(5):877-80 [25360491.001]
  • [Cites] Kidney Int. 2014 Nov;86(5):991-1000 [24805104.001]
  • [Cites] Perit Dial Int. 2007 Jul-Aug;27(4):432-40 [17602152.001]
  • [Cites] PLoS One. 2013 Dec 30;8(12):e84257 [24386357.001]
  • [Cites] Kidney Int Suppl. 2006 Nov;(103):S3-11 [17080109.001]
  • [Cites] Int J Cardiol. 2015 Nov 1;198:95-101 [26159246.001]
  • [Cites] Nephrol Dial Transplant. 2010 Aug;25(8):2737-44 [20189930.001]
  • [Cites] Curr Opin Nephrol Hypertens. 2015 May;24(3):276-83 [25774747.001]
  • [Cites] J Am Soc Nephrol. 2009 Jan;20(1):155-63 [19092128.001]
  • [Cites] Am J Kidney Dis. 2016 Mar;67(3 Suppl 1):Svii, S1-305 [26925525.001]
  • [Cites] Perit Dial Int. 2001;21 Suppl 3:S307-13 [11887842.001]
  • [Cites] J Am Soc Nephrol. 2003 Feb;14(2):415-24 [12538742.001]
  • [Cites] Perit Dial Int. 2014 Nov-Dec;34(7):714-23 [25185014.001]
  • [Cites] Am J Kidney Dis. 2015 Sep;66(3):489-98 [25958081.001]
  • [Cites] Nephrol Dial Transplant. 2011 Sep;26(9):2940-7 [21325351.001]
  • [Cites] JAMA. 1970 Sep 28;213(13):2268-9 [5468937.001]
  • [Cites] Perit Dial Int. 2005 Feb;25 Suppl 3:S84-7 [16048265.001]
  • [Cites] J Am Soc Nephrol. 2002 May;13(5):1279-87 [11961016.001]
  • [Cites] Nephrol Dial Transplant. 2002 Sep;17(9):1661-6 [12198220.001]
  • [Cites] BMC Nephrol. 2015 Apr 14;16:53 [25885318.001]
  • [Cites] Nephrol Dial Transplant. 2008 May;23(5):1475-8 [18303111.001]
  • [Cites] Nephron Clin Pract. 2005;99(3):c86-91 [15665551.001]
  • [Cites] Yonsei Med J. 2015 May;56(3):666-75 [25837171.001]
  • [Cites] Nephrol Dial Transplant. 2008 Dec;23(12):3972-6 [18577531.001]
  • [Cites] Nephrol Dial Transplant. 2016 Jan;31(1):120-8 [26311215.001]
  • [Cites] Contrib Nephrol. 2012;178:30-4 [22652712.001]
  • (PMID = 28428932.001).
  • [ISSN] 2211-9132
  • [Journal-full-title] Kidney research and clinical practice
  • [ISO-abbreviation] Kidney Res Clin Pract
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Korea (South)
  • [Keywords] NOTNLM ; Cardiovascular diseases / Hemodialysis / Mortality / Peritoneal dialysis
  •  go-up   go-down


68. Alexander M, Zagheni E, Barbieri M: A Flexible Bayesian Model for Estimating Subnational Mortality. Demography; 2017 Oct 10;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reliable subnational mortality estimates are essential in the study of health inequalities within a country.
  • Information on mortality rates are pooled across geographic space and are smoothed over time.
  • The model estimates have direct applications to the study of subregional health patterns and disparities.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29019084.001).
  • [ISSN] 1533-7790
  • [Journal-full-title] Demography
  • [ISO-abbreviation] Demography
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Bayesian hierarchical model / France / Mortality / Principal components / Subnational estimation
  •  go-up   go-down


69. Falade BA, Bauer MW: 'I have faith in science and in God': Common sense, cognitive polyphasia and attitudes to science in Nigeria. Public Underst Sci; 2017 Feb 01;:963662517690293

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nigeria is a large country with a complex diversity of religious, ethnic and cultural practices that condition the reception and elaboration of science in everyday life.
  • Scientific knowledge and religiosity have a direct bearing on expectations of progress and feeling of fear and worry about science; mythical image is independent of this.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28194998.001).
  • [ISSN] 1361-6609
  • [Journal-full-title] Public understanding of science (Bristol, England)
  • [ISO-abbreviation] Public Underst Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; attitudes / cognitive polyphasia / faith / interaction / religion / science / trust
  •  go-up   go-down


70. Huang CF, Yeh ML, Huang CI, Lin YJ, Tsai PC, Lin ZY, Chan SY, Chen SC, Yang HI, Huang JF, Lu SN, Dai CY, Jen CL, Yuan Y, L'Italien G, Wang LY, Lee MH, Yu ML, Chuang WL, Chen CJ: Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance. Oncotarget; 2017 Jul 04;8(27):43925-43933

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • These results may provide important information for decision-making regarding the prioritization of current direct antiviral agents in resource-limited countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Virol. 2013 Apr;56(4):293-8 [23246359.001]
  • [Cites] Hepatology. 2016 May;63(5):1506-16 [26773546.001]
  • [Cites] Clin Cancer Res. 2017 Apr 1;23 (7):1690-1697 [27733478.001]
  • [Cites] Sci Rep. 2015 Nov 25;5:17030 [26602024.001]
  • [Cites] Gut. 2014 Dec;63(12):1943-50 [24615378.001]
  • [Cites] Hepatology. 2014 Jan;59(1):109-20 [23908124.001]
  • [Cites] EBioMedicine. 2017 Feb;15:81-89 [27998720.001]
  • [Cites] Eur J Cancer Prev. 2015 Mar;24(2):89-99 [24809655.001]
  • [Cites] Gut. 2014 Aug;63(8):1325-32 [24162593.001]
  • [Cites] J Hepatol. 2010 Feb;52(2):160-6 [20034694.001]
  • [Cites] J Hepatol. 2012 Jan;56(1):34-40 [21703176.001]
  • [Cites] J Hepatol. 1991 Nov;13(3):372-4 [1808228.001]
  • [Cites] J Hepatol. 2014 Jul;61(1):67-74 [24613362.001]
  • [Cites] Hepatology. 2013 Jun;57(6):2135-42 [23322699.001]
  • [Cites] Hepatology. 2015 Sep;62(3):932-54 [26111063.001]
  • [Cites] J Hepatol. 2016 Aug;65(2):266-72 [27155531.001]
  • [Cites] Ann Intern Med. 2013 Mar 5;158(5 Pt 1):329-37 [23460056.001]
  • [Cites] J Clin Oncol. 2010 Oct 20;28(30):4587-93 [20855826.001]
  • [Cites] J Viral Hepat. 2014 Mar;21(3):153-62 [24438677.001]
  • [Cites] J Hepatol. 2014 Feb;60(2):253-9 [24096049.001]
  • [Cites] Gut. 2011 May;60(5):688-94 [21068131.001]
  • [Cites] Antivir Ther. 2006;11(8):985-94 [17302368.001]
  • [Cites] Hepatology. 2011 Jan;53(1):7-13 [21254157.001]
  • [Cites] Gut. 2014 Oct;63(10):1648-57 [24225939.001]
  • [Cites] Hepatology. 2015 Oct;62(4):1190-200 [26146815.001]
  • [Cites] Hepatology. 2013 Apr;57(4):1333-42 [23172780.001]
  • (PMID = 28159934.001).
  • [ISSN] 1949-2553
  • [Journal-full-title] Oncotarget
  • [ISO-abbreviation] Oncotarget
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; HCC / HCV / spontaneous clearance / treatment
  •  go-up   go-down


71. Lempp H, Abayneh S, Gurung D, Kola L, Abdulmalik J, Evans-Lacko S, Semrau M, Alem A, Thornicroft G, Hanlon C: Service user and caregiver involvement in mental health system strengthening in low- and middle-income countries: a cross-country qualitative study. Epidemiol Psychiatr Sci; 2017 Nov 08;:1-11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Service user and caregiver involvement in mental health system strengthening in low- and middle-income countries: a cross-country qualitative study.
  • AIMS: The aims of this paper are to: (i) explore the experiences of involvement of mental health service users, their caregivers, mental health centre heads and policy makers in mental health system strengthening in three low- and middle-income countries (LMICs) (Ethiopia, Nepal and Nigeria);.
  • METHODS: A cross-country qualitative study was conducted, interviewing 83 stakeholders of mental health services.
  • They reported very limited access to direct participation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29113598.001).
  • [ISSN] 2045-7960
  • [Journal-full-title] Epidemiology and psychiatric sciences
  • [ISO-abbreviation] Epidemiol Psychiatr Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Health system strengthening / low- and middle-income countries / mental health gap / mental health system / qualitative study / service user and caregiver involvement
  •  go-up   go-down


72. Cock MJW, Beseh PK, Buddie AG, Cafá G, Crozier J: Molecular methods to detect Spodoptera frugiperda in Ghana, and implications for monitoring the spread of invasive species in developing countries. Sci Rep; 2017 Jun 22;7(1):4103

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Molecular methods to detect Spodoptera frugiperda in Ghana, and implications for monitoring the spread of invasive species in developing countries.
  • We discuss possible routes of entry to Africa, of which the likeliest is adults and/or egg masses transported on direct commercial flights between the Americas and West Africa, followed by dispersal by adult flight within Africa.
  • As authenticated barcodes for vouchered specimens of more pests become available, this approach has the potential to become a valuable in-country tool to support national capability in rapid and reliable pest diagnosis and identification.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Mol Mar Biol Biotechnol. 1994 Oct;3(5):294-9 [7881515.001]
  • [Cites] PLoS One. 2017 Feb 6;12 (2):e0171743 [28166292.001]
  • [Cites] Genetica. 2015 Jun;143(3):305-16 [25694156.001]
  • [Cites] Proc Biol Sci. 2003 Feb 7;270(1512):313-21 [12614582.001]
  • [Cites] BMC Bioinformatics. 2004 Aug 19;5:113 [15318951.001]
  • [Cites] Genome. 2016 Sep;59(9):641-60 [27584861.001]
  • [Cites] Mol Biol Evol. 1993 May;10(3):512-26 [8336541.001]
  • [Cites] PLoS One. 2013 Jul 08;8(7):e66213 [23861743.001]
  • [Cites] Mol Biol Evol. 2013 Dec;30(12):2725-9 [24132122.001]
  • [Cites] Mol Phylogenet Evol. 2012 Dec;65(3):855-70 [22939903.001]
  • [Cites] Nucleic Acids Res. 2004 Mar 19;32(5):1792-7 [15034147.001]
  • [Cites] Mol Ecol Notes. 2007 May 1;7(3):355-364 [18784790.001]
  • [Cites] PLoS One. 2015 Apr 08;10(4):e0122407 [25853412.001]
  • [Cites] PLoS One. 2016 Oct 27;11(10 ):e0165632 [27788251.001]
  • [Cites] J Econ Entomol. 2012 Apr;105(2):573-82 [22606829.001]
  • [Cites] Bull World Health Organ. 1987;65(5):659-62 [3501345.001]
  • [Cites] Clin Microbiol Infect. 2003 Mar;9(3):172-85 [12667249.001]
  • [Cites] Nucleic Acids Res. 1994 Nov 11;22(22):4673-80 [7984417.001]
  • (PMID = 28642581.001).
  • [ISSN] 2045-2322
  • [Journal-full-title] Scientific reports
  • [ISO-abbreviation] Sci Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


73. Kennedy R, Wojcik S, Lazer D: Improving election prediction internationally. Science; 2017 02 03;355(6324):515-520

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study reports the results of a multiyear program to predict direct executive elections in a variety of countries from globally pooled data.
  • We developed prediction models by means of an election data set covering 86 countries and more than 500 elections, and a separate data set with extensive polling data from 146 election rounds.
  • Direct evidence for economic indicators as predictors of election outcomes is relatively weak.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017, American Association for the Advancement of Science.
  • (PMID = 28154078.001).
  • [ISSN] 1095-9203
  • [Journal-full-title] Science (New York, N.Y.)
  • [ISO-abbreviation] Science
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


74. de Vries R, Blane D, Netuveli G: Long-term exposure to income inequality: implications for physical functioning at older ages. Eur J Ageing; 2014 Mar;11(1):19-29

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The 'inequality hypothesis' proposes that higher levels of societal income inequality have a direct negative causal effect on health.
  • Data on individual health and covariates were drawn from three large, comparable surveys of older people, covering 16 countries: the English Longitudinal Study of Ageing, the Survey of Health and Retirement in Europe and the U.S.
  • The grip strength and lung function associations were partially explained by between-country differences in height, and in the latter case this factor may fully account for the apparent effect of inequality.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMJ. 2002 Jan 5;324(7328):23-5 [11777800.001]
  • [Cites] Health Serv Res. 2003 Feb;38(1 Pt 1):137-51 [12650385.001]
  • [Cites] Public Health. 2008 Mar;122(3):221-8 [17981309.001]
  • [Cites] BMJ. 1996 Apr 20;312(7037):999-1003 [8616393.001]
  • [Cites] Public Health. 2008 May;122(5):487-96 [18222508.001]
  • [Cites] J Epidemiol Community Health. 2004 May;58(5):374-80 [15082734.001]
  • [Cites] Am J Public Health. 2008 Dec;98(12):2187-90 [18923110.001]
  • [Cites] Am J Public Health. 2000 Dec;90(12):1892-7 [11111262.001]
  • [Cites] JAMA. 1999 Feb 10;281(6):558-60 [10022113.001]
  • [Cites] Soc Sci Med. 2008 May;66(9):1882-94; discussion 1903-8 [18308438.001]
  • [Cites] Milbank Q. 2004;82(1):5-99 [15016244.001]
  • [Cites] Soc Sci Med. 2010 Feb;70(4):496-7; discussion 498-500 [19945205.001]
  • [Cites] Health Econ. 2007 Feb;16(2):163-78 [16941555.001]
  • [Cites] BMJ. 2007 Oct 27;335(7625):873 [17954512.001]
  • [Cites] J Biosoc Sci. 1991 Jan;23(1):113-28 [1999442.001]
  • [Cites] Health Serv Res. 1999 Apr;34(1 Pt 2):215-27 [10199670.001]
  • [Cites] Health Place. 2009 Mar;15(1):198-203 [18514014.001]
  • [Cites] Soc Sci Med. 2006 Apr;62(7):1768-84 [16226363.001]
  • [Cites] BMJ. 2010 Sep 09;341:c4467 [20829298.001]
  • [Cites] Soc Sci Med. 2008 Apr;66(8):1719-32 [18280021.001]
  • [Cites] BMJ. 2009 Nov 10;339:b4471 [19903981.001]
  • (PMID = 28804311.001).
  • [ISSN] 1613-9372
  • [Journal-full-title] European journal of ageing
  • [ISO-abbreviation] Eur J Ageing
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Income inequality / Inequality hypothesis / Lag-times / Older people / Physical functioning
  •  go-up   go-down


75. Gómez-Galán M, Pérez-Alonso J, Callejón-Ferre ÁJ, López-Martínez J: Musculoskeletal disorders: OWAS review. Ind Health; 2017 Aug 08;55(4):314-337

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The objective of the present work is to review the literature on the applications of the OWAS method in the diverse sectors or fields of knowledge and countries from its publication to March 2017.
  • The use of OWAS method has been classified by categories of knowledge, by country and by year.
  • This method needs to be complemented with other indirect or direct methods.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Work. 2012;41 Suppl 1:5746-8 [22317673.001]
  • [Cites] Appl Ergon. 1993 Dec;24(6):405-12 [15676938.001]
  • [Cites] Appl Ergon. 2016 May;54:120-30 [26851471.001]
  • [Cites] Work. 2012;42(2):289-97 [22699196.001]
  • [Cites] Appl Ergon. 1999 Aug;30(4):311-8 [10416843.001]
  • [Cites] Coll Antropol. 2008 Mar;32(1):267-76 [18494213.001]
  • [Cites] Int J Occup Saf Ergon. 2007;13(1):3-14 [17362654.001]
  • [Cites] Appl Ergon. 1995 Apr;26(2):101-8 [15677006.001]
  • [Cites] Appl Ergon. 1995 Dec;26(6):411-5 [15677042.001]
  • [Cites] Appl Ergon. 1996 Jun;27(3):177-87 [15677058.001]
  • [Cites] J Occup Health. 2013;55(4):244-58 [23748207.001]
  • [Cites] Ergonomics. 1995 Feb;38(2):361-76 [7895739.001]
  • [Cites] Int J Occup Saf Ergon. 2017 Mar;23 (1):110-117 [27192477.001]
  • [Cites] Ergonomics. 1999 May;42(5):674-95 [10327891.001]
  • [Cites] Int J Occup Environ Health. 2016 Apr;22(2):151-8 [27362732.001]
  • [Cites] Appl Ergon. 2001 Oct;32(5):461-71 [11534791.001]
  • [Cites] Appl Ergon. 2008 Jan;39(1):57-69 [17512492.001]
  • [Cites] Int J Occup Saf Ergon. 2010;16(1):69-79 [20331920.001]
  • [Cites] Work. 2012;41 Suppl 1:5355-60 [22317549.001]
  • [Cites] Work. 2014;48(4):539-45 [24346265.001]
  • [Cites] Int J Occup Environ Health. 2014 Oct;20(4):333-9 [25224808.001]
  • [Cites] Ann Agric Environ Med. 2014;21(2):407-11 [24959799.001]
  • [Cites] Int J Occup Saf Ergon. 2013;19(2):245-50 [23759194.001]
  • [Cites] Appl Ergon. 1998 Aug;29(4):281-3 [9701543.001]
  • [Cites] Ergonomics. 2001 Dec 15;44(15):1341-67 [11936827.001]
  • [Cites] Scand J Rehabil Med. 1970;2(2):92-8 [5523831.001]
  • [Cites] Work. 2012;41 Suppl 1:1239-45 [22316889.001]
  • [Cites] Ergonomics. 1990 Feb;33(2):209-20 [2354698.001]
  • [Cites] Int J Occup Saf Ergon. 2011;17(4):423-32 [22152507.001]
  • [Cites] Appl Ergon. 2014 May;45(3):420-7 [23849897.001]
  • [Cites] Ergonomics. 1991 Sep;34(9):1197-213 [1743178.001]
  • [Cites] Int J Occup Saf Ergon. 2009;15(3):309-17 [19744372.001]
  • [Cites] Work. 2012;41 Suppl 1:5389-91 [22317560.001]
  • [Cites] Appl Ergon. 1996 Aug;27(4):281-4 [15677069.001]
  • [Cites] Int Arch Occup Environ Health. 1998 Jul;71(5):336-42 [9749972.001]
  • [Cites] Work. 2012;41 Suppl 1:453-61 [22316766.001]
  • [Cites] Appl Ergon. 2000 Apr;31(2):201-5 [10711982.001]
  • [Cites] Work. 2012;41 Suppl 1:5511-5 [22317599.001]
  • [Cites] Ergonomics. 2016 Nov;59(11):1487-1493 [26853262.001]
  • [Cites] Appl Ergon. 1993 Apr;24(2):91-9 [15676903.001]
  • [Cites] Int J Occup Saf Ergon. 2007;13(3):305-21 [17888239.001]
  • [Cites] Ergonomics. 1994 May;37(5):909-19 [8206059.001]
  • [Cites] Appl Ergon. 2003 Nov;34(6):571-9 [14559417.001]
  • [Cites] Med Pr. 2009;60(3):187-95 [19746886.001]
  • [Cites] Ann Occup Hyg. 1993 Dec;37(6):615-22 [8304682.001]
  • [Cites] Arch Phys Med Rehabil. 1997 Aug;78(8):860-6 [9344307.001]
  • [Cites] Ergonomics. 2009 Sep;52(9):1169-82 [19606368.001]
  • [Cites] Work. 2012;41 Suppl 1:401-5 [22316758.001]
  • [Cites] Work. 2012;41 Suppl 1:1821-7 [22316979.001]
  • [Cites] Int J Occup Med Environ Health. 2012 Jun;25(3):265-74 [22791592.001]
  • [Cites] Appl Ergon. 1997 Jun;28(3):213-9 [9414360.001]
  • [Cites] Ergonomics. 1993 Jul;36(7):807-31 [8339720.001]
  • [Cites] Appl Ergon. 1977 Dec;8(4):199-201 [15677243.001]
  • [Cites] Appl Ergon. 1991 Feb;22(1):43-8 [15676798.001]
  • [Cites] Appl Ergon. 2014 Jan;45(1):126-32 [23608710.001]
  • [Cites] Med Lav. 2013 Nov-Dec;104(6):440-7 [24640831.001]
  • [Cites] Appl Ergon. 1996 Jun;27(3):171-6 [15677057.001]
  • [Cites] Appl Ergon. 1987 Sep;18(3):233-7 [15676628.001]
  • [Cites] Ann Agric Environ Med. 2015;22(2):286-92 [26094525.001]
  • [Cites] Am Ind Hyg Assoc J. 1995 May;56(5):443-58 [7754975.001]
  • [Cites] Med Lav. 2009 Mar-Apr;100(2):142-50 [19382524.001]
  • [Cites] Appl Ergon. 1995 Jun;26(3):199-211 [15677019.001]
  • [Cites] Ind Health. 2007 Apr;45(2):268-78 [17485871.001]
  • [Cites] Ergonomics. 1998 Sep;41(9):1261-89 [9754031.001]
  • [Cites] Work. 2012;41 Suppl 1:5392-4 [22317561.001]
  • [Cites] Int Arch Occup Environ Health. 1992;63(6):423-8 [1544692.001]
  • [Cites] Med Pr. 2008;59(4):287-92 [19143220.001]
  • [Cites] Appl Ergon. 2014 Jul;45(4):976-85 [24370268.001]
  • [Cites] Appl Ergon. 1981 Mar;12(1):13-7 [15676393.001]
  • [Cites] J Occup Rehabil. 1996 Sep;6(3):191-200 [24234979.001]
  • [Cites] Work. 2011;38(3):301-6 [21447890.001]
  • [Cites] Appl Ergon. 1992 Aug;23(4):263-7 [15676874.001]
  • [Cites] Scand J Work Environ Health. 2010 Jan;36(1):3-24 [19953213.001]
  • (PMID = 28484144.001).
  • [ISSN] 1880-8026
  • [Journal-full-title] Industrial health
  • [ISO-abbreviation] Ind Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Keywords] NOTNLM ; Ergonomics / OWAS / Observation methods / Posture evaluation / Prevention
  •  go-up   go-down


76. Rachmi CN, Li M, Alison Baur L: Overweight and obesity in Indonesia: prevalence and risk factors-a literature review. Public Health; 2017 Jun;147:20-29
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: Overweight/obesity is a problem faced by both high- and low- and middle-income countries.
  • METHODS: We conducted a literature search for articles published in English (through Medline via OvidSP, Scopus, Global Health via OvidSP and Web of Science electronic databases) and Indonesian languages (several websites, direct contact with Indonesian public health researchers, practitioners and Ministry of Health staff) from earliest to March 2016.
  • Interventions at the household level and beyond are needed to successfully lower the prevalence of overweight/obesity in the country.

  • Genetic Alliance. consumer health - Obesity.
  • MedlinePlus Health Information. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 28404492.001).
  • [ISSN] 1476-5616
  • [Journal-full-title] Public health
  • [ISO-abbreviation] Public Health
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Adolescent / Adults / Children / Indonesia / Obesity / Prevalence
  •  go-up   go-down


77. Andrade A, Dominski FH, Coimbra DR: Scientific production on indoor air quality of environments used for physical exercise and sports practice: Bibliometric analysis. J Environ Manage; 2017 Jul 01;196:188-200

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The databases Scielo, Science Direct, Scopus, Lilacs, Medline via Pubmed, and SportDiscus were searched from their inception to March 2016.
  • Bibliometric analysis was performed for authors, institutions, countries, and collaborative networks, in relation to publication year, theme, citation network, funding agency, and analysis of titles and keywords of publications.
  • Country, area, and impact factor of the journals were analyzed.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28284941.001).
  • [ISSN] 1095-8630
  • [Journal-full-title] Journal of environmental management
  • [ISO-abbreviation] J. Environ. Manage.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Air pollutants / Air pollution / Bibliometric / Health / Indoor / Motor activity / Sports
  •  go-up   go-down


78. Plöthner M, Klora M, Rudolph D, Graf von der Schulenburg JM: Health-Related Genetic Direct-to-Consumer Tests in the German Setting: The Available Offer and the Potential Implications for a Solidarily Financed Health-Care System. Public Health Genomics; 2017 Jun 23;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Health-Related Genetic Direct-to-Consumer Tests in the German Setting: The Available Offer and the Potential Implications for a Solidarily Financed Health-Care System.
  • BACKGROUND: The global genetic direct-to-consumer (DTC) market will reach a volume of USD 230 billion in 2018.
  • In November 2016, we updated the information of the webpages in terms of country, language, types of health-related tests, additional offer of non-health-related DTC test, information about sensitivity and specificity, certification and accreditation, costs as well as reference to German Act on Genetic Testing.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 S. Karger AG, Basel.
  • (PMID = 28641282.001).
  • [ISSN] 1662-8063
  • [Journal-full-title] Public health genomics
  • [ISO-abbreviation] Public Health Genomics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Direct-to-consumer genetic testing / Germany / Health-care system / Health-related offer
  •  go-up   go-down


79. Bali S, Stewart KA, Pate MA: Long shadow of fear in an epidemic: fearonomic effects of Ebola on the private sector in Nigeria. BMJ Glob Health; 2016;1(3):e000111

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, in contrast to other Ebola-affected countries, Nigeria fared significantly better due to its swift containment of the disease.
  • This paper introduces and defines the term <i>fearonomic effect</i> as the direct and indirect economic effects of both misinformation as well as fear-induced aversion behaviour, exhibited by individuals, organisations or countries during an outbreak or an epidemic.
  • Themes were generated from the interviews on the direct and indirect impact of Ebola on the private sector; the impact of misinformation and fear-based aversion behaviour in the private sector.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] MMWR Morb Mortal Wkly Rep. 2014 Oct 3;63(39):867-72 [25275332.001]
  • [Cites] N Engl J Med. 2015 Jan 8;372(2):188-9 [25564905.001]
  • [Cites] Int J Qual Health Care. 2007 Dec;19(6):349-57 [17872937.001]
  • [Cites] BMJ. 2014 Oct 14;349:g6178 [25315514.001]
  • [Cites] Lancet. 2015 Nov 28;386(10009):2204-21 [26615326.001]
  • [Cites] Global Health. 2012 Jun 13;8:15 [22695277.001]
  • [Cites] PLoS Curr. 2015 Apr 08;7:null [25914860.001]
  • [Cites] S Afr Med J. 2015 Jun;105(6):431-2 [26716149.001]
  • [Cites] Soc Sci Med. 2006 Dec;63(12):3113-23 [16978751.001]
  • [Cites] Lancet. 2014 Dec 20;384(9961):2207 [25625391.001]
  • [Cites] Emerg Infect Dis. 2015 May;21(5):856-9 [25897646.001]
  • [Cites] J Med Ethics. 2015 Nov;41(11):917-9 [26091816.001]
  • [Cites] N Engl J Med. 2014 Oct 9;371(15):1458-9 [25237780.001]
  • [Cites] N Engl J Med. 2014 Dec 18;371(25):2348-9 [25372947.001]
  • [Cites] Am J Public Health. 2004 Apr;94(4):562-4 [15054005.001]
  • [Cites] Am J Bioeth. 2008 Aug;8(8):28-9 [18802855.001]
  • [Cites] Emerg Infect Dis. 2016 Mar;22(3):433-41 [26886846.001]
  • [Cites] BMJ. 2014 Dec 10;349:g7348 [25497512.001]
  • [Cites] PLoS One. 2016 Feb 24;11(2):e0150080 [26910462.001]
  • [Cites] Lancet. 2015 Jan 3;385(9962):29-35 [25458732.001]
  • [Cites] JAMA. 2004 May 26;291(20):2483-7 [15161900.001]
  • [Cites] Emerg Infect Dis. 2004 Feb;10(2):358-63 [15030713.001]
  • [Cites] Int Health. 2016 Jan;8(1):5-12 [26678568.001]
  • [Cites] J Infect Dis. 2016 May 1;213 Suppl 3:S140-6 [26908718.001]
  • (PMID = 28588965.001).
  • [ISSN] 2059-7908
  • [Journal-full-title] BMJ global health
  • [ISO-abbreviation] BMJ Glob Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


80. Stephens J, Kaura S, Botteman MF: Cost-effectiveness of zoledronic acid versus placebo in the management of skeletal metastases in lung cancer patients (LC pts): Comparison across three European countries. J Clin Oncol; 2009 May 20;27(15_suppl):8081

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cost-effectiveness of zoledronic acid versus placebo in the management of skeletal metastases in lung cancer patients (LC pts): Comparison across three European countries.
  • METHODS: Estimated direct costs and quality-adjusted life-years (QALYs) experienced by LC pts with bone metastases receiving placebo (PBO) or ZOL were modeled and compared.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 27962656.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


86. Taib BG, Rylands J, Povall S, Jones TM, Taylor-Robinson D: Protocol: systematic review of the association between socio-economic status and survival in adult head and neck cancer. Syst Rev; 2017 Aug 02;6(1):151

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The aim of this review is to investigate whether lower compared to higher socioeconomic status (SES) influences survival in head and neck squamous cell cancer (HNSCC) and explore possible explanations for any relationship found.
  • Online databases including MEDLINE, Web of Knowledge, ESBCO Host and Scopus will be used to locate observational studies of adults with a primary diagnosis of head and neck cancer in EU15+ countries (15 members of the EU, Australia, Canada, Norway, USA and New Zealand) where the outcomes report associations between SES and survival.
  • DISCUSSION: This review will quantify the association between SES and survival outcomes for adult head and neck cancer patients in developed countries.
  • The results will help identify gaps in the literature and therefore direct further novel research in the field.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 2015 Dec 5;386(10010):2257-74 [26382241.001]
  • [Cites] Cancer. 2007 Dec 1;110(11):2568-75 [17955501.001]
  • [Cites] Br J Cancer. 2008 Sep 23;99 Suppl 1:S38-9 [18813255.001]
  • [Cites] Int J Cancer. 1984 Nov 15;34(5):603-12 [6500740.001]
  • [Cites] Cancer Causes Control. 2005 Feb;16(1):5-14 [15750853.001]
  • [Cites] Syst Rev. 2015 Jan 01;4:1 [25554246.001]
  • [Cites] Head Neck. 2011 Aug;33(8):1092-8 [20967872.001]
  • [Cites] J Clin Oncol. 1997 Apr;15(4):1680-9 [9193369.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 May;95(5):570-5 [12738948.001]
  • [Cites] Oral Oncol. 2001 Sep;37(6):513-20 [11435178.001]
  • [Cites] Int J Cancer. 2014 Nov 15;135(10):2404-12 [24706381.001]
  • [Cites] Br J Cancer. 2007 Mar 12;96(5):818-20 [17339893.001]
  • [Cites] Int J Cancer. 2015 Mar 1;136(5):1125-39 [24996155.001]
  • [Cites] Br J Cancer. 2008 Sep 23;99 Suppl 1:S35-7 [18813254.001]
  • [Cites] Health Place. 2012 Jul;18(4):861-8 [22445028.001]
  • [Cites] Cancer. 2003 Oct 1;98(7):1497-503 [14508838.001]
  • [Cites] J Natl Cancer Inst. 2008 Dec 17;100(24):1763-70 [19066273.001]
  • [Cites] J Clin Oncol. 2014 Oct 20;32(30):3349-52 [25225434.001]
  • [Cites] CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 [21296855.001]
  • [Cites] J Otolaryngol Head Neck Surg. 2014 Jan 14;43:2 [24422754.001]
  • [Cites] BMJ. 2011 Oct 18;343:d5928 [22008217.001]
  • [Cites] Cancer Epidemiol. 2010 Dec;34(6):682-8 [20558124.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2006 May;18(4):283-92 [16703745.001]
  • [Cites] Cancer Causes Control. 2005 Feb;16(1):1-3 [15750852.001]
  • [Cites] Oncologist. 2010;15(9):994-1001 [20798198.001]
  • [Cites] BMC Med Res Methodol. 2008 Feb 25;8:8 [18298827.001]
  • (PMID = 28768525.001).
  • [ISSN] 2046-4053
  • [Journal-full-title] Systematic reviews
  • [ISO-abbreviation] Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Head and neck cancer / Meta-analysis / Socio-economic inequalities / Socio-economic status / Survival / Systematic review
  •  go-up   go-down


87. Juneja S, Gupta A, Moon S, Resch S: Projected savings through public health voluntary licences of HIV drugs negotiated by the Medicines Patent Pool (MPP). PLoS One; 2017;12(5):e0177770
MedlinePlus Health Information. consumer health - Over-the-Counter Medicines.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Medicines Patent Pool (MPP) was established in 2010 to ensure timely access to low-cost generic versions of patented antiretroviral (ARV) medicines in low- and middle-income countries (LMICs) through the negotiation of voluntary licences with patent holders.
  • In this study, we estimate the savings generated by licences negotiated by the MPP for ARV medicines to treat HIV/AIDS in LMICs for the period 2010-2028 and generate a cost-benefit ratio-based on people living with HIV (PLHIVs) in any new countries which gain access to an ARV due to MPP licences and the price differential between originator's tiered price and generics price, within the period where that ARV is patented.
  • We found that the direct savings generated by the MPP are estimated to be USD 2.3 billion (net present value) by 2028, representing an estimated cost-benefit ratio of 1:43, which means for every USD 1 spent on MPP, the global public health community saves USD 43.

  • Genetic Alliance. consumer health - HIV.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Global Health. 2010 May 25;6:9 [20500827.001]
  • [Cites] J Int AIDS Soc. 2011 Mar 27;14:15 [21439089.001]
  • [Cites] PLoS One. 2016 Oct 13;11(10 ):e0164619 [27736953.001]
  • [Cites] J Int AIDS Soc. 2010 Sep 14;13:35 [20840741.001]
  • [Cites] Global Health. 2011 Oct 12;7:39 [21992405.001]
  • (PMID = 28542239.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Retroviral Agents; 0 / Drugs, Generic; 0 / Nonprescription Drugs
  •  go-up   go-down


88. Oyero OG, Toyama M, Mitsuhiro N, Onifade AA, Hidaka A, Okamoto M, Baba M: SELECTIVE INHIBITION OF HEPATITIS C VIRUS REPLICATION BY ALPHA-ZAM, A &lt;i&gt;NIGELLA SATIVA&lt;/i&gt; SEED FORMULATION. Afr J Tradit Complement Altern Med; 2016;13(6):144-148
Genetic Alliance. consumer health - Hepatitis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Hepatitis C virus (HCV) infection became curable because of the development of direct acting antivirals (DAAs).
  • As a result, hepatitis C will continue to cause substantial morbidity, and mortality among chronically infected individuals in low and middle income countries.
  • Thus, urgent need exists for developing cheaper drugs available to hepatitis C patients in these countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Infect Dis. 2003 Jun 15;187(12):1951-8 [12792872.001]
  • [Cites] EXCLI J. 2013 Nov 11;12:943-55 [27298610.001]
  • [Cites] Biochem Biophys Res Commun. 2011 Dec 2;415(4):714-9 [22085716.001]
  • [Cites] World J Gastroenterol. 2013 Apr 28;19(16):2529-36 [23674855.001]
  • [Cites] Phytother Res. 2000 Aug;14 (5):323-8 [10925395.001]
  • [Cites] Pharmacol Res. 2000 Mar;41(3):283-9 [10675279.001]
  • [Cites] Hepatology. 2013 Jun;57(6):2164-70 [23280550.001]
  • [Cites] Lancet Infect Dis. 2002 May;2(5):293-302 [12062995.001]
  • [Cites] Phytother Res. 2003 Apr;17(4):299-305 [12722128.001]
  • [Cites] World J Gastroenterol. 2008 Sep 7;14(33):5204-9 [18777598.001]
  • [Cites] J Clin Pharmacol. 2004 Jan;44(1):20-9 [14681338.001]
  • [Cites] Neurochem Res. 2008 Jan;33(1):87-96 [17713854.001]
  • [Cites] J Vet Med A Physiol Pathol Clin Med. 2001 Dec;48(10):593-9 [11848252.001]
  • [Cites] Phytother Res. 2007 Sep;21(9):895-7 [17562570.001]
  • [Cites] Demography. 2010 Aug;47(3):555-78 [20879677.001]
  • [Cites] J Ethnopharmacol. 2002 Jan;79(1):1-11 [11744288.001]
  • [Cites] J Virol. 2005 Nov;79(21):13778-93 [16227297.001]
  • [Cites] J Hepatol. 2006 Oct;45(4):529-38 [16879891.001]
  • [Cites] Phytother Res. 2009 May;23(5):696-700 [19089849.001]
  • [Cites] Gastroenterology. 2004 Apr;126(4):1005-14 [15057740.001]
  • [Cites] Hepat Mon. 2010 Fall;10(4):258-69 [22312391.001]
  • [Cites] J Viral Hepat. 2007 Dec;14(12):821-9 [18070284.001]
  • [Cites] J Adv Pharm Technol Res. 2012 Oct;3(4):200-1 [23378939.001]
  • [Cites] Hepatology. 2007 Nov;46(5):1350-6 [17680653.001]
  • [Cites] Hepatology. 2005 Jan;41(1):106-14 [15619235.001]
  • (PMID = 28480371.001).
  • [ISSN] 2505-0044
  • [Journal-full-title] African journal of traditional, complementary, and alternative medicines : AJTCAM
  • [ISO-abbreviation] Afr J Tradit Complement Altern Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  • [Chemical-registry-number] 0 / Antiviral Agents; 0 / Plant Preparations
  • [Keywords] NOTNLM ; Alpha-zam / Nigella sativa / antiviral assay / chronic hepatitis / hepatitis C virus
  •  go-up   go-down


89. Correia-da-Silva M, Sousa E, Pinto MMM, Kijjoa A: Anticancer and cancer preventive compounds from edible marine organisms. Semin Cancer Biol; 2017 Oct;46:55-64

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A direct impact of food on health, which demonstrates that dietary habit is one of the most important determinants of chronic diseases such as cancers, has led to an increased interest of the consumers toward natural bioactive compounds as functional ingredients or nutraceuticals.
  • Epidemiological studies revealed that the populations of many Asian countries with high consumption of fish and seafood have low prevalence of particular type of cancers such as lung, breast, colorectal and prostate cancers.
  • Interestingly, many of these marine organisms not only constitute as seafood delicacy but also as ingredients used in folk medicine of some East and Southeast Asian countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28392464.001).
  • [ISSN] 1096-3650
  • [Journal-full-title] Seminars in cancer biology
  • [ISO-abbreviation] Semin. Cancer Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Keywords] NOTNLM ; Antitumor / Cancer chemoprevention / Fish and fish protein hydrolysates / Mollusk / Sea cucumber / Seafood
  •  go-up   go-down


90. Liu Z, Beaver K, Speed S: Being healthy: A Grounded Theory study of help seeking behaviour among Chinese elders living in the UK. Int J Qual Stud Health Well-being; 2014 Jan;9(1):24820

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The health of older people is a priority in many countries as the world's population ages.
  • The UK, like other countries, has an increasingly aging Chinese population about who relatively little is known.
  • We also present data about how they direct their health-related activities towards meeting their physical and psychological goals of being healthy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28169659.001).
  • [ISSN] 1748-2631
  • [Journal-full-title] International journal of qualitative studies on health and well-being
  • [ISO-abbreviation] Int J Qual Stud Health Well-being
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; elderly Chinese / grounded theory / help seeking
  •  go-up   go-down


91. Dalu T, Wasserman RJ, Wu Q, Froneman WP, Weyl OLF: River sediment metal and nutrient variations along an urban-agriculture gradient in an arid austral landscape: implications for environmental health. Environ Sci Pollut Res Int; 2017 Nov 15;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Developing countries are yet to fully appreciate the direct impacts of pollution on aquatic ecosystems and as such, information on pollution dynamics is scant.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 29143261.001).
  • [ISSN] 1614-7499
  • [Journal-full-title] Environmental science and pollution research international
  • [ISO-abbreviation] Environ Sci Pollut Res Int
  • [Language] eng
  • [Grant] United States / National Research Foundation / / 88746; United States / National Research Foundation / / 77444; United States / Science and Technology Planning Project of Guangdong Province / / 2015A020215036, 2014B030301055
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Bloukrans River / Environmental health / Metals / Nutrients / Pollution / Sediment contaminant assessment
  •  go-up   go-down


92. Lu DY, Wu HY, Yarla NS, Lu TR, Xu B, -Ding J: Ebola Epidemics Control, Origin and Therapeutics. Infect Disord Drug Targets; 2017 Jul 03;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The direct communications between affected countries and rest of world were cut off then.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
  • (PMID = 28675995.001).
  • [ISSN] 2212-3989
  • [Journal-full-title] Infectious disorders drug targets
  • [ISO-abbreviation] Infect Disord Drug Targets
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United Arab Emirates
  • [Keywords] NOTNLM ; Ebola / Ebola transmission / antiviral drugs / disease complications / drug patents / human genomes / traditional Chinese medicine / virus origin
  •  go-up   go-down


93. Nzenze SA, Madhi SA, Shiri T, Klugman KP, de Gouveia L, Moore DP, Karstaedt AS, Tempia S, Nunes MC, von Gottberg A: Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization. Am J Epidemiol; 2017 Aug 15;186(4):435-444
HIV InSite. treatment guidelines - HIV InSite .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
  • The limited capability in most low- to middle-income countries to study the benefit of pneumococcal conjugate vaccine (PCV) in protecting against invasive pneumococcal disease (IPD) calls for alternate strategies to assess this.
  • We used a mathematical model to predict the direct and indirect effectiveness of PCV by analyzing serotype-specific colonization prevalence and IPD incidence prior to and following childhood PCV immunization in South Africa.

  • MedlinePlus Health Information. consumer health - Pneumococcal Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © The Author(s) 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
  • (PMID = 28482004.001).
  • [ISSN] 1476-6256
  • [Journal-full-title] American journal of epidemiology
  • [ISO-abbreviation] Am. J. Epidemiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / 13-valent pneumococcal vaccine; 0 / Heptavalent Pneumococcal Conjugate Vaccine; 0 / Pneumococcal Vaccines; 0 / Vaccines, Conjugate
  • [Keywords] NOTNLM ; HIV / invasive pneumococcal disease / mathematical model / pneumococcal carriage / pneumococcal conjugate vaccine
  •  go-up   go-down


94. Pipman Y: WE-H-201-03: Enthusiasm and Generosity of Spirit Necessitate a Volunteering Structure to Make Them More Meaningful. Med Phys; 2016 Jun;43(6):3839

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The desperate need for radiotherapy in low and mid-income countries (LMICs) has been well documented.
  • Wil Ngwa - A recent United Nations Study reports that in developing countries more people have access to cell phones than toilets.
  • Yakov Pipman - The number and scope of volunteer Medical Physics activities in support of low-to-middle income countries has been increasing gradually.
  • Perry Sprawls - With the growing capability and complexity of medical imaging methods in all countries of the world, the expanding role of medical physicists includes optimizing imaging procedures with respect to image quality, radiation dose, and other conflicting factors.
  • With access to appropriate educational resources local medical physicists in all countries can provide direct clinical support and educational for other medical professionals.
  • This is being supported through the process of Collaborative Teaching that combines the capabilities and experience of medical physicists in countries spanning the spectrum of economic, technological, and clinical development.
  • 2. Use collaborative teaching resources to enhance the role of medical physicists in all countries of the world.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2016 American Association of Physicists in Medicine.
  • (PMID = 28048404.001).
  • [ISSN] 2473-4209
  • [Journal-full-title] Medical physics
  • [ISO-abbreviation] Med Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Cancer / Learning / Medical image quality / Medical physicists / Physics education / Radiation therapy / Telephones
  •  go-up   go-down


95. Ngwa W: WE-H-201-02: Emerging Models and Opportunities in Global Health for Medical Physicists Powered by Information and Communication Technologies. Med Phys; 2016 Jun;43(6):3839

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • : The desperate need for radiotherapy in low and mid-income countries (LMICs) has been well documented.
  • Wil Ngwa - A recent United Nations Study reports that in developing countries more people have access to cell phones than toilets.
  • Yakov Pipman - The number and scope of volunteer Medical Physics activities in support of low-to-middle income countries has been increasing gradually.
  • Perry Sprawls - With the growing capability and complexity of medical imaging methods in all countries of the world, the expanding role of medical physicists includes optimizing imaging procedures with respect to image quality, radiation dose, and other conflicting factors.
  • With access to appropriate educational resources local medical physicists in all countries can provide direct clinical support and educational for other medical professionals.
  • This is being supported through the process of Collaborative Teaching that combines the capabilities and experience of medical physicists in countries spanning the spectrum of economic, technological, and clinical development.
  • 2. Use collaborative teaching resources to enhance the role of medical physicists in all countries of the world.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2016 American Association of Physicists in Medicine.
  • (PMID = 28046328.001).
  • [ISSN] 2473-4209
  • [Journal-full-title] Medical physics
  • [ISO-abbreviation] Med Phys
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Cancer / Information and communication theory / Learning / Medical image quality / Medical physicists / Radiation therapy / Telephones
  •  go-up   go-down


96. Forrester JA, Boyd NJ, Fitzgerald JEF, Wilson IH, Bekele A, Weiser TG: Impact of Surgical Lighting on Intraoperative Safety in Low-Resource Settings: A Cross-Sectional Survey of Surgical Providers. World J Surg; 2017 Dec;41(12):3055-3065

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: We received 100 complete responses, representing a range of surgical centres from 39 countries.
  • Eighty per cent reported the quality of their surgical lighting presents a patient safety risk with 18% having direct experience of poor-quality lighting leading to negative patient outcomes.
  • Only 9% of respondents regularly use a surgical headlight, with the most common barriers reported as unaffordability and poor in-country suppliers.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet Glob Health. 2015 Apr 27;3 Suppl 2:S13-20 [25926315.001]
  • [Cites] Health Policy Plan. 2012 May;27(3):234-44 [21441566.001]
  • [Cites] Bull World Health Organ. 2016 Mar 1;94(3):201-209F [26966331.001]
  • [Cites] Lancet. 2015 Aug 8;386(9993):569-624 [25924834.001]
  • [Cites] Ann R Coll Surg Engl. 2013 Jan;95(1):5-7 [23317709.001]
  • [Cites] Glob Health Sci Pract. 2013 Aug 14;1(2):249-61 [25276537.001]
  • [Cites] J Med Internet Res. 2004 Sep 29;6(3):e34 [15471760.001]
  • [Cites] Lancet. 2008 Jul 12;372(9633):139-44 [18582931.001]
  • [Cites] World J Surg. 2011 Aug;35(8):1770-80 [21562869.001]
  • [Cites] World J Surg. 2012 May;36(5):1056-65 [22402968.001]
  • [Cites] Lancet. 2015 May 30;385(9983):2209-19 [25662414.001]
  • [Cites] World Neurosurg. 2013 Nov;80(5):e91-4 [22381874.001]
  • [Cites] World J Surg. 2010 May;34(5):941-6 [20151131.001]
  • [Cites] Ethiop Med J. 2014 Jul;52(3):107-12 [25812283.001]
  • [Cites] World J Surg. 2011 Jun;35(6):1183-93 [21487845.001]
  • [Cites] Anesth Analg. 2010 Jun 1;110(6):1644-6 [20008912.001]
  • (PMID = 29051968.001).
  • [ISSN] 1432-2323
  • [Journal-full-title] World journal of surgery
  • [ISO-abbreviation] World J Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


97. Black E, Kisely S, Alichniewicz K, Toombs M: Mood and anxiety disorders in Australia and New Zealand's indigenous populations: A systematic review and meta-analysis. Psychiatry Res; 2017 Sep;255:128-138

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The Indigenous populations of Australia and New Zealand are considered at higher risk of mood and anxiety disorders but many studies do not include direct comparisons with similar non-Indigenous controls.
  • Overall, Indigenous people in both countries did not have significantly higher rates of disorder.
  • However, in terms of specific disorders, there were differences in risk by gender, country (Australia or NZ), disorder type, and prevalence (current, 12-month or lifetime).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier B.V.
  • (PMID = 28544944.001).
  • [ISSN] 1872-7123
  • [Journal-full-title] Psychiatry research
  • [ISO-abbreviation] Psychiatry Res
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  • [Keywords] NOTNLM ; Aboriginal and Torres Strait Islander peoples / Australia / Indigenous / Maori / New Zealand / Psychiatric disorders
  •  go-up   go-down


98. Otsuki N, Sakata M, Saito K, Okamoto K, Mori Y, Hanada K, Takeda M: Both sphingomyelin and cholesterol in the host cell membrane are essential for &lt;i&gt;Rubella virus&lt;/i&gt; entry. J Virol; 2017 Oct 25;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Compelling evidence for direct binding of RuV to lipid membranes at neutral pH was obtained using liposome co-flotation assays.
  • Ca<sup>2+</sup>-dependent binding observed in lymphoid cells occurs by the direct interaction between E1 protein fusion loops and SM/Chol-enriched membranes.
  • Despite effective rubella vaccines being available, rubella outbreaks still occur in many countries.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 American Society for Microbiology.
  • (PMID = 29070689.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


99. Bhurgri H, Samiullah S: Colon Cancer Screening - Is It Time Yet? J Coll Physicians Surg Pak; 2017 Jun;27(6):327-328
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Studies have shown that screening for colorectal cancer provided 152 to 313 life-years-gained (LYG) per 1000 forty-year-old individuals.3 Anumber of modalities exist for CRC screening, which can broadly be categorized into stool-based tests and direct visualization tests.
  • Direct visualization tests include endoscopic procedures such as colonoscopy and flexible sigmoidoscopy; and radiographic tests such as CT colonography, which has largely replaced air contrast barium enemas.4 The only reported population-based data for CRC in Pakistan comes from Bhurgri et al. in 2011.5It described Pakistan as a low risk region with an age standardized incidence rate (ASR) world per 100,000 of 7.1 in males and 5.2 in females, but with a much younger age and advanced stage at diagnosis.
  • It ranks 7th in incidence among males, and 8th among females, with tobacco related malignancies topping the list.6 There has since been additional cross-sectional data from Pakistan echoing these findings of a younger age and advanced disease at presentation.7 Speaking from a public health perspective, Pakistan, while still battling communicable diseases, is now seeing an increasing incidence of non-communicable diseases population-based screening programs for CRC were not justified in most developing countries, citing low reported incidence and low resource health authorities; but that in limited regions with an ageing population and a shift to Western lifestyle, organized screening strategies needed to be developed.
  • In a resource poor, conservative country like Pakistan, with poor health literacy, there exist many barriers to CRC screening which were summed up very articulately by Ahmed F in 2013.
  • There is also no centralized cancer registry to effectively unify and coordinate data from across the country.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28689518.001).
  • [ISSN] 1681-7168
  • [Journal-full-title] Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
  • [ISO-abbreviation] J Coll Physicians Surg Pak
  • [Language] eng
  • [Publication-type] Editorial
  • [Publication-country] Pakistan
  •  go-up   go-down


100. Abraham OJ, Miguel TS, Inocencio HC, Blondy CC: A quick and effective in-house method of DNA purification from agarose gel, suitable for sequencing. 3 Biotech; 2017 Jul;7(3):180

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Genetic population and other studies require the analyses of many samples, and therefore, the high cost represents an obstacle for carrying out such projects in countries where there is great biodiversity, such as the tropical and subtropical developing countries, where funds are limited.
  • Modifying an already known method for DNA recovery from gel, the first in-house protocol of DNA recovery suitable for direct use in sequencing is presented herein.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nucleic Acids Symp Ser. 1999;(42):101-2 [10780399.001]
  • [Cites] Bioinformatics. 2012 Apr 15;28(8):1166-7 [22368248.001]
  • [Cites] Bioinformatics. 2012 Jun 15;28(12):1647-9 [22543367.001]
  • [Cites] J Cell Commun Signal. 2008 Jun;2(1-2):25-45 [18766469.001]
  • [Cites] Anal Biochem. 1993 Jan;208(1):209-11 [8434790.001]
  • [Cites] Anal Biochem. 1997 Mar 15;246(2):260-2 [9073365.001]
  • [Cites] Curr Genet. 1992 Jul;22(1):83-4 [1611671.001]
  • [Cites] Anal Biochem. 2000 Dec 1;287(1):167-75 [11078596.001]
  • [Cites] PLoS One. 2009 Nov 18;4(11):e7750 [19924285.001]
  • [Cites] J Cancer. 2012;3:93-5 [22359530.001]
  • [Cites] Biotechniques. 1993 Dec;15(6):976-8 [8292349.001]
  • [Cites] Mycologia. 2013 Mar-Apr;105(2):285-96 [22962348.001]
  • [Cites] Anal Biochem. 2002 Mar 1;302(1):1-9 [11846370.001]
  • [Cites] Anal Biochem. 2001 Sep 15;296(2):162-6 [11554710.001]
  • (PMID = 28664367.001).
  • [ISSN] 2190-572X
  • [Journal-full-title] 3 Biotech
  • [ISO-abbreviation] 3 Biotech
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; DNA for sequencing / DNA purification from gel / Home-spin columns / Low cost method
  •  go-up   go-down






Advertisement